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Abstract 
Background: Plant UDP-dependent glycosyltransferases (UGTs) play important roles 
in biology via the glycosylation of secondary metabolites. The future prospects of 
UGTs look promising, for example, it may serve as promising path for progress in 
expanding drug targets and synthesising glycan-based drug with enhanced bioactivity. 
Nevertheless, the current poor understanding of UGTs at molecular level (e.g. kinetic 
and structure) has led to a limited understanding of their biological roles and has also 
hampered their potential applications.  
Aims: This project aims to 1) build up a mass spectrometry (MS) based approach to 
study families of UGTs including their substrate specificities, kinetic parameters and 
mechanisms of action (Chapter 3); 2) identify catalytic key amino acids (ckAAs) in 
the various UGTs (Chapter 4); and finally, 3) apply the methods above in the study of 
selected Rhamnosyltransferases (RhaTs) 78D1 and 89C1 (Chapter 5).   
Methodology: A triple quadrupole MS (QQQ-MS) was used as this instrument 
required limited modification of substrates and provided direct monitoring of the 
glycosylated product. ‘Full scan mode’ gave the initial screening of any potential 
glycosylated product, and the ‘product ion’ mode provided additional confirmation of 
the formation of the glycosylated product. The ‘multiple reaction monitoring (MRM)’ 
mode quantified the products formation as a function of reaction time and provided 
kinetic data of the UGTs (Chapter 3).  
The study of catalytic key amino acids (ckAAs) was based on the multiple sequence 
alignment (MSA) method via the AA sequence comparison with template UGTs that 
have known crystal structures. Subsequent site-directed mutagenesis (SDM) was used 
to substantiate/disprove the functional role of potential ckAAs: mutants (with potential 
ckAAs mutated) were checked by MS to find out whether the original activities were 
maintained and/or new activities were gained. A further activity comparison (kcat/KM) 
between the active mutant and the wild type (WT) could indicate the influence from a 
particular AA (Chapter 4). 
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Results and conclusions: 29 recombinant UGTs from groups B, D, F, H and L were 
examined. New donor activities (e.g. UDP-GlcNAc towards 73B4 and 78D2) were 
reported. Full kinetic studies of these WT UGTs indicated that they followed the Bi-
Bi sequential mechanism. Whilst most followed the Bi-Bi random sequential 
mechanism, exceptions could be found such as that for 73B4 facilitating the UDP-
GlcNAc reaction (Chapter 3). 
Based on the interactions between the donor and template UGT (e.g. VvGT1, PDB 
2C1Z), mutations of the potential ckAAs oriented towards the sugar (positions C2, C3, 
C4 and C6), phosphate and uridine were designed with alanine and an AA with a 
similar structural and chemical character. An activity comparison (kcat/KM) between 
the WT and active mutants indicated that most of the potential ckAAs within the PSPG 
motif inferred from MSA, were conserved and possibly followed a similar interaction 
pattern. However, exceptions could be found (e.g. 78D2 D380). Taking the results of 
both MSA and SDM together, the ckAAs in the active sites in each target UGT 
towards a specific donor were identified (Chapters 4 and 5).  
Additionally, the study of Rhamnosyltransferases (RhaT) 78D1 and 89C1 showed that 
new activities were acquired by point mutagenesis: 78D1 N375Q acquired UDP-Glc 
and UDP-GlcNAc activities; and 89C1 H357Q acquired UDP-Glc activity (Chapter 
5).
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Impact Statement 
It is almost redundant to state the significance of glycans in nature. Thus, the enzyme 
that is responsible for the synthesis of glycans, i.e. glycosyltransferases (GTs), attracts 
much attention. GTs are widely distributed in all kingdoms of life and play numerous 
biological roles in vivo (e.g. xenobiotic detoxification in human and defence in plant). 
They may be disease-associated. Additionally, GTs may provide alternative tool for 
the synthesis of glycan-based drugs. Thus, the understanding of GTs at the molecular 
level, through kinetic, catalytic mechanism and active site, is significant for the 
understanding of their biological roles and may further shed light on potential 
application such as drug discovery.  
This project contributed the understanding of GTs, using plant UDP-dependent GTs 
(UGTs).   
The study of characterisation of wild type UGTs will be helpful to understand the 
biological functions of UGTs. In addition, this research may shed light on glycan-
based drug discovery, as plant UGTs may serve as potential tools in chemo-enzymatic 
synthesis of glycans with pharmaceutical effects. 
The identification of catalytic key amino acids (ckAAs) of UGTs lay the foundation 
of enzyme catalytic mechanism and specificity of sugar donors and acceptors. It will 
further shed light on many applications, such as GT inhibitor and the genetic 
engineering of GTs. 
Although this project focused on plant UGTs, it will inform subsequent exploitation 
of other GTs (e.g. animal GTs) as they share similarities that possibly result from the 
process of evolution (e.g. arms race and co-evolution).
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Glycans are fundamental macromolecules on which all life depends. They participate 
in a vast array of biological processes, are prevalent on the cell surface (e.g. glycolipids 
and glycoproteins)1, modulate cell adhesion (e.g. attachment of glycans to polysialic 
acid to regulate cell adhesion in neural cells2), and are specifically recognised by 
glycan-binding proteins (e.g. during pathogen evasion)3. In 2012, a report4 from the 
US National Research Council suggested that the study of glycoscience is highly 
significant for the study of life science and may bring advancements in many fields, 
such as human health. 
As a significant toolkit for the development of glycoscience, glycosyltransferases 
(GTs) are involved in the biosynthesis of glycans by transferring sugars from a donor 
to an acceptor. The understanding of GTs at the molecular level, through kinetic, 
catalytic mechanism and active site, is significant for the understanding of their 
biological roles and may further shed light on potential application such as the 
synthesis of biologically relevant glycans.  
This chapter firstly describes the general principles of glycans, and then followed by 
a more detailed introduction of plant UGTs. Finally, the general scheme of this project 
is described. 
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1.1 General principles of glycans and importance of GTs 
Over the past decades, studies have shown that glycans functions pervade biology at 
all levels5 (e.g. the structural and modulatory properties6 and specific recognition6). 
More importantly, it has been shown that the aberrant glycosylation contributes to 
aberrant glycans, which underlines the aetiology of various diseases such as infectious 
diseases7, cancers8, diabetes9, and immune diseases10. These discoveries emphasise the 
need for studies of glycosylation, particularly of the GTs involved in diseases and 
those useful for practical applications (e.g. biomarkers11). 
This section briefly introduces important principles of glycans, including their 
prevalence, structural diversity, and biological functions, and the importance of GTs. 
1.1.1 Prevalence and structural diversity of glycans 
Glycans are ubiquitous in biology. No example of a living cell is not coated with a 
layer of glycans on their surfaces in 3 billion years of evolution (Figure 1.1A)4: 
glycolipids12 (Figure 1.1B) and glycoproteins13 (Figure 1.1B) are frequently present in 
the outer leaflet of the eukaryotic plasma membrane, with their carbohydrate portions 
exposed on the cell surface12. In addition, several types of glycans are found in 
cytoplasm14 [e.g. nucleocytoplasmic O-linked b-N-acetylglucosamine (O-GlcNAc), 
see in Figure 1.1B] and extracellular matrix15 (e.g. hyaluronic acid, see in Figure 1.1B). 
Glycans exhibit great structural diversity (Figure 1.1B). This feature mainly stems 
from 1) the linkage between monosaccharides, i.e. a monosaccharide may link to 
different groups of the other (e.g. the core of N-glycan); 2) anomeric state, i.e. a 
monosaccharide can attach to another residue through either a or b glycosidic linkage 
at anomeric centre (e.g. the core of N-glycan); 3) the monosaccharide composition 
[e.g. glucose (Glc) or galactose (Gal)]; 4) the aglycone part (e.g. protein or lipid).  
  Chapter 1 
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Figure 1.1: The prevalence and structure diversity of glycans. (A): Image of a red blood cell showing 
that a layer of glycans on the membrane surface16. (B): Some common classes of glycans in mammalian 
cells. Glycans can be found in various types of macromolecules with high level of structure diversity. 
1.1.2 Biological roles of glycans 
As fundamental molecules in nature, it is not surprising that glycans play a variety of 
biological roles. These biological roles range from being relatively subtle to crucial 
for the development, growth, functioning, or survival of organisms that synthesise 
them6. Given the enormous diversity of glycans, understanding all specific biological 
roles of glycans is therefore challenging and not yet evident. Three broad categories 
of glycan biological roles are recognised6: 1) the structural and modulatory properties 
of glycans; 2) the specific recognition of glycans; and 3) molecular mimicry of host 
glycans. There is a degree of overlap among these categories, such as the ‘structural 
property’ is required for the ‘specific recognition of glycans’ in some cases6. 
Glycans have a variety of biological effects based on their primary structural 
properties, and/or the modulating functions of the proteins and lipids to which they are 
attached6. For example, neural cell surface glycans can physically mask sites on 
proteins that are susceptible to cleavage by extracellular matrix proteases2. Neural cell 
surface glycans also act as modulators of cell adhesion2. For example, they can attach 
to the long chains of polysialic acid, which prevents the homophilic interactions with 
neural cell adhesion molecules on opposing cells.   
Another significant category of biological function is the specific recognition of 
glycans, which is accomplished by glycan-binding proteins (GBPs), including 
intrinsic GBPs (responsible for cell-cell interactions and glycan recognition by 
extracellular molecules and the same cell) and extrinsic GBPs (responsible for 
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recognition and communication with pathogenic microbial adhesins, agglutinins, or 
toxins)6 (Figure 1.2). As an extrinsic substance, a pathogen must specifically recognise 
and then evade the host cell. Before specific recognition, pathogens often decorate 
themselves with similar or identical glycan structures as those present on host cell 
surfaces3 as part of the molecular mimicry function of host glycans (the 3rd category 
of glycan biological function). Taken together, the pathogen can avoid the immune 
surveillance, recognise the host cells, and finally evade the immune system of the host. 
For example, Nontypeable Human influenza (NTHi) mimics the molecular signature 
of the host by incorporating sialic acid into the bacterial lipooligosaccharide17. Then, 
an NTHi protein (HMW1) interacts with sialylated lacto/neolactoglycolipids that 
located on the host cells to facilitate infection18.  
 
Figure 1.2: GBPs in recognising glycans6: intrinsic recognition between ‘self’ cells (left) and extrinsic 
recognition between ‘self’ cell and ‘M’ (right). Molecular mimicry of host glycans adds further 
complexity to potential roles. 
1.1.3 Glycosyltransferases 
Because of the importance of glycans, an increasing number of studies has been 
conducted to examine glycosyltransferases (GTs), as they determine the biosynthesis 
of glycans19 and play significant roles in vivo. For example, different blood group GTs 
can determine blood group by glycosylating H-antigen (the core precursor antigen that 
is present in blood group O)20, such as GTB transfers galactose (Gal) to the terminal 
of H-antigen and determines blood group B21. 
Recently, GTs have been recognized for their important roles in the aetiologies of 
many diseases15. Aberrant expression of GTs is associated with diseases such as 
cancer22. GnT-III is one of good exemplifications (Figure 1.3). It transfers GlcNAc to 
N-glycan via a 1,4-linkage and finally establishes a ‘bisecting GlcNAc’ structure. 
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The ‘bisecting GlcNAc’ is not or only minimally elongated23. GnT-III cannot be or is 
only minimally detected in the normal liver and hepatocytes, but is highly expressed 
in hepatoma cells24. In hepatoma cells, GnT-III reduces cancer growth and 
aggressiveness by increasing cell adhesion through functional modification of some 
cell adhesion molecules (e.g. E-cadherin)25, inhibiting some other GTs (e.g. GnT-V) 
that promote cell proliferation and growth26, and inhibiting a2,3-sialyation27. 
Interestingly, GnT-III does not always act as a tumour-suppressing factor, but 
enhances cancer progression on specific cancer types (e.g. spleen cancer)28 and 
specific environment around the tumour (e.g. diethylnitrosamine-induced liver cancer 
model)29. Recently, a study of Alzheimer’s disease has revealed a broadened role for 
GnT-III in disease30,31, of which GnT-III deficient mice showed less amyloid- 
formation in the brain and improved short-term memory.  
 
Figure 1.3: The role of GnT-III in normal cells (not expressed) and diseased cells (highly expressed). 
GnT-III produces ‘bisecting GlcNAc’ structure, which is associated with tumour and Alzheimer. 
Therefore, the understanding of GTs in diseases will further contribute to explaining 
the mechanisms of disease, and more importantly, it enable the development practical 
applications such as early diagnosis32, glycan inhibitors and antagonists 33 and glycan-
function modulators34.  
 
So far, we have briefly introduced some general principles of glycans and emphasised 
the significance of GTs in biology. The following section will focus on some 
knowledge of GTs, more specifically, on plant UDP-dependent GTs (UGTs). The 
study of plant UGTs is not only helpful to understand their biological functions in 
planta (e.g. regulating the bioactivity of secondary metabolites, hormones, and 
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toxins35), but also benefits the understanding of other GTs (e.g. animal GTs) as they 
share similarities that possibly result from the process of evolution (e.g. arms race and 
co-evolution)36. In addition, plant UGTs are soluble and readily to obtain, hence, they 
may serve as potential tools for further applications, such as the synthesis of glycans37.   
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1.2 Plant UGTs 
As at November 2017, there are more than 370,000 known and putative GT genes. 
They have been classified into 105 distinct families [based on amino acid (AA) 
sequence homology] by the Carbohydrate Active enZYmes database (CAZy)38. 
Therein, family 1 contains the largest number of GT genes (more than 13,000).  
As mentioned above, the study of plant UGTs may serve as promising path for GT 
study and for further applications. The present section will introduce the current 
understanding of plant UGTs, from the aspects of their function, catalytic behaviour, 
and structure. Furthermore, we will briefly discuss the techniques that used in our 
project. 
1.2.1 Plant secondary metabolism and glycosylation therein 
Plant secondary metabolites (SMs) are a diverse group of organic compounds such as 
flavonoids, terpenes, phenolic compounds, and alkaloids. They play significant roles 
in plant survival process such as by providing herbivore and pathogen protection39,40, 
acting as endogenous regulators of plant growth41, and pollinator attractors40. For 
example, flavonoids are responsible for the petal pigments in different Papaver 
nudicaule cultivars, which is helpful for pollinator attraction42. 
In plants, SMs are frequently modified by glycosylation that catalysed by plant UGTs. 
Glycosylation can increase the solubility and mobility of these SMs. For example, 
glycosylated flavonoids are able to move from the endoplasmic reticulum to different 
cellular compartments and are secreted through the plasma membrane and the cell 
wall43. Furthermore, plant UGTs may be involved in plant defence mechanisms. For 
example, tobacco salicylic acid- and pathogen-inducible UGTs (TOGTs) can mediate 
glucosylation that enables scopoletin accumulation in cells with Tobacco mosaic virus 
lesions, enhancing oxidative stress and weakening anti-viral resistance44.  
In addition to their many important biological roles, glycosylated SMs may have 
pharmaceutical effects for human health. For example, the cornel iridoid glycoside 
(CIG) treatment improves memory deficits in fimbria-fornix transection rats, by 
modulating the expression of related proteins (e.g. increasing NGF and decreasing Cyt 
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c)45. However, obtaining glycosylated SMs can be challenging: their isolation from 
plants involves complex purification steps and is limited by the supply of plant 
materials37. Traditional chemical synthesis requires complicated reaction controls in 
order to produce glycans with proper regio- and stereo- chemistries46. Thus, studies on 
plant UGTs may suggest a potential approach to facilitate the synthesis of glycans47, 
such as UGT94F2 is an iridoid-specific GT, which may be a potential biocatalyst in 
the synthesis of iridoid glycosides48.  
1.2.2 Substrate specificity of plant UGTs 
The first question in UGT study is that a large number of UGTs’ functions, in vivo or 
in vitro, are still unknown. For example, in the model organism Arabidopsis thaliana 
(At), 119 UGT genes have been identified, and the overall organisation and 
evolutionary relationships among individual members can be illustrated by 
phylogenetic tree (Figure 1.4). However, more than half of them have not been 
assigned with a function. In the 29 UGTs that will be investigated in our project (the 
UGTs in dotted rectangles, Figure 1.4), less than half of them are function-known in 
literature (the UGTs in black dotted rectangles, Figure 1.4). 
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Figure 1.4: Unrooted phylogenetic tree (showing as rooted) of 119 At UGTs. Geneious software49 with 
the neighbour-joining method was used. The bar 9.0 at the bottom means the scale of tree view. The 
UGTs that will be studied in this project are highlighted in dotted rectangles: the activities of the ones 
with black dotted rectangles have been identified in previous research, while the activities of the ones 
with red dotted rectangles have not been identified in previous research. 
As literature shows, UGTs utilise UDP-dependent sugars. For example, UDP-glucose 
(UDP-Glc), UDP-galactose (UDP-Gal), UDP-rhamnose (UDP-Rha), and UDP-xylose 
(UDP-Xyl) can serve as donors for UGTs (Figure 1.5, left)50. Generally, UGTs show 
high selectivity for a specific donor. Although some UGTs have broad donor ranges, 
they often display a preference for a specific donor. For example, Vitis vinifera VvGT1 
exhibits activity towards a broad range of donors including UDP-Glc, dTDP-Glc, 
UDP-GlcNAc, UDP-Gal, UDP-mannose (UDP-Man), GDP-Glc, dTDP-Xyl, and 
UDP-Xyl. However, it shows a high donor preference towards UDP-Glc, with 
catalytic efficiency (kcat/KM) towards the other molecules of less than 6% of that 
  Chapter 1 
 24 
towards UDP-Glc (except for the catalytic efficiency with dTDP-Glc, which is 42% 
of that with UDP-Glc)35. Another example is UGT88A1, which uses UDP-Glc, UDP-
Gal, and UDP-glucuronic acid (acceptor: apigenin). The catalytic efficiency of UDP-
Gal and UDP-GA are only 3% and 2% compared to that of UDP-Glc, respectively51. 
Compared to donor, the available acceptor molecules are much more diverse 
(examples in Figure 1.5, right). Plant SMs are frequently used acceptors which include 
flavonoids52, terpenoids53, and many other low-molecular-weight substrates54-56. UGTs 
can attach a glycosyl moiety to groups containing O (-OH and -COOH)52, N (-NH2)57, 
S (-SH)58, and C (C-C in aromatic molecules)59 atoms. 
 
Figure 1.5: Examples of available sugars (left) and acceptors (right) of plant UGTs (the groups attaching 
sugar moiety are highlighted in green circle). 
Since enzymes from the same family frequently exhibit different substrate specificities, 
precise functional predictions solely based only on the AA sequence are not reliable 
or accurate60. The correlation between the degree of AA sequence identity and function 
is complex. The same substrate specificity may be observed in highly divergent UGTs, 
while different substrate specificity may be observed in highly homologous UGTs. 
For example, Dorotheanthus bellidiformis betanidin 6-O-glucosyltransferase (6-GT) 
has similar substrate specificity (betacyanin, anthocyanidins, and flavonols) as 
betanidin 5-O-glucosyltransferase (5-GT), although they only share 19% AA identity61 
(Figure 1.6, top). On the contrary, Streptomyces fradiae UrdGT1b and UrdGT1c share 
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91% AA sequence identity, however, UrdGT1b uses dNDP-D-olivose, while 
UrdGT1c uses dNDP-L-rhodinose62 (Figure 1.6, bottom). Thus, in order to 
characterise the substrate specificities of UGTs, experimental in vitro or in vivo assays 
are strongly required.  
 
Figure 1.6:  The correlation between the degree of AA sequence identity and function is complex: 6-
GT and 5-GT share low AA identity but using the same acceptors (top). UrdGT1b and UrdGT1c share 
high AA identity but using different donors (bottom). The green region is where two UGTs have the 
same AA. The red region is where two UGTs have different AA. The grey region is where the gap 
located. 
1.2.3 Kinetic study of UGTs 
Enzyme kinetics focuses on the rate of enzyme-catalysed reactions. The understanding 
of in vitro UGT kinetics is significant in shedding light on their catalytic process in 
vivo and their potential applications, such as synthesis of glycans63. 
Cleland (1963) has classified enzyme-catalysed reactions and designated them using 
the terms Uni, Bi, Ter, and Quad, according to the number of substrates and products 
involved64. The Uni-substrate enzyme kinetic model, a Michaelis-Menten model, 
provides a basis for complex enzyme kinetic models65. The Michaelis-Menten model 
explains the correlation between the reaction velocity and substrate concentration ([S]), 
and describes enzyme behaviour using kinetic parameters, such as KM and Vmax. KM has 
two meanings: 1) it is the concentration of substrate at which half of the active sites 
are occupied and reveals the [S] required for significant catalysis to occur; 2) it is an 
indication of the affinity between the substrate (S) and the enzyme (E) under the 
condition that the rate constant for ES → E + S >> rate constant for ES → E + P. Vmax 
reflects the turnover number of an enzyme, i.e. the amount of product formed in a unit 
  Chapter 1 
 26 
of time under the conditions in which the enzyme is fully saturated with the substrate. 
Because Vmax is concentration dependent, a derived kinetic parameter, kcat, expressed 
as Vmax divided by [E], is more commonly used.     
GT-catalysed reactions represent the Bi-Bi enzymatic catalysis system with two 
reactants and two products. The Bi-Bi enzyme kinetics can be further classified into 
different mechanisms, depending on whether an EAB complex (Figure 1.7) is formed 
during the catalytic process. Particularly, if substrate A binds E first and product P is 
released, and then substrate B binds E and product Q is released, this is classified as a 
ping-pong mechanism (also known as a non-sequential mechanism). This mechanism 
results in parallel lines in the reciprocal form of the Michaelis curves (Lineweaver-
Burk plots) (Figure 1.7, right). In contrast, if A and B bind E first and the products are 
then released, the mechanism is named as a sequential mechanism. This mechanism 
is distinguished as a group of intersecting lines in the reciprocal form of the Michaelis 
curves (Lineweaver-Burk plots) (Figure 1.7, left).   
 
Figure 1.7: Classification of Bi-Bi enzymatic catalysed reaction mechanisms. The formation of the EAB 
complex is the determinant to distinguish sequential or Ping-pong mechanisms. In the reciprocal forms 
of the Michaelis curves, sequential mechanism gives intersected lines, while Ping-pong mechanism 
gives parallel lines. 
Practically, these kinetic profiles can be obtained by using fixed concentrations of one 
substrate to produce a pseudo-Uni substrate condition; however, the utility of these 
data is limited and the data do not reflect the in vivo reality of the enzyme. To obtain 
a complete kinetic picture, full kinetic analysis using a series of fixed concentrations 
of one substrate and varying the concentrations of the other substrate is necessary. The 
deduction of equation of Bi-Bi mechanism is seen in Appendix. 
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1.2.3.1 MS based GT characterisation assays 
To evaluate GT-catalysed reactions, a broad range of assays have been developed to 
probe substrate specificity and kinetics. Thermodynamic or structural characteristics 
of the transient intermediate state of an enzyme during the reaction leads to a more 
direct and accurate kinetic understanding of the enzyme, however, the detection of 
intermediates is usually difficult because of their fleeting nature66. Thus, monitoring 
of product formation over time is the primary method used to test GT substrate 
specificity and GT kinetics67. 
There are many GT assays to monitor the reaction product, generally divided into label 
(e.g. fluorescence-based method68) and label-free methods. Label-free GT assays are 
attractive as the sample is relatively simple to prepare and can be used directly. In this 
research, we used the Agilent Triple Quadrupole LC/MS system to monitor the GT 
reaction, which uses LC to separate the products as traditional HPLC and uses MS to 
accurately quantify the product.     
MS is an analytical technique that gives the mass-to-charge ratio (m/z) of charged 
particles. A sample is transformed into ions via ionisation [e.g. electrospray ionisation 
(ESI)]. Subsequently, ions travel through an MS analyser (e.g. quadrupole) and are 
separated based on their m/z ratios. The ion signals can be quantified in the MS 
detector, and are represented as a spectrum of ion abundance (y-axis) vs. m/z (x-axis)69. 
A quadrupole is an MS analyser that consists of four rods with direct current (DC) and 
radio frequency (RF) voltages applied70. Ions with specific m/z values can pass through 
the quadrupole to reach the detector only when their corresponding fixed DC and RF 
are applied. Thus, a range of DC and RF voltage settings is used to scan the ions in a 
sample, while a fixed DC and RF voltage setting monitors specific ions in the MS. A 
triple quadrupole MS (Q1q2Q3) is composed of three quadrupoles. The arrangement of 
Q1q2Q3 allows for different analysis modes: full scan, product ion scan, precursor ion 
scan, neutral loss scan, and multiple reaction monitoring scan (MRM) modes (Table 
1.1)70. 
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Table 1.1: The arrangement of Q1q2Q3 in different modes 
 Q1 q2 Q3 
Full scan Scan CID off Scan 
Product ion scan Fixed CID on Scan 
Precursor scan Scan CID on Fixed 
Neutral loss scan Scan at m/z=mproduct CID on Scan at m/z=mproduct-mneutral molecule 
MRM scan Scan at m/z=mprecursor CID on Scan at m/z=mproduct 
To examine the GT substrate specificity, the ‘full scan’ mode is used for the initial 
screening to determine whether a potential glycosylated product is formed in the 
reaction containing the tested substrates and GT. Once the potential glycosylated 
product ion (with an appropriate MS modification, e.g. [M+H+]+ or [M-H+]- in positive-
ion or negative-ion modes, respectively) is detected in ‘full scan’ mode, a subsequent 
‘product ion’ mode is used to fragment the potential glycosylated product to confirm 
substrate utilisation by the enzyme by verifying aglycone ion formation after 
fragmentation. However, collision-induced dissociation (CID) in q2 may result in the 
heterolytic or homolytic cleavage of the glycosidic bond, resulting in 1 and/or 2 Da 
mass shifts. For example, previous studies have shown that flavonoid glycosides yield 
aglycone fragments with 1 and/or 2 Da mass shifts from the parental deprotonated 
molecules in the negative-ion mode (Figure 1.8)71.  
 
Figure 1.8: Proposed fragmentation pathway of KMP-3-O-Glc by homolytic and heterolytic cleavage. 
In addition to qualitative analysis of product formation, Q1q2Q3 can quantify the 
formation of glycosylated product thus to obtain GT kinetic data via the MRM mode. 
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The MRM mode functions as a double mass filter, with the collision energy applied 
in q2. For example, glycosylated product can be fragmented into aglycone in q2. To 
quantify glycosylated product, it would be first selected by Q1 and dissociated into 
aglycone in q2. Aglycone would then be selected for detection by Q3. Thus, the 
‘glycosylated product à aglycone’ transition can be monitored for the quantification 
of glycosylated product, which dramatically reduces the noise and increases selectivity 
of the method, as has been widely acknowledged72. Typically, the chance of an isobaric 
interference at the same exact mass as the fragmentation ion is remote. Compared to 
the ‘product ion’ mode, MRM allows quantification of the glycosylated product 
instead of qualitative analysis. This method has been widely used in previous GT 
studies. For example, the kinetic behaviour of PgUGT74AE2 were obtained by 
monitoring its ginsenoside products, such as Rh2 (transition at m/z 645.3 → 23.2) and 
F2 (transition at m/z 807.5 → 627.5), using the MRM mode73. The kinetics of 
UGT71C1 (transferring Glc to lariciresinol) were evaluated by monitoring the 
transition of the glycosylated product at m/z 521.1 (MW of lariciresinol glucoside) → 
359.2 (MW of aglycone fragment) in the MRM mode74. 
1.2.4 Crystal structures and active sites of plant UGTs 
In 1994, Vrielink research group unveiled the discovery of GT structure by reporting 
the first crystal structure of GT (bacteriophage T4-GlcT)75. To date, 28 crystal 
structures have been solved for GT1 family proteins: 19 are from bacteria, one from 
human, two from yeasts, and seven from plants. The solved crystal structures provide 
important information regarding GT structures and interactions with substrate.  
1.2.4.1 Structure of plant UGTs 
The crystal structures of seven plant UGTs have been solved (Table 1.2): Medicago 
truncatula (Mt) UGT 71G176, 85H277, and 78G178; Vitis vinifera VvGT135; Clitoria 
ternatea UGT 78K6 (Ct3GT-A)79,80; At UGT 72B181; and Oryza sativa Os7982. 
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Table 1.2: Plant UGTs with known crystal structure 
Plant UGT Function PDB In complex with 
UGT 71G176 Saponin biosynthesis 2ACV UDP 
2ACW UPG 
UGT 78G178 Flavonoid 3GlcT 3HBJ UDP 
3HBF UDP, MYC 
UGT 85H277 Flavonoid 3GlcT 2PQ6 - 
VvGT135 Anthocyanin 3GlcT 2C1X UDP 
2C1Z U2F, KMP 
2C9Z UDP, QUE 
UGT 78K6 (Ct3GT-A)79,80 Anthocyanin 3GlcT 3WC4 GOL, ACT 
UGT 72B181 O-GT/N-GT 4REL KMP, GOL, ACT 
4REM DLM, GOL 
4REN P5M, GOL 
2VCE U2F, TC7, EDO 
2VCH UDP, EDO 
2VG8 UDP, TRS, EDO 
Os7982 Flavonoid GlcT 5TMB UDP 
5TMD U2F, 7ED 
5TME UDP 
All solved plant UGTs adopt a GT-B fold that the two Rossmann-like domains (C- 
and N-terminal) face towards each other and are loose-associated (Figure 1.9, left)19. 
The C-terminal domain is usually structurally conserved and responsible for the 
nucleotide sugar-donor binding, while the N-terminal domain is more pronouncedly 
variable as it has evolved to accommodate a variety of acceptors83. A cleft between the 
two domains is responsible for substrate binding. A PSPG motif, mainly responsible 
for donor binding, is conserved found and located in the cleft close to the C-terminal.  
Figure 1.9: Representative structure of plant UGTs (VvGT1, PDB: 2C1Z) (left) and AA constitution of 
119 At UGT PSPG motifs (right). The overall structure of plant UGTs comprises N- and C- terminal 
domain. A cleft between the two domains is responsible for substrate binding. The conserved PSPG 
motif is located in the cleft close to C-terminal domain and binds the donor. The AA constitution of the 
PSPG motif shows its conservation: the size of letter depends on the degree of conservation of AAs. 
Colours of letters represent AAs with different chemical properties. Green: polar AAs; Blue: basic AAs; 
Red: acidic AAs; Black: hydrophobic AAs. 
Plant UGT structures are highly similar, particularly in their C-terminal domains84. For 
example, an overall structure comparison between VvGT1 and 85H238 revealed 24% 
‘structurally equivalent and identical residues’ and 44% ‘structurally equivalent and 
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similar residues’. Especially, 57% ‘structurally equivalent and identical residues’ and 
58% ‘structurally equivalent and similar residues’ are in the C-terminal domain, 
indicating that the C-terminal domains of VvGT1 and 85H2 are more conserved than 
N-terminal domains. 
Some flexible regions are present in different UGTs which typically vary in sequence, 
length, and conformation. The differences can be pronounced on loops N3, N5, and 
N5α, which are allocated in the N-terminal domain. For example, 85H2 and 72B1 
contain a short α-helix in the N5 loop, while two short stretches of β sheets are present 
in the corresponding loop of 71G1. Further, differences may also occur around the 
substrate binding cleft. For example, the linker region in 85H2 is longer than that in 
VvGT1 and 71G1, and contains several deletions and insertions. Specifically, 
insertions of additional residue are observed between Cβ2 and Cα2, with a deletion 
between Cβ6 and Cα6. The differences among these plant UGTs indicate that the 
active site for substrate binding is flexible and varies in each enzyme. 
PSPG motif of plant UGTs 
As mentioned above, a 44-AA conserved PSPG sequence is observed in plant UGTs85. 
This motif is thought to have evolved from a common ancestor, and has been defined 
as a signature motif of plant UGTs that participate in the glycosylation of SMs86. 
Figure 1.9 (right) shows the conserved PSPG motif in 119 At UGTs: ‘W-2x-Q-3x-L-
1x-H-1x-A/S-1x-G-G/C-F-L/V/W-T/S-H-C-G-W-1x-S/T-2x-E-4x-G-V/C/L-P/Q-4x-
P-3x-D/E-Q’. Further, in silico motif diversity analysis using the MEME tool revealed 
that the PSPG motif is consistently present in all UGT sequences in the C-terminal 
domain87. The presence of the PSPG motif has been widely accepted and applied in 
bioinformatics studies to identify new UGTs88.  
In addition to in AA sequence analysis, the PSPG motif is observed in crystal 
structures. This motif is located at the C-terminal of UGTs, where most donor-binding 
AAs are located. Figure 1.10 gives an example of the conserved manner by which the 
PSPG motif binds UDP-Glc in 71G1 and VvGT1. UDP-Glc is stacked in the PSPG 
motif and directly interacts with some AAs within the motif as follows: AAs 1, 11, 
and 34 directly bind the uridine portion of UDP-Glc; AAs 19, 23, and 24 interact with 
the phosphate portion of UDP-Glc; AAs 43 and 44 interact with the glucose moiety of 
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UDP-Glc. Although other AAs within the PSPG motif do not directly bind the donors, 
they play critical roles in stabilising the motif structure and appropriately stacking 
UDP-Glc. For example, 71G1 E356 (AA 18 within the PSPG motif) does not directly 
interact with the uridine moiety in the crystal structure; however, the E356P mutant 
exhibits no detectable UGT activity76. This is likely because E356 is within the loop 
region of AAs 339–334 (WAPQVE), which acts as a hydrophobic platform for 
stacking of uridine and helps W339 (AA 1 within the PSPG motif) to form p-p 
interactions with the uracil ring. Thus, the E356P substitution disturbs the loop 
conformation and results in loss of activity, resulting in a loss of activity76. 
 
Figure 1.10: Structure of the PSPG motif in VvGT1 (light blue) and 71G1 (plum) and key binding AAs 
in donor binding.  
1.2.4.2 Catalytic key amino acids in plant UGTs 
In an enzymatic reaction, substrates are accommodated in the active site of the enzyme 
and undergo chemical reactions. The active site of an enzyme is composed of binding 
site and catalytic site. AAs in the binding site (binding AAs, bAAs) interact with the 
substrate to form an enzyme-substrate complex, such as by forming temporary bonds 
(e.g. hydrogen bonds89) or by non-covalent interactions (e.g. van der Waals forces90). 
AAs in the catalytic site (catalytic AAs, cAAs) catalyse a reaction such as by acting 
as a Brønsted base to activate the substrate for a nucleophilic attack91. Both bAAs and 
cAAs are key factors in enzymatic reactions and are often referred to as the catalytic 
key AAs (ckAAs)92,93. 
In enzymatic reactions catalysed by plant UGTs, donor binding is generally conserved. 
UGTs mainly interact with a nucleotide sugar donor via hydrogen-bonding and p-
stacking94, or, in some cases, via hydrophobic stacking interactions95,96.   
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Figure 1.11 shows some key bAAs in the active site of UGTs, as exemplified by 
VvGT1 (tan)35, 71G1 (pink)76, and 72B1 (cyan)81. The binding patterns of plant UGT 
are generally conserved, but with some variations possible. The last two AAs (D/E-Q) 
within the PSPG motif are conserved for binding of Glc-O2, O3, and O4. However, 
the binding pattern at the C6 position of the sugar is not as conserved as that at the 
C2–C4 positions. In VvGT1 and 71G1, T141 and T143 bind Glc-O6, while 72B1 does 
not appear to have any bAA at the C6 position. The relatively lower conservation of 
the binding pattern at the C6 position of the sugar may be because bAAs binding C6 
binding are at the N-terminal. As described above, the N-terminal domain of UGTs is 
mainly responsible for binding the acceptor and is more variable than the donor-
binding C-terminal domain. As shown in the crystal structures of VvGT1 and 71G1, 
T141 and T143 are in the N-terminal domain but interact with Glc-O6 by crossing the 
entire N-terminal domain.   
T280 (VvGT1 numbering) and AA 19 of the PSPG motif (e.g. VvGT1 H350) are 
conserved for phosphate binding. Another bAA (e.g. VvGT1 T19), located in the N-
terminal domain, is not as highly conserved. In the three example UGTs, only VvGT1 
T19 binds phosphate, while 71G1 and 72B1 do not. In the other crystals, 78G1 T25 
and 78K6 S16 (the equivalent sites of VvGT1 T19) bind phosphate in the same manner 
as VvGT1 T19. 
The binding pattern of uridine is most highly conserved, with AAs 1 (e.g. VvGT1 
W332) and 34 (e.g. VvGT1 E358) interacting with the uracil ring and ribose by 
forming a p-p bond and hydrogen bond, respectively. 
 
Figure 1.11: Some key bAAs in VvGT1 (tan), 71G1 (pink) and 72B1 (cyan).  
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Apart from some bAAs for the donor, interactions with donors can be determined by 
simple steric occlusion in some cases. This might be a possible explanation of how 
GTs are able to transfer sugars indiscriminately in some cases97,98, and even transfer 
some non-carbohydrates (e.g. glycerol)99.  
1.2.4.3 Genetic engineering of plant UGTs 
Although plant UGTs may have many commercial and economic applications, the 
stringent specificity or low performance of individual UGT is disadvantageous and 
limits glycoengineering47. The function and performance of individual UGT have 
evolved to satisfy their natural roles, but not industrial biotechnology (human 
activity)100. Thus, the manipulation of UGTs to create novel ‘chimera’ enzymes with 
desired or enhanced activity is an important future prospect for potential applications, 
such as to provide new tools for synthesising of glycans. 
With the availability of protein structure, particularly the interaction between enzyme 
and substrate, a rational approach is used to propose substitutions resulting in 
enhanced or desired traits. This approach has the significant advantage of increasing 
the probability of success with less effort and time100. For instance, F148 and Y202 in 
71G1 are in close proximity and are located at one end of a channel shown to 
accommodate quercetin (Que) in a docking experiment based on the solved crystal 
structure of 71G1 Figure 1.12, A)101. Subsequently, the following substitution to alter 
the regio-selectivity of Que glycosylation was proposed: reducing the size of either 
F148 or Y202 to expand the volume of the binding pocket where the C-ring of Que is 
located, so that the volume change of the binding pocket would allow the –OH at the 
C3 position to move closer to the C1 reaction centre on UDP-Glc. Thus, F148V and 
Y202A mutants were constructed and the regio-selectivity of Que glycosylation was 
successfully altered (from 3¢-O-position of the B-ring to the C-O position of the C 
ring)101.   
Another successful example is 85H2. Based on 85H2 crystal structure, the docking 
data shows that I305 is involved in the substrate binding pocket and resides in the 
proximity to the acceptor (Figure 1.12, B)77. Structure analysis and docking 
experiment further indicated that changing I to T/S might result in a more favourable 
hydrogen bonding interaction and environment than in the original protein. 
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Subsequently, I305T was constructed and proved the prediction, as the UDP-Glc 
activity towards KMP or biochanin A increased 37- and 19- fold, respectively102. 
However, manipulation of the active site cannot absolutely and solely rely on crystal 
structures, as the number of solved crystal structures is limited. Thus, a semi-rational 
approach is required100. Semi-rational approaches combine some known knowledges, 
such as consensus sequence and function, and helps for predicting AA substitutions 
with the desired properties. 
A well-known example is that of switching the donor specificity of AcGaT (UDP-Gal 
to UDP-Glc activity) by altering H374 to Q103. The idea initially originated from 
multiple sequence alignment (MSA) analysis of GlcTs and GalTs, which revealed that 
Q and H were conserved as AA 44 within the PSPG motifs in GlcTs and GalTs, 
respectively (Figure 1.12, C). Thus, it was inferred that this site confers the sugar-
specific recognition of Glc and Gal. Point mutagenesis experiments were subsequently 
designed, wherein AcGaT H374 was substituted with Q. Subsequently, the donor 
specificity of AcGaT was successfully switched from UDP-Gal to UDP-Glc. 
More examples of active site manipulation using semi-rational approaches exist. 
Using the known crystal structure of VvGT1 as a template, the structure of VvGT5 was 
constructed and its substrates (UDP-glucuronic acid and KMP) were docked in the 
active site. The model predicted that an interaction existed between the guanidinium 
group of R140 and the carboxyl group of glucuronic acid. Further, at the equivalent 
site of VvGT1, W140 was present, which was oriented towards the bound U2F, while 
R140 was observed in VvGT5 instead (Figure 1.12, D). These observations suggested 
the possible important role of R140 in recognising UDP-glucuronic acid. To validate 
this prediction, point mutagenesis to introduce the R140W substitution was performed. 
The mutant not only exhibited a pronounced Glc transfer activity (the same activity as 
VvGT1), but also lost its original glucuronic acid transfer activity 104. 
  Chapter 1 
 36 
 
Figure 1.12: Examples of genetic engineering of plant UGTs.  
In summary, rational or semi-rational approaches for UGT genetic engineering have 
been successfully used to manipulate the UGT active sites in some cases. The 
manipulation of UGTs will be important to drive their potential applications in the 
future. Notably, the successful cases of genetic engineering ask the understanding of 
the active site of UGTs. 
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1.3 General scheme of the project 
As introduced above, improved understanding of plant UGTs will help enhance the 
understanding of GTs and enable potential applications, such as probing of their in 
vivo biological activity, synthesis of valuable glycoconjugates, and manipulation of 
the active site for desired or enhanced activity. The present project aimed to broaden 
the understanding of plant UGTs, focusing on substrate specificity, kinetic behaviour, 
and identification of catalytic key amino acids (ckAAs).  
In the current project, 29 recombinant At UGTs (Figure 1.4) from group B (89B1 and 
89C1), D (73B4, 73B5, 73C1, 73C2, 73C3, 73C4, 73C5, 73C6, 73C7, and 73D1), F 
(78D1 and 78D2), H (76C2, 76C3, 76C4, 76C5, 76E3, 76E4, 76E5, 76E9, 76E11, 
76E12, 76F1, and 76F2) and L (74C1, 75C1, and 75D1) were studied. Generally, 
groups D, H, and L are the three main groups and comprise large numbers of At UGTs 
(11%, 18%, and 15%, respectively, of 119 At UGTs). These three groups represent At 
UGTs with different functions (e.g. UDP-Glc and UDP-Rha activity). In addition, we 
aimed to identify the function for these function-unknown UGTs (the UGTs in red 
dotted rectangles, Figure 1.4). Although they have been predicted to use flavonoid 
from the existing genomic sequences in the UniProt database, no experimental data 
was found. Furthermore, we aimed to draw the complete picture of kinetic behaviours 
of tested UGTs if active. 
In addition to the interest to probe the functions and kinetics of tested UGTs, the 
correlation between AA sequence and function interest us. This will provide insight 
useful for UGT genetic engineering. Thus, UGTs from the relatively small groups, 
groups B and F, were also chosen for analysis, as AA sequences of UGTs from these 
small groups are more closely related than those of large groups. Thus, the differences 
in their functions may have indicated the correlation between AA sequence and 
function (e.g. 78D1 and 78D2 share high AA identity (71%) but with different donor 
specificities).  
This thesis will report the in vitro substrate specificity of the 29 UGTs listed above 
determined using a donor library (a-D-UDP-Glc, a-D-UDP-Gal, a-D-UDP-GlcNAc, 
a-D-UDP-GalNAc, b-L-UDP-Rha, b-L-dTDP-Rha, a-D-GDP-Glc, and b-L-GDP-Fuc) 
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and acceptor library (48 acceptors, including alcoholic, anthraquinone, coumarin, 
alkaloid, saponin, antibiotic, flavonoid, cyanogenic, plant hormone, and other 
phenolic compounds). Based on their substrate specificities, kinetics analyses with 
positive substrates were carried out (Chapter 3).   
Apart from substrate specificity and kinetic studies, ckAAs in the active sites of UGTs 
have been identified. The UGTs used were the same as those in kinetic studies, whose 
substrate specificities have been identified. Studies of GlcTs 73B4, 73B5, 73C1, 73C5, 
73C6, 76E11, 76E12, 78D2, and 89B1 are described in Chapter 4, while RhaTs 78D1 
and 89C1 are described in Chapter 5. Rather than using a computational method, e.g. 
molecular modelling, the potential ckAAs were identified by multiple sequence 
alignment (MSA) with seven crystal structures of known plant UGTs as the templates, 
and examined experimentally for the initial rate comparisons (kcat/KM) of the WT and 
mutants (the potential ckAAs were changed to other AAs). 
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2.1 Materials  
Chemicals  
Glycerol, bromophenol blue, sodium dodecyl sulfate (SDS), acrylamide, ammonium 
persulfate (APS), tetramethylethylenediamine (TEMED), Luria-Bertani (LB) medium, 
agar, ampicillin, Tris, uridine 5¢-diphosphoglucose disodium salt hydrate, uridine 5¢-
diphosphogalactose disodium salt hydrate, guanosine 5¢-diphosphoglucose sodium 
salt, guanosine 5¢-diphospho-b-L-fucose sodium salt, uridine 5¢-diphospho-N-
acetylglucosamine sodium salt, uridine 5¢-diphospho-N-acetylgalactosamine sodium 
salt, kaempferol (KMP), KMP-3-glucoside, quercetin, MgCl2, liquid 
chromatography/mass spectrometry (LC-MS) solvents (water and acetonitrile), 
Coomassie Brilliant Blue G, bovine serum albumin (BSA), quinine, atropine, 
anthranilic acid, and caffeic acid were from Sigma Aldrich (United Kingdom); 
deoxynivalenol, aloe-emodin, galantamine hydrobromide, and diacerein were 
purchased from Cambridge Bioscience; gossypol, theobromine, acetone cyanohydrin, 
and gibberellin A4 were purchased from Insight Biotechnology Ltd.; benzoic acid and 
hydroquinone were purchased from VWR International Ltd.; dTDP-rhamnose was 
purchased from Carbosynth; UDP-rhamnose was synthesised by Dr Min Yang’s group. 
The GSTrap fast flow column was from GE Healthcare; VivaSpin concentrators were 
from Generon; the QIAprep miniprep kit and XL-1 blue competent cells were obtained 
from Agilent; Instant Blue was ordered from BioLab. The Kinetex 5 µm C18 100A 
New Column (50 ´ 4.6 mm) was obtained from Phenomenex; UGT recombinant 
plasmids (Arabidopsis UGT-endcoding sequences inserted in pGEX-2T vector) were 
kindly provided by the University of York and Shandong University.  
Apparatus/Instrument  
The 6400-series triple quadrupole LC-MS (QQQ-LC-MS) was from Agilent. Mini-
PROTEAN® Tetra Cell systems for SDS electrophoresis and Mini-Sub® Cell GT cell 
for agarose electrophoresis were obtained from Bio-Rad. The cell shaker was from 
Thermo Fisher Scientific. The autoclave, cells incubator, and sonicator were supplied 
by Wolf Labs. The ultracentrifuge was obtained from Beckman.  
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2.2 Methods 
The methods in this project are split into four sections, as follows. 1) protein 
production (Section 2.2.1): purified WT and protein mutants were obtained following 
the same procedures, including plasmid transformation, protein expression, and 
purification. 2) multiple sequence alignment (MSA) and site-directed mutagenesis 
(SDM) (Section 2.2.2): MSA was used to infer the potential catalytic key amino acids 
(ckAAs) interacting with the donor. The potential ckAAs were substituted using SDM. 
This method was used to identify the ckAAs in UGTs. 3) MS-based enzyme activity 
test (Section 2.2.3): by checking glycosylated product formation, both qualitatively 
and quantitatively, information on substrate specificity, kinetics, and activity 
comparison were obtained. Qualitative analysis was used to check substrate 
specificities of WT and mutant enzymes. Quantitative analysis was used for the kinetic 
study (Chapter 3) and activity comparisons of WT and protein mutants (Chapter 4). 
4). Homology modelling and protein overlay (Section 2.2.4): construction of a model 
of target UGT and overlying it on template UGT allowed a convenient way of 
displaying and discussing the interactions between target UGTs and substrates. 
Protein production  
29 WT recombinant UGTs (UGT73B4, 73B5, 73C1, 73C2, 73C3, 73C4, 73C5, 73C6, 
73C7, 73D1, 74C1, 75C1, 75D1, 76C2, 76C3, 76C4, 76C5, 76E3, 76E4, 76E5, 76E9, 
76E11, 76E12, 76F1, 76F2, 78D1, 78D2, 89B1, and 89C1) and 106 mutants (listed in 
Table 2.1) were obtained using the following standard operating procedures: 1) 
plasmid transformation; 2) protein expression; and 3) protein purification and storage.  
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Table 2.1: List of 106 Mutants 
WT 73B4 73B5 73C1 73C5 73C6 76E11 76E12 78D2 
Mutants R7A G154A G148A G150A G151A T134A T135A T22A 
 G127A E394A D393A D397A D397A D373A D375A T286A 
 S270A E397D D393E D397E D397E D373E D375E W338A 
 W331A E397E D393K D397K D397K D373K D375K H356A 
 H349A E397N Q394A Q398A Q398A D373N D375N E264A 
 E357A Q398A Q394E Q398E Q398E Q374A Q376A D380A 
 E373A Q398N Q394H Q398H Q398H Q374E Q376E D380E 
 E373D Q398H Q394N Q398N Q398N Q374H Q376H D380K 
 E373Q Q398E    Q374N Q376N D380N 
 E373K       Q381A 
 Q374A       Q381E 
 Q374N       Q381H 
 Q374H       Q381N 
 Q374E       C357A- 
C374A 
         
WT 78D1 89B1 89C1      
Mutants A23T P145A G20A      
 A141T D389A F126A      
 T280A D389E S250A      
 W332A D389K W314A      
 H350A D389N H332A      
 E358A Q390A E340A      
 D374A Q390E D356A      
 N375A Q390H H357A      
 N375Q Q390N H357Q      
 
2.2.1.1 Plasmid transformation 
Plasmid encoding WT recombinant or mutant UGTs (1 µL) was gently mixed with 
XL-1 blue competent cells (20 µL). After placing the plasmid/cell mixture on ice for 
30 min, it was treated by heat shock at 42°C for 30 s. The plasmid/cell mixture was 
then incubated on ice for another 5 min, mixed with LB media (950 µL) without any 
antibiotics, and incubated in a shaker at 160 rpm (37°C) for 1 h. Subsequently, the 
plasmid/cell mixture (50 µL) was spread onto an agar plate with 50 µg/mL of 
ampicillin, and incubated overnight at 37°C. A single colony was then picked from 
the plate and incubated overnight in a liquid LB medium with 50 µg/mL of ampicillin 
with shaking at 160 rpm (37°C), and, finally, stored in 80% glycerol.  
2.2.1.2 Protein expression 
The glycerol stocks of UGTs were inoculated into LB medium (10 mL) with 50 µg/mL 
of ampicillin and incubated overnight in a shaker at 160 rpm (37°C). Then, the seed 
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culture was transferred into LB medium (500 mL) and grown under the same 
conditions until the culture OD600 reached 0.4–0.6, i.e. the cells entered the logarithmic 
phase of growth. The system was cooled to 20°C for 1 h, and protein production was 
then induced by the addition of isopropyl-b-D-1-thiogalactopyranoside (IPTG) (final 
concentration: 0.1 mM) overnight.  
2.2.1.3 Protein purification and storage 
Cells were harvested by centrifuging at 9,000 rpm (4°C) for 30 min. The cell pellet 
was collected and re-suspended in Tris buffer (20 mM, pH 7.8, 10 mL). The suspended 
cells were broken by sonication at an amplitude 80, on ice, and subsequently 
centrifuged at 14,000 × g (4°C) for 30 min. The supernatant was collected for 
purification.  
Proteins in the above supernatant were purified using GSTrapTM FF column via the 
following steps:  
1. Buffer preparation: binding buffer (PBS, pH 7.3) and elution buffer (50 mM 
Tris with 10 mM reduced glutathione; final pH 8.0) were prepared. 
2. Sample preparation: the above supernatant was filtered through a 45-µm filter 
to prevent any precipitate clogging the column.  
3. A syringe was filled with the binding buffer and was connected to the column. 
Five column volumes (one column volume: 1 mL) of the binding buffer, were 
used to equilibrate the column. 
4. The sample from step 2 was applied onto the column, at a flow rate of 0.2–1 
mL/min. In this step, any proteins with a GST tag would bind to the resin in 
the column.  
5. To prevent biding of unspecific contaminants, the column was washed with 5 
to 10 column volumes (5–10 mL) of the binding buffer at a flow rate of 1–2 
mL/min.  
6. Five column volumes (5 mL) of the elution buffer were applied to the column 
at 1–2 mL/min. In this step, the targeted proteins that bound to the column in 
step 4 were eluted. The first 3 mL of protein effluent were collected. 
7. Cleaning and storage of the column: the column was washed with two column 
volumes (2 mL) of washing buffer (6 M guanidine hydrochloride), followed 
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by five column volumes (5 mL) of PBS. This step was required for the removal 
of hydrophobic bound substances. 
8. The column was finally stored in 20% ethanol. 
The purified protein in the elution buffer was transferred to a storage buffer (1 mM 
Tris, 1 mM MgCl2, and 10% glycerol, pH 7.6) via Vivaspin (30,000 molecular weight 
cut-off), for improved protein storage environment and further application.  
A Vivaspin tube was filled with the above-purified protein and centrifuged at 10,000 
rpm for 5 min. The liquid in the filtrate tube was removed and protein was collected 
in the concentrate. Finally, the concentrated protein was transferred into the storage 
buffer prepared beforehand. 
2.2.1.4 Protein verification and concentration test  
SDS-PAGE 
To test the purity of the protein, SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed.  
1. Glass cassette and casting stand 
The short plate was positioned in front of the spacer plate and placed in the            
casting frame (Bio-Rad Mini-PROTEAN®). The casting frame was inserted 
into the casting stand and locked. 
 
2. Gel preparation 
Separating gel (10%) and stacking gel (5%) solutions were prepared as 
described in Table 2.2. APS and TEMED were added last, as they initiate the 
gel polymerisation. Firstly, the separating gel solution was poured between the 
glass plates. After it cooled down, the stacking gel was poured over the 
separating gel, and a comb was immediately inserted on top. The comb was 
removed after the gel had set. 
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Table 2.2: SDS gels recipe 
  
 
 
 
3. Electrophoresis 
For each protein sample, protein (5 µL), loading buffer (5 µL), and DTT (1 M, 2 
µL) were mixed, and then heated at 95°C for 10 min to completely denature the 
proteins. 
Each sample was loaded into a specific well of the prepared gel. The 
electrophoresis was performed at 40 V for the first 20 min, to let the samples reach 
the separating gel. The voltage was then increased to 150 V and maintained until 
the end of the electrophoresis. 
4. Gel staining 
The gel was stained with Instant Blue solution for 1 h, rinsed with ddH2O for 1 h, 
and its image was then acquired using an optical camera. 
Bradford assay 
Coomassie reagent was prepared by dissolving Coomassie Blue G (30 mg) in absolute 
ethanol (100 mL). Then, phosphoric acid (55 mL) was added, followed by ddH2O, for 
the final volume of 1 L.  
BSA was used to generate the calibration curve. Six samples (in triplicate) were 
prepared, containing 1, 2, 3, 4, 5, or 6 µg of BSA dissolved in 100 µL of the protein 
storage buffer (1 mM Tris, 1 mM MgCl2, and 10% glycerol, pH 7.6). Then, 100 µL of 
the sample was mixed with 1 mL of the Bradford reagent. The average OD value from 
Stacking gel (5%) Separating gel (10%) 
30% polyacrylamide (mL) 0.850 30% polyacrylamide (mL) 3.333 
1 M Tris, pH 6.8 (mL) 0.625 1.5 M Tris, pH 8.8 (mL) 2.500 
10% APS (mL) 0.050 10% APS (mL) 0.100 
10% SDS (mL) 0.050 10% SDS (mL) 0.100 
TEMED (mL) 0.005 TEMED (mL) 0.004 
H2O (mL) 3.420 H2O (mL) 3.967 
Total volume (mL) 5.000 Total volume (mL) 10.000 
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triplicate samples at 595 nm (control: blank, protein storage buffer only) was plotted 
against its corresponding BSA concentration (Figure 2.1). 
 
Figure 2.1: Bradford calibration curve. The experiments were run in triplicate and average reading value 
from triplicate samples under 595 nm was plotted. 
To determine the UGT concentrations, 10 µL of UGT preparations were diluted 10 
times by the addition of 90 µL of storage buffer, and mixed with 1 mL of the Bradford 
reagent. The OD value at 595 nm was obtained for each sample. Protein concentration 
in each sample was calculated using the equation obtained from the calibration curve. 
2.2.2 MSA and SDM 
2.2.2.1 MSA 
MSA was performed using 11 target UGTs (73B4, 74B5, 73C1, 73C5, 73C6, 76E11, 
76E12, 78D1, 78D2, 89B1, and 89C1) and seven template UGTs (VvGT1, 71G1, 72B1, 
78G1, 78K6, 85H2, and OS79). Their AA sequences were first revised to the FASTA 
format (Figure 2.2). 
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Figure 2.2: FASTA format of AA sequences of target UGTs: sequence of AAs follows > (the identifier 
of the sequence) + the name of the UGT 
The AA sequences of target UGTs in the FASTA format were imported to the 
sequence alignment tool Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/). 
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Parameter settings are shown in Figure 2.3. The outcomes of sequence alignment are 
presented after automated calculation.    
 
 
Figure 2.3: Parameter settings for MSA. 
In target UGTs, at sites equivalent to those where ckAAs are located in the template 
UGTs, i.e. T19, T141, T280, W332, H350, E358, D374, and Q375 (VvGT1 
numbering), potential ckAAs were selected and subsequently substituted using SDM 
(as summarised in Table 2.1). 
2.2.2.2 SDM 
SDM was performed to obtain specific protein mutants, generally following the 
standard procedure: WT-encoding plasmid extraction (used as template plasmid in 
SDM), primer design, and SDM. 
WT-encoding plasmid extraction 
The WT-encoding plasmids for target UGTs (73B4, 73B5, 73C1, 73C5, 73C6, 76E11, 
76E12, 78D1, 78D2, 89B1, and 89C1) were extracted from the bacterial glycerol 
stocks, and purified prior to SDM.  
Using a QIAprep® Spin Miniprep kit, the plasmids were extracted at room 
temperature, as follows: 1) bacterial culture (5 mL) was incubated at 37°C overnight 
in LB medium (10 mL) with 50 µg/mL of ampicillin. Cells were harvested by 
centrifugation at 14,000 rpm for 3 min; 2) the cells were re-suspended in buffer P1 
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(250 µL) of the kit; 3) buffer P2 (250 µL, with LyseBlue reagent as an indicator) was 
added, and the sample mixed thoroughly until the solution became clear blue, this was 
usually controlled within 5 min; 4) buffer N3 (350 µL) was added, and the sample 
mixed until the solution turned colourless; 5) the mixture was centrifuged for 10 min 
at 13,000 rpm, and supernatant (800 µL) was transferred to the QIAprep spin column; 
6) the column was washed with buffer PE (750 µL) and centrifuged for 1 min at 12,000 
rpm, discarding the flow-through; 7) another 1-min at 12,000 rpm centrifugation was 
employed to remove the residual washing buffer; 8) the column was placed in a clean 
1.5-mL Eppendorf tube, ddH2O (50 µL) was added to the centre of the column, and 
left for 1 min; the plasmid was eluted after a 1-min centrifugation at 12,000 rpm. 
Primer design 
Primers to generate the mutants (listed in Table 2.1) were designed based on the back-
to-back principle, using the primer design tool NEBaseChanger™ 
(http://nebasechanger.neb.com/). The cDNA sequences of 11 target UGTs were 
obtained from http://www.p450.kvl.dk/UGT.shtml. The DNA sequences that coded 
the sites to be mutated were selected, and replaced by DNA sequences that coded the 
desired AA.  
Herein, the primer design for 73B4 R7A is exemplified to demonstrate the standard 
procedure for this step (Figure 2.4): 1) 73B4 cDNA was imported into 
NEBaseChanger™; 2) the cDNA region encoding R7 was selected (AA 19–21, AGA); 
3) the 3-AA sequence GCC was set as the desired sequence (alanine: GCA or GCT, 
or GCC, or GCG); 4) the forward and reverse primers were automatically designed, 
with their specific properties also provided, e.g. melting temperature (Tm) and 
annealing temperature (TA), that were required for the next step. 
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Figure 2.4: Primer design for 73B4 R7A. The genetic code of R is highlighted and shown in amber 
character. They are replaced by the genetic code of A (highlighted in red rectangle). The physical 
properties of primers are also calculated (highlighted in blue rectangle)    
Following the same procedure, primers for other mutants were designed and 
summarised in Tables 2.3–2.13. The designed primers were synthesised at Eurofins. 
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Table 2.3: Primer design of 73B4 mutants. Genetic codes of mutant site were underlined.  
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
R7A AGA (19th-21st) GCTTTTCGCTGCCAGAGGAGCCAAATC TTGGCCATCTACTTTCTAC 60 
G127A GGC (379th-381st) TGTGTTCCACGCCACATCATCCT AGTCTTGGAACACCGATC 66 
S270A AGT (808th-810th) GTCCTTTGGTGCCGGAACCGGCT AAGTAAACTACTGAGCCAGG 63 
W331A TGG (991st-993rd) AATACGCGGAGCCGCCCCGCAAG ATCAGCCCTTTTCCTTTATTC 61 
H349A CAT (1045th-1047th) ATTTGTGACGGCCTGCGGATGGAAC CCTCCGATTGCTTTGTGG 59 
E357A GAG (1069th-1071st) CTCGACTTTGGCAGGCATTGCCG TTCCATCCGCAATGCGTC 63 
E373A  
GAA (1117th-1119th) 
GATGGGGGCAGCACAGTTCTACAA  
GGCCAAGTCACCATAGGC 
67 
E373K GATGGGGGCAAAACAGTTCTACAA 65 
E373D GATGGGGGCAGACCAGTTCTACAA 67 
E373Q GATGGGGGCACAACAGTTCTACAA 66 
Q374A  
CAG (1120th-1122nd) 
GGGGGCAGAAGCATTCTACAACGAG  
ATCGGCCAAGTCACCATAG 
61 
Q374N GGGGGCAGAAAACTTCTACAACGAG 61 
Q374H GGGGGCAGAACACTTCTACAACGAG 63 
Q374E GGGGGCAGAAGAGTTCTACAACGAG 65 
 
Table 2.4: Primer design of 73B5 mutants. Genetic codes of mutant site were underlined. 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
G154A GGT (460th-462nd) TGTGTTCCACGCCACATCTTTCTTTTC AGTCTTGGTACACCGAGC 63 
E397A  
GAA (1189th-1191st) 
AATGGGGGCAGCCCAGTTCTACA  
GGCCATGTTACCATAGGC 
65 
E397D AATGGGGGCAGACCAGTTCTACA 65 
E397K AATGGGGGCAAAACAGTTCTACA 65 
E397N AATGGGGGCAAACCAGTTCTACA 64 
Q398A  
CAG (1192nd-1194th) 
GGGGGCAGAAGCATTCTACAATGAG  
ATTGGCCATGTTACCATAG 
60 
Q398N GGGGGCAGAAAACTTCTACAATGAG 59 
Q398H GGGGGCAGAACACTTCTACAATGAG 61 
Q398E GGGGGCAGAAGAGTTCTACAATGAG 61 
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Table 2.5: Primer design of 73C1 mutants. Genetic codes of mutant site were underlined. 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
G148A GGC (442nd-444th) ATCTTTCATGGCATGTGTTGCTTC ATTTTTGGTATACCAAGATTCTTG 60 
D393A  
GAC (1177th-1179th) 
ACTGTTTGGAGCCCAATTCTGCAATG  
GGCCACGTGAGTAATGGA 
65 
D393E ACTGTTTGGAGAGCAATTCTGCAATG 63 
D393K ACTGTTTGGAAAGCAATTCTGCAATG 64 
Q394A  
CAA (1180th-1182nd) 
GTTTGGAGACGCATTCTGCAATGAGAAATTGGCG  
AGTGGCCACGTGAGTAATG 
62 
Q394E GTTTGGAGACGAGTTCTGCAATGAGAAATTGGCG 63 
Q394H GTTTGGAGACCACTTCTGCAATGAGAAATTGGCG 65 
Q394N GTTTGGAGACAACTTCTGCAATGAGAAATTGGCG 61 
 
Table 2.6: Primer design of 73C5 mutants. Genetic codes of mutant site were underlined. 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
G150A GGC (448th-450th) CCTCTTCCATGCCATGGGTTGCT ATCTTTGGGATATTGAACTTCTTG 63 
D397A  
GAC (1189th-1191st) 
GCTATTCGCAGCCCAATTCTGCAATG  
GGCCATGTAAGTAGCGGT 
66 
D397E GCTATTCGCAGAGCAATTCTGCAATG 67 
D397K GCTATTCGCAAAGCAATTCTGCAATG 66 
Q398A  
CAA (1192nd-1194th) 
ATTCGCAGACGCATTCTGCAATGAGAAATTGGTCG  
AGCGGCCATGTAAGTAGC 
62 
Q398E ATTCGCAGACGAGTTCTGCAATGAGAAATTGGTCG 62 
Q398H ATTCGCAGACCACTTCTGCAATGAGAAATTGGTCG 61 
Q398N ATTCGCAGACAACTTCTGCAATGAGAAATTGGTCG 62 
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Table 2.7: Primer design of 73C6 mutants. Genetic codes of mutant site were underlined. 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
G151A GGC (451st-453rd) CCTCTTCCATGCCATGGGTTGCT ATCTTTGGTATTTTGAACTTCTTGG 66 
D397A  
GAC (1189th-1191st) 
ACTATTTGCAGCCCAATTCTGCAAC  
GGCCATGTAAGCATTGGTAG 
63 
D397E ACTATTTGCAGAGCAATTCTGCAAC 61 
D397K ACTATTTGCAAAGCAATTCTGCAAC 62 
Q398A  
CAA (1192nd-1194th) 
ATTTGCAGACGCATTCTGCAACGAGAAACTGG  
AGTGGCCATGTAAGCATTG 
60 
Q398E ATTTGCAGACGAGTTCTGCAACGAGAAACTGG 62 
Q398H ATTTGCAGACCACTTCTGCAACGAGAAACTGG 61 
Q398N ATTTGCAGACAACTTCTGCAACGAGAAACTGG 61 
 
Table 2.8: Primer design of 76E11 mutants. Genetic codes of mutant site were underlined. 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
T134A ACC (400th-402nd) CATTTTCAGCGCCACAAGTGCCA ACGTTTGAAGCTTAAACTCTTTG 64 
D373A  
GAT (1117th-1119th) 
GTTTTCCAGTGCCCAAATGGTGAATG  
GGCTTGCAAATCATTGGAAC 
60 
D373E GTTTTCCAGTGAGCAAATGGTGAATG 63 
D373K GTTTTCCAGTAAGCAAATGGTGAATG 59 
D373N GTTTTCCAGTAACCAAATGGTGAATG 60 
Q374A  
CAA (1120th-1122nd) 
TTCCAGTGATGCAATGGTGAATGCG  
AACGGCTTGCAAATCATTG 
61 
Q374E TTCCAGTGATGAGATGGTGAATGCG 59 
Q374H TTCCAGTGATCACATGGTGAATGCG 60 
Q374N TTCCAGTGATAATATGGTGAATGCG 60 
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Table 2.9: Primer design of 76E12 mutants. Genetic codes of mutant site were underlined. 
 
 
 
 
 
 
 
Table 2.10: Primer design of 78D1 mutants. Genetic codes of mutant site were underlined. 
 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
A23T GCT (67th-69th) CCCCGTTGGCACCCATGCCGGTC AAAAACGCGAGAACTGCCAC 67 
A141T GCC (421st-423rd) TGCCTTCTGGACGGGCGGAGCAA ACCCAAGTCGCGTTCAGC 69 
T280A ACC (838th-840th) TAGCTTCGGCGCCGTCATGGAAC ATGTACGCTACAGAAGCAGCTG 69 
W332A TGG (994th-996th) AGTGGTTCCTGCCGCTCCACAAG ATCCCTTGCTCTCTTGTC 58 
H350A CAT (1048th-1050th) GAATGTGACAGCCTGTGGATGGAACTCAGTGTTG ACACCCATTGCCTCGTGT 63 
E358A GAG (1072nd-1074th) CTCAGTGTTGGCCAGTGTGTCGG TTCCATCCACAATGTGTC 59 
D374A GAT (1120th-1122nd) GATTTTGGCGGCCAATAGGCTCAACG GGTCTGCCGATCATCGGT 65 
N375A AAT (1123rd-1125th) TTTGGCGGATGCAAGGCTCAACG ATCGGTCTGCCGATCATC 67 
N375Q TTTGGCGGATCAAAGGCTCAACG 67 
 
 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
T135A ACA (403rd-405th) CATTTTCAGCGCAACAAGTGCCAC ATGTTTGGAAGCTTACACTC 66 
D375A  
GAT (1123rd-1125th) 
ATTTTCGGGTGCCCAAAAGGTGAAC  
GGCCTGCAGATCATTGGA 
67 
D375E ATTTTCGGGTGAGCAAAAGGTGAAC 66 
D375K ATTTTCGGGTAAGCAAAAGGTGAAC 60 
D375N ATTTTCGGGTAACCAAAAGGTGAAC 61 
Q376A  
CAA (1126th-1128th) 
TTCGGGTGATGCAAAGGTGAACG  
AATGGCCTGCAGATCATTG 
62 
Q376E TTCGGGTGATGAGAAGGTGAACG 61 
Q376H TTCGGGTGATCACAAGGTGAACG 63 
Q376N TTCGGGTGATAATAAGGTGAACG 59 
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Table 2.11: Primer design of 78D2 mutants. Genetic codes of mutant site were underlined. 
 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
T22A ACT (64th-66th) TCCTTTCGGCGCCCATGCAGCTC AAAGCGAGAACTGCCACG 66 
T286A ACG (856th-858th) TAGCTTTGGTGCCGTCATGACACCG ATGTACGCCACAGAACCAG 63 
W338A TGG (1012nd-1014th) AGTGGTTCCAGCCGCACCGCAAG ATCCCTTGCTCTCTTGTC 60 
H356A CAT (1066th-1068th) GTTTGTGACGGCCTGTGGATGGAACTCGG ACACCCGTTGCTTCGTGT 65 
E364A GAG (1090th-1092nd) CTCGGTGTTGGCCAGTGTATCGG TTCCATCCACAATGCGTC 63 
D380A  
GAT (1138th-1140th) 
ATTTTTTGGGGCCCAGAGATTGAACGG  
GGCCTGCAAATCATCGGT 
63 
D380E ATTTTTTGGGGAGCAGAGATTGAACGG 63 
D380K ATTTTTTGGGAAGCAGAGATTGAACGG 63 
D380N ATTTTTTGGGAACCAGAGATTGAACGG 64 
Q381A  
CAG (1141st-1143rd) 
TTTTGGGGATGCCAGATTGAACGGAAG  
AATGGCCTGCAAATCATC 
60 
Q381E TTTTGGGGATGAGAGATTGAACGGAAG 61 
Q381H TTTTGGGGATCACAGATTGAACGGAAG 59 
Q381N TTTTGGGGATAACAGATTGAACGGAAG 60 
C357A- 
C374A 
TGT (1069th-1071st)- 
TGC (1120th-1122nd) 
GTATCGGGTGGTGTACCGATGATTGCCAGGCCATT
TTTTGGGGATC 
ACTCTCCAACACCGAGTTCCATCCA
GCAATGCGTCACAAACACACC 
63 
 
Table 2.12: Primer design of 89B1 mutants. Genetic codes of mutant site were underlined. 
 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
P145A CCC (433rd-435th) CGATTTCTCTGCCTCCGCTGCTA AAACGAGGGATTCCGAGG 64 
D389A  
GAC (1165th-1167th) 
GATGAGAGCTGCCCAGTACACTGAC  
GGCCACGTCAGCATCAAA 
63 
D389E GATGAGAGCTGAGCAGTACACTGAC 65 
D389K GATGAGAGCTAAGCAGTACACTGAC 62 
D389N GATGAGAGCTAACCAGTACACTGAC 63 
Q390A  
CAG (1168th-1170th) 
GAGAGCTGACGCCTACACTGACGCGTC  
ATCGGCCACGTCAGCATC 
67 
Q390E GAGAGCTGACGAGTACACTGACGCGTC 66 
Q390H GAGAGCTGACCACTACACTGACGCGTC 65 
Q390N GAGAGCTGACAACTACACTGACGCGTC 65 
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Table 2.13: Primer design of 89C1 mutants. Genetic codes of mutant site were underlined. 
 
Mutants  Targeted sequence Forward primer Reverse primer TA (⁰C) 
G20A GGT (58th-60th) TCCACAATCCGCCCACATGGTTC AACGGTATCACCAGAACG 60 
P147A CCC (439th-441st) TTAGTTTCTTAGCCATCAATGCTCATTC AGGATGGCGTCGGGGAGA 64 
W314A TGG (940th-942nd) GATAAGAGGAGCCGCCCCACAAACTATG ACGAGTCCTTTCTCCTTC 63 
H332A CAT (994th-996th) TTACCTAACTGCCTTGGGTTGGGGTTCG GATCCAACGGCTCGATGC 64 
E340A GAA (1018th-1020th) TTCGGTTCTGGCCGGAATGGTCG CCCCAACCCAAATGAGTTAG 61 
D356A GAC (1066th-1068th) GATGCAAGCAGCCCATTTCTTTAAC GGCCACGCTAGCAACATA 62 
H357A CAT (1069th-1071st) GCAAGCAGACGCATTCTTTAACAC ATCGGCCACGCTAGCAAC 61 
H357Q GCAAGCAGACCAGTTCTTTAACAC 62 
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Exponential amplification (EA) 
The sample for EA was prepared as follows: Q5® Hot Start High-Fidelity 2x master 
mix (12.5 µL) was mixed with WT-encoding plasmid (1 µL, purified as above, 1–25 
ng/µL), and forward and reverse primers (10 µM stock, 1.25 µL each); ddH2O was 
added for a final volume of 25 µL.  
The prepared sample was performed to a standard EA process (Figure 2.5): 1) initial 
denaturation (98°C for 30 s); 2) denaturation (98°C for 10 s); 3) primer annealing (50–
72°C for 20 s, according to the annealing temperature, TA, of primers for specific 
mutants, listed in Tables 2.3–2.13); 4) extension (72°C for 161 s); 5) final extension 
(72°C for 2 min); 6) standing at 4°C. Steps 2 to 4, were repeated 25 times.  
 
Figure 2.5: Schematic diagram of EA process. 
EA product verification – agarose gel 
The EA product was checked by agarose gel electrophoresis. Briefly, 0.8% agarose 
gel with 0.1% SYBR® Safe DNA gel stain was prepared in TBE buffer, cooled, and 
solidified in a gel caster. EA product (5 µL) and loading buffer (5 µL) were mixed, 
and loaded in a gel lane. Electrophoresis was performed at 35 V in TBE tank buffer 
for 3 h. The gel was evaluated using the Gel Imager, and a clear gel band at around 6 
kb indicated successful EA process.   
Treatment and enrichment 
EA product (verified by agarose gel; 1 µL) was mixed with 2x KLD reaction buffer 
(5 µL) and 10x KLD enzyme mix (1 µL). Nuclease-free water (3 µL) was added for a 
final volume of 10 µL. The sample was then incubated for 5 min at room temperature 
and used in transformation. 
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Transformation and mutant plasmid verification 
The mutated plasmids (products of the ‘treatment and enrichment’ step) were 
transformed into XL-1 blue competent cells, using the same procedure as in Section 
2.2.1.1. A few representative mutated plasmids were selected and sent to Source 
Bioscience for DNA sequencing for verification. These mutated plasmids were 73C6 
Q398A, 78D1 N375Q, 78D2 Q381E, and a plasmid encoding a double-point mutant 
78D2 C357A-C374A (Table 2.14).   
Table 2.14: Verified mutant plasmids by Sanger sequencing. 
 
2.2.3 MS-based enzyme activity test 
2.2.3.1 Substrate specificity (GAR) screening  
Substrate specificity screening was performed using LC-MS/MS by monitoring the 
formation of the product (glycosylated product) in the negative-ion mode. The ‘full 
scan’ mode was used for an initial screening of the UGT’s activity to determine 
whether a potential glycosylated product had formed in the reactions containing the 
tested UGTs and tested substrates. If such a glycosylated product was detected, the 
‘product ion’ mode was subsequently applied to fragment the potential glycosylated 
product, to confirm the activity by determining whether aglycone was produced during 
this step. The result was displayed as a GAR panel, using colours red (no activity), 
amber (ambiguous activity), and green (positive activity). 
Sample preparation 
Donor GAR screening 
Donor GAR screening was used to examine the substrate specificities of 29 WT UGTs 
and 106 UGT mutants (acceptor: KMP). The donor library contained eight sugar 
Mutant plasmid Targeted sequences 
(in WT) 
Outcome sequences 
(in mutant, verified by Sanger sequencing) 
73C6 Q398A CAA (1192nd-1194th) GCA (1192nd-1194th) 
78D1 N375Q AAT (1123rd-1125th) CAG (1123rd-1125th) 
78D2 Q381E CAG (1141st-1143rd) GAG (1141st-1143rd) 
78D2 C357A-C374A TGT (1069th-1071st)-
TGC (1120th-1122nd) 
GCA (1069th-1071st) - GCC (1120th-1122nd) 
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donors (Figure 2.6 and Table 2.15): a-D-UDP-Glucose (UDP-Glc), a-D-UDP-
Galactose (UDP-Gal), a-D-UDP-N-acetylglucosamine (UDP-GlcNAc), a-D-UDP-N-
acetylgalactosamine (UDP-GalNAc), b-L-UDP-Rhamnose (UDP-Rha), b-L-dTDP-
Rhamnose (dTDP-Rha), a-D-GDP-Glucose (GDP-Glc), and b-L-GDP-Fucose (GDP-
Fuc). 
KMP (10 µL, 100 µM), donor (10 µL, 100 µM), and UGT (10 µL, 0.01–0.1 mg/mL) 
were mixed in a buffer (50 µL, 1 mM Tris with 1 mM MgCl2, pH 7.6). The samples 
were incubated at 37°C overnight. 
 
Figure 2.6: Donor library. 
Table 2.15: Exact molecular weight of glycosylated products with different sugar donors (KMP as 
acceptor). 
Donor UDP-
Glc 
UDP-
Gal 
GDP-
Glc 
GDP-
Fuc 
UDP-
GlcNAc 
UDP-
GalNAc 
UDP-
Rha 
dTDP-
Rha 
Exact MW (Dalton) 448 448 448 432 489 489 432 432 
 
Acceptor GAR screening 
Acceptor GAR screening was used to examine the substrate specificities of 29 WT 
UGTs. UDP-Glc was used as the donor for 27 WT UGTs, and UDP-Rha was used as 
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the donor for 78D1 and 89C1. The acceptor library contained 48 acceptors, listed in 
Figure 2.7 and Table 2.16. 
Similar to the donor GAR screening, acceptor (10 µL, 100 µM), donor (10 µL, 100 
µM), and UGT (10 µL, 0.01–0.1 mg/mL) were mixed in a buffer (50 µL, 1 mM Tris 
with 1 mM MgCl2, pH 7.6). The samples were incubated at 37°C overnight. 
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Figure 2.7: Sugar acceptor library– the numbers in brackets correspond to the number in the subsequent 
green-amber-red (GAR) screen assay. 
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Table 2.16: Exact molecular weight of glycosylated product with different acceptors. 
No. Chemical name Formula MW 
(Dalton) 
 
(Dalton) 
MW+Glc 
(Dalton) 
(Dalton) 
MW+Rha 
(Dalton) 
(Dalton) 
1 Salicin C13H18O7 286.28 448.28 432.28 
2 Anthraquinone C14H8O2 208.22 370.22 354.22 
3 Aloe-emodin C15H10O5 270.24 432.24 416.24 
4 Diacerein C19H12O8 368.30 530.30 514.30 
5 Umbelliferone C9H6O3 162.14 324.14 308.14 
6 4-methyl-umbelliferone C10H8O3 176.14 338.14 322.14 
7 Esculetin C9H6O4 178.14 340.14 324.14 
8 7-Hydroxylcoumerin-3-carboxylic 
acid 
C10H6O5 206.15 368.15 352.15 
9 Scopoletin C10H8O4 192.16 354.16 338.16 
10 Theobromine C7H8N4O2 180.16 342.16 326.16 
11 Solanine C45H73NO15 868.06 1030.06 1014.06 
12 Novobiocin C31H36N2O11 612.62 774.62 758.62 
13 Chloramphenicol C11H12Cl2N2O5 323.13 485.13 469.13 
14 Carbenicillin C17H18N2O6S 378.40 540.40 524.40 
15 Vancomycin C66H75Cl2N9O24 1449.30 1611.30 1595.30 
16 Baicalein C15H10O5 270.24 432.24 416.24 
17 Luteolin C16H10O6 286.24 448.24 432.24 
18 Quercetin C15H10O7 302.24 464.24 448.24 
19 Fisetin C16H10O6 286.24 448.24 432.24 
20 Kaempferol C16H10O6 286.24 448.24 432.24 
21 Taxifolin C15H12O7 304.25 466.25 450.25 
22 Amygdalin C20H27NO11 457.43 619.43 603.43 
23 α-Cyano-4-hydroxyl-cinnamic acid C10H7NO3 189.17 351.17 335.17 
24 1-Thio-S-cyanomethyl-N-acetyl-D-
glucosamine 
C10H16N2O5S 276.08 438.08 422.08 
25 Zeatin C10H13N5O 219.25 381.25 365.25 
26 Indole-3-acetic acid C10H9NO2 175.19 337.19 321.19 
27 Abscisic acid C15H20O4 264.32 426.32 410.32 
28 Kinetin C10H9N5O 215.22 377.22 361.22 
29 Jasmonic acid C12H18O3 210.27 372.27 356.27 
30 Methyl jasmonic acid C13H20O3 224.14 386.14 370.14 
31 Gibberellin A3 C19H24O6 348.16 510.16 494.16 
32 Gibberellin A4 C19H24O5 332.16 494.16 478.16 
33 Arbutin C12H16O7 272.25 434.25 418.25 
34 Sinapic acid C11H12O5 224.21 386.21 370.21 
35 Galantamine C17H21NO3 287.35 449.35 433.35 
36 Caffeic acid C9H8O4 180.16 342.16 326.16 
37 Cinnamic acid C9H8O2 148.16 310.16 294.16 
38 3,4-Di hydroxylcinnamic acid C8H8O3 152.05 314.05 298.05 
39 α-Cyano-4-hydroxyl-cinnamic acid C10H7NO3 189.04 351.04 335.04 
40 Benzoic acid C7H6O2 122.12 284.12 268.12 
41 4-Hydroxylbenzoic acid C8H8O2 136.05 298.05 282.05 
42 3,4-Dihydroxylbenzoic acid C8H8O3 152.05 314.05 298.05 
43 2,5-Dihydroxylbenaoic acid C8H8O3 152.05 314.05 298.05 
44 Deoxynivalenol C15H20O6 296.32 458.32 442.32 
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45 Anthranilic acid C7H7NO2 137.14 299.14 283.14 
46 Quinine C20H24N2O2 324.42 486.42 470.42 
47 Hydroquinone C6H6O2 110.11 272.11 256.11 
48 Gossypol C30H30O8 518.56 680.56 664.56 
 
‘Full scan’ mode to detect the product formation 
After incubation overnight, samples were passed through a column (Kinetex 5 µm C18 
100A New Column, 50 × 4.6 mm) in MS experiments.  
LC conditions: the LC system was equipped with a binary solvent: water (with 0.1% 
formic acid) and acetonitrile (ACN). From 0.0–1.0 min, the percentage of ACN 
increased gradually from 30% to 45%; from 1.0–2.5 min, the percentage of ACN 
remained at 45%; from 2.5–5.0 min, the percentage of ACN decreased gradually to 
the initial percentage (30%). All analyses were performed in this gradient condition at 
a flow rate of 0.5 mL/min at room temperature. The sample volume injected was 10 
µL, with a run time of 5 min. 
MS conditions: The ‘full scan’ mode of the quadrupole MS analyser was used in the 
negative-ion mode, with a range of 100–1000 MW for the donor GAR screening and 
100–2000 MW for the acceptor GAR screening [fragmentor voltage (Frag) 135 V and 
cell accelerator voltage (CAV) 7 V]. The source parameters were set as follows: gas 
temperature of 300°C and flow of 5 L/min; nebuliser pressure of 45 psi; sheath gas 
temperature of 250°C at a flow of 11 L/min; the capillary voltage at 3500 V, negative; 
and the nozzle voltage at 500 V, negative. 
Once the glycosylated product peak (the exact MW are shown in Tables 2.15 and 2.16) 
was detected in the ‘full scan’ mode, ‘product ion’ mode analysis was performed to 
double-check the existence of the glycosylated product, as follows.  
‘Product ion’ mode to confirm the product formation 
Samples that exhibited positive activity, as described above, were passed through the 
same column as above.  
LC conditions: the same as above. 
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MS conditions: The ‘product ion’ mode of MS was used. Ions of the glycosylated 
product MW-1 were selected as the ‘precursor ions’ (e.g. KMP-Glc, 447; KMP-Gal, 
447; KMP-Rha, 431; and KMP-GlcNAc, 488), allowing them to travel through the 
collision cell at collision energy (CE) of 10 eV, to produce ‘product ions’. The 
conditions of source, nebuliser pressure, sheath gas, capillary, and nozzle voltage were 
the same as above.   
2.2.3.2 Full kinetics 
MRM parameter optimisation 
To determine the optimal MRM parameters for the glycosylated product and the 
internal standard, the software MassHunter Optimizer was used to optimise the Frag 
and CE for MRM transition and conditions. 
A standard sample was prepared containing UDP-Glc (10 µL, 100 µM), KMP (10 µL, 
100 µM), quercetin (10 µL, 100 µM), commercial KMP-3-Glc standard (10 µL, 100 
µM), UDP (10 µL, 100 µM), and buffer (50 µL, 1 mM Tris and 1 mM MgCl2, pH 7.6). 
This sample was used to probe the MRM parameters of KMP-Glc and quercetin. Since 
KMP-GlcNAc, KMP-Gal, and KMP-Rha were not commercially available, their 
MRM parameters were probed using a glycosylated product generated by an 
enzymatic reaction. To probe the MRM parameters of KMP-GlcNAc, a sample 
containing UDP-GlcNAc, KMP, and 78D2 incubated together overnight at 37oC was 
used. To probe the MRM parameters of KMP-Rha, a sample containing UDP-Rha, 
KMP, and 78D1 incubated together overnight at 37oC was used. To probe the MRM 
parameters of KMP-Gal, a sample containing UDP-Gal, KMP, and 73C5 incubated 
together overnight at 37oC was used.  
A range of MRM parameters were set, including a coarse range from 100 to 300, 
collision energy from 5 to 100, and a low mass cut-off of 100. Using different MRM 
parameters, the Glycosylated-KMP underwent different transitions (precursor ion → 
product ion). The transition with the highest abundance under specific conditions was 
used in subsequent experiments.  
Using the MRM parameter optimiser, the optimal MRM transitions and conditions for 
every analyte were obtained (Table 2.17): 
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Table 2.17:MRM parameters of analyte 
Compound MRM Transition  Frag (eV) CE (eV) CAV (eV) 
KMP-Glc 447.1 → 284.1 235 33 4 
KMP-GlcNAc 488.0 → 285.0 200 24 4 
KMP-Gal 447.1 → 284.1 235 30 4 
KMP-Rha 431.0 → 285.0 200 16 4 
Quercetin 301.0 → 151.1 170 17 4 
Other settings: the source parameters were set to gas temperature of 300°C and flow 
of 5 L/min; nebuliser pressure of 45 psi; sheath gas temperature of 250°C at a flow of 
11 L/min; capillary voltage at 3500 V, negative; and nozzle voltage at 500 V, negative. 
Selection of enzyme concentrations ([E]) 
Since a suitable [E] is required to observe a clear progressive curve (the curve of 
product quantity Vs time) with a linear section, [E] selection was performed prior to a 
full kinetic study. 
Below, [E] selection prior to the full kinetic study of 78D2 is described, to exemplify 
how this step was performed.  
Three samples were prepared. They all contained UDP-Glc (10 µM) and KMP (10 
µM) in a buffer (1 mM Tris and 1 mM MgCl2, pH 7.6), and different concentrations 
of 78D2 (0.0002, 0.0010, and 0.0020 mg/mL). The final sample volume was 150 µL.  
The glycosylated product was sampled after 5, 15, 30, and 50 min. For example, after 
5 min since the addition of 78D2, 25 µL of mixture from the original (reaction) 
Eppendorf tube were withdrawn and transferred to a new Eppendorf tube. An equal 
volume of ACN was added to the new Eppendorf tube to precipitate the protein and 
prevent further reaction. The sample/ACN mixture was then centrifuged for 10 min at 
14,000 rpm. The supernatant (40 µL) was transferred to a well of a 96-well plate. 
Quercetin (the internal standard, 10 µL from 100 µM stock solution) and ddH2O (50 
µL) were added to the well. The glycosylated products formed after 15, 30, and 50 
min were sampled in the same manner. 
Product formation was quantified using the MRM mode of MS, as described above 
(the LC conditions were the same as described in section 2.2.3.1). 
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The [E] yielding the optimal progressive curve was used in the subsequent kinetic 
study (discussed in Section 3.1.2). This initial evaluation was carried out to select the 
suitable [E] for the kinetic study for every enzyme. The enzyme concentrations used 
are summarised in Table 2.18. 
Table 2.18: The final concentration of UGTs used in the full kinetics test. 
Donor UGTs Concentration (mg/ml) 
UDP-Glc 89B1 0.0030 
73B4 0.0030 
73B5 0.0015 
73C1 0.0015 
73C5 0.0015 
73C6 0.0015 
78D2 0.0010 
76E11 0.0055 
76E12 0.0015 
UDP-Gal 73C5 0.0055 
78D2 0.0030 
UDP-GlcNAc 73B4 0.0070 
78D2 0.0015 
Selection of the substrate concentration ([S]) – Ion suppression 
In order to explore whether and how ion suppression took place, and whether it 
subsequently impacted the linear response of ESI-MS in kinetic assays, correlation 
curves of concentrations of commercial KMP-3-O-Glc and KMP-3-O-Glc/quercetin 
MRM counts were prepared at different UDP-Glc concentrations. 
Four sets of samples were prepared: 1) quercetin (10 µM) mixed with different 
concentrations of KMP-3-O-Glc (0.001, 0.002, 0.005, 0.01, 0.02, 0.05, and 0.1 µM) 
in seven individual Eppendorf tubes, no UDP-Glc; 2) quercetin (10 µM) mixed with 
different concentrations of KMP-3-O-Glc in seven individual Eppendorf tubes, with 
low UDP-Glc (5 µM); 3) quercetin (10 µM) mixed with different concentrations of 
KMP-3-O-Glc (0.001, 0.002, 0.005, 0.01, 0.02, 0.05, and 0.1 µM) in seven individual 
Eppendorf tubes, with intermediate UDP-Glc (50 µM); 4) quercetin (10 µM) was 
mixed with different concentrations of KMP-3-O-Glc (0.001, 0.002, 0.005, 0.01, 0.02, 
0.05, and 0.1 µM) in seven individual Eppendorf tubes, with high UDP-Glc (100 µM). 
The same LC-MS conditions were applied as above, to generate correlation curves of 
concentrations of commercial KMP-3-O-Glc and KMP-3-O-Glc/quercetin MRM 
counts. 
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Full UGT kinetics  
To perform the full UGT kinetic study, the experiment was set up to use four groups 
of samples with KMP concentrations fixed at 2, 5, 10, and 20 µM. In each group, five 
samples with the following donor concentrations were used: 2, 5, 10, 20, and 50 µM 
(UDP-Glc for 73B4, 73B5, 73C1, 73C5, 73C6, 76E11, 76E12, 78D2, and 89B1; UDP-
Gal for 73B4 and 78D2; and UDP-GlcNAc for 73B4 and 78D2). In total, 20 samples 
with different KMP and donor concentrations were prepared (Figure 2.8). 
Each sample contained 10 µL of UGT (the final concentration varied, as listed in Table 
2.18) and buffer (1 mM Tris and 1 mM MgCl2, pH 7.6) added for a final volume of 
150 µL. The glycosylated products were collected at different time points, as described 
above (Figure 2.8). The experiment was conducted at room temperature. 
KMP-Glc formation in all 80 samples (20 reaction samples ´ four time points) was 
monitored under the LC-MS condition described above. Velocity at different 
concentration was calculated and, thus, the full enzyme kinetics were investigated. 
 
Figure 2.8: Schematic chart of sample preparation for the full kinetics test. 
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A calibration curve correlating the concentration of the glycosylated product and ions 
of the glycosylated product/internal standard was generated each time, in parallel to a 
full kinetic experiment. For that, six samples were prepared containing different 
concentrations of commercial KMP-3-O-Glc (0.001, 0.002, 0.005, 0.01, 0.02, or 0.05 
µM), quercetin (10 µM), UDP-Glc (10 µM), and KMP (10 µM).  
Product inhibition assays of UGTs 
Product inhibition assays were performed for 73C5. 
Four sets of kinetic experiments were carried out: 1) with UDP as the inhibitor (0, 50, 
and 200 µM), KMP (fixed at 100 µM), with varying concentrations of UDP-Glc (2, 5, 
10, and 20 µM); 2) with UDP as the inhibitor (0, 50, and 500 µM), UDP-Glc (fixed at 
100 µM), with varying concentrations of KMP (2, 5, 10, and 20 µM); 3) with KMP-
3-Glc as the inhibitor (0, 1, and 5 µM), KMP (fixed at 100 µM), with varying 
concentrations of UDP-Glc (2, 5, 10, and 20 µM); and 4) with KMP-3-Glc as the 
inhibitor (0, 1, and 5 µM), UDP-Glc (fixed at 100 µM), with varying concentrations 
of KMP (2, 5, 10, and 20 µM). 
The glycosylated products were collected at different time points, as described above, 
and the subsequent MS analysis procedure followed the same procedure as that 
described above. 
2.2.3.3 Activity comparison of WT and mutants 
Two sets of reaction samples were prepared: the control group (WT) and the 
experimental group (mutant). The control group contained the donor (15 µL, 1 mM), 
KMP (15 µL, 1 mM), buffer (105 µL, 1 mM Tris, and 1 mM MgCl2, pH 7.6), and WT 
enzyme (15 µL, the same concentration as used in the full kinetic study). The 
experimental group contained the same starting materials, but the enzyme used was 
the corresponding mutant (same concentration as WT). 
For example, when comparing the activities of 73B4 WT and 73B4 R7A, the two 
groups of samples were: the control group, with UDP-Glc (10 µM), KMP (10 µM), 
and WT 73B4 (0.0030 mg/mL); and the experimental groups, with the same reactants 
but with the protein mutants 73B4 R7A (0.0030 mg/mL), accordingly.  
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Aliquots were withdrawn after 5, 15, 30, and 50 min, and were treated as described 
above. The products were quantified using the MRM mode of MS, as above. 
Progressive reaction curves with the two enzymes were then obtained. The initial rates 
of enzymatic velocity with different enzymes were compared in this closed system as 
a function of the reaction time.  
Using this same approach, comparisons of the activities of WT 73B4, 74B5, 73C1, 
73C5, 73C6, 76E11, 76E12, 78D1, 78D2, 89B1, and 89C1 with their corresponding 
mutants were performed, with the appropriate WT (control) and 1–5 corresponding 
mutants (the experimental group). 
2.2.4 Homology modelling and protein overlay 
2.2.4.1 Homology modelling  
In the current project, Swiss-Model was used to build protein models of C-terminal of 
the target UGTs by homology modelling, using the C-terminal in crystal structures of 
template UGTs. Below, an example is provided on how to build a homology model of 
the C-terminal of UGT 73B4. 
Since the homology modelling is more accurate if the template protein and target 
protein share a higher percentage of identical residues, the percentages of identical 
residues between C-terminal of 73B4 and template UGTs (71G1, 85H2, 78G1, VvGT1, 
78K6, 72B1, and OS79) with known crystal structures were compared. The 
comparison revealed that the C-terminal of 73B4 and 71G1 shared the highest 
percentage of identical residues (46%). Hence, the C-terminal of 71G1 was used as 
the template for building the C-terminal model of 73B4. 
The subsequent modelling was set up using the ‘User template’ program on Swiss-
Model website (https://swissmodel.expasy.org) with default parameters. The C-
terminal crystal structure of the template 71G1 (PDB: 2ACW) was used. 
Following the same step-by-step procedure, C-terminal models of the other target 
UGTs were built, with their optimal template UGTs. 
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2.2.4.2 Protein overlay  
To overlay the structure of two proteins, UCSF Chimera (Mac version) was used. In 
Section 2.2.4.1, 71G1 was used as the template to build a C-terminal model of 73B4 
because of their high AA sequence identity. However, VvGT1 was used for the overlay 
in this step, as the VvGT1+U2F+KMP complex can reveal detailed information of 
how 73B4 might interact with its substrates (no 71G1+donor+acceptor complex was 
solved).   
Thus, the protein overlay of VvGT1 and 73B4 was performed using ‘MatchMaker’ 
function of the chimera software with the default parameters (Figure 2.9). 
 
Figure 2.9: Parameter settings in ‘MatchMaker’  
Using the same method, protein overlays of the model and template UGTs were 
generated to reveal possible interactions between the models and the substrates. 
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As introduced in Chapter 1, plant UGTs catalyse the addition of a sugar moiety from 
sugar donors to sugar acceptors and are of significance in plant secondary metabolites. 
Owing to breakthroughs in whole genome sequencing, high-throughput screening and 
analysis of sequences, an increasing number of UGT genes have been identified105,106. 
However, experimental data of their in vitro activities have not been fully obtained. 
This chapter will describe the in vitro characterisation of recombinant UGTs from 
groups B, D, F, H and L of Arabidopsis thaliana (At), using mass spectrometry (MS)-
based methods to investigate substrate specificity, kinetic parameters and catalytic 
mechanisms.
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3.1 Method development of MS-based GT activity assay 
The study of GT's glycosylation reactions was divided into qualitative and quantitative 
analyses, both achieved using MS. One advantage of MS is that it can conduct a label-
free enzyme assay, allowing the rapid determination of substrate specificity and 
catalytic reaction rate for an enzyme with no influence on the reaction itself107. This 
section describes the development of the MS-based method that was used to examine 
1) enzyme substrate specificities and 2) full kinetics by monitoring the product 
formation qualitatively and quantitatively respectively. The general scheme of 
operation is shown in Figure 3.1, and details will be discussed in the following sections.  
 
Figure 3.1: General scheme of the workflow of MS-based enzyme activity test. 
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3.1.1 Qualitative analysis for enzyme activity 
Qualitative analysis was used to detect the formation of the desired glycosylated 
product against various substrates of interest. The positive activity of a UGT against a 
substrate was preliminarily identified by detecting the expected glycosylated product’s 
mass ions (with appropriate modification by MS, e.g. [M-H+]- in negative-ion mode) 
using the ‘full scan’ mode of MS. The formation of the potential glycosylated product 
was further confirmed by MS/MS analysis using the ‘product ion’ mode. The presence 
of the ions of the aglycone indicated a confirming rather than a false signal of the 
potential glycosylated product in the previous step.  
As MS has unique requirements of experimental conditions, the conditions for the 
enzyme reaction and the MS analysis were not the same as other methods such as UV 
spectroscopy. It is therefore necessary to discuss the procedure of sample preparation 
and MS conditions in this research. 
3.1.1.1 Sample preparation 
Selection of buffer and its concentration 
A buffer is important in maintaining the pH of a reaction. Common buffers used in 
previous literature for GT assays included Tris108-112, potassium phosphate113-116, PBS73, 
TAPS117 and HEPES59,118. In this project, Tris buffer was used and it has several 
advantages such as having good buffering capacity, low cost and most importantly is 
relatively MS friendly119. Although Tris buffer may be disadvantageous for some 
enzyme assays such as inhibiting certain enzymes (for example bimetallohydrolases120 
and Bacillus licheniformis alpha-amylase121) and incidentally destabilizing enzyme 
structure122, the literature indicated that Tris buffer is suitable for GT assays123, and has 
been frequently used in GT assays.  
Previous studies have shown that GTs can tolerate a wide range of pH. For example, 
one study showed that 74D1 was active from pH 6.0 to 9.0 (and even with a weak 
activity at pH 5.0), with its maximum activity was achieved in pH 6.0 (50 mM HEPES), 
followed by pH 7.0 (50 mM Tris or 50 mM MES)124. Another study for the 
detoxification of 2,4,6-trinitrotoluene (TNT) in At, revealed that UGT73B4 and 73C1 
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(both of which were studied in this project) were active over the pH range of 6.5-8.5 
either in Tris or in phosphate buffer57. 
Although buffer is indispensable for enzyme assays, it is not favourable for MS 
analysis. High concentrations of buffer and salts may exert adverse effects on MS 
performance such as making ion formation less reproducible and causing severe 
adduction or ion suppression125. For example, non-volatile substances in buffers may 
not be fully evaporated by ESI and will add to the analyte that causes ion suppression126. 
Additionally, the metal ions in salts may cause peak broadening with cluster and 
adduct formation125. Hence, samples for MS are required to be desalted and the buffer 
must be changed in some cases127. Alternatively, concentrations of buffer should be 
lowered to be MS friendly119. 
From previous reports, a low concentration of buffer with low concentration of a metal 
cofactor (1 mM Tris, 1mM MgCl2) was a compromise solution used for an enzyme 
reaction that was directly analysed by MS and used in many previous studies35,128-130. 
Whilst the concentrations of Tris and metal were kept low, the conditions were 
sufficient to maintain a good environment for the enzyme reaction. In experiments in 
this section, a typical reaction contained 100 µM of substrate concentrations and this 
was 10% of the concentration of the buffer. If 100% product was produced, then 100 
µM of H+ would be produced in the reaction and this would change the pH to 7.3 based 
on the Henderson-Hasselbalch equation (pH=pKa+ log([A-]/[HA]). Considering the 
turnover of reaction cannot be 100%, the buffer will be sufficient to support the 
reaction in a good environment during the reaction.   
Temperature and reaction time 
In general, enzyme activity changes with temperature. It was observed that the 
optimum temperature for enzyme activity is far from the physiological temperature of 
the plant source in some cases122. As a clear positive activity or inactivity was 
sufficient for qualitative analysis, 37oC was selected to increase the probability of 
detecting positive activity. This temperature is a common optimum temperature for 
plant GT enzymatic reactions131,132, though, the ‘body temperature’ of plants rarely 
reaches 37oC except in desert and tropical environments.  
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The reaction was incubated overnight and this incubation time ensured that the enzyme 
had sufficient time to catalyse the reaction. A long-time of incubation has been used 
in many screening experiments previously73,115. It is possible that the enzyme might 
become unstable or even degrade in such long-time incubation, leading to a decrease 
or loss of catalytic capability. However, the possible activity decrease of the enzyme 
was not the main concern in our qualitative analysis. The main concern of the 
qualitative analysis was whether the product could be formed rather than the amount 
or the rate of product formation. Hence, the possible activity decrease of the enzyme 
did not affect the judgement as to whether the product was formed.  
Given the fact that the pH of Tris buffer is sensitive to temperature, the actual pH of 
the reaction might not be exactly 7.6, which was measured at 20oC, but may have 
approximately a 0.5 pH unit change; however, this change is still in the acceptable pH 
range for glycosylation.  
Considering the above conditions, in this project, sample concentrations used for 
qualitative analysis were as follows: donor (100 µM), acceptor (100 µM), and enzyme 
in buffer (50 µL, 1 mM Tris, 1 mM MgCl2, pH 7.6). Samples were incubated at 37oC 
overnight and the reaction was followed by qualitative MS analysis.  
3.1.1.2 MS conditions 
After preparation of the conditions as detailed above, samples were examined by MS 
on whether there was a glycosylated product formed. Two modes of MS were 
performed: ‘full scan’ mode and ‘product ion’ mode.  
‘Full scan’ mode was used to evaluate if glycosylated product was formed, by 
checking whether there was a peak observed with the corresponding exact molecular 
weight (MW) of glycosylated product and or its adduct minus one, as negative-ion 
mode was used. Negative-ion mode was used as the glycosylated product would 
readily give up a proton and therefore this mode was more sensitive than the positive-
ion mode. ‘Full scan’ mode provided information about all ions in the mixture within 
the set detection range. The detection range should be large enough to include all 
possible ions. However, if the range was too large, the detection sensitivity would be 
lowered, since more ions need to be scanned per unit of time and the desired ions 
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would have less chance to accumulate in the detector. The scanning range for donor 
specificity screening was set at 100-1000 Daltons owing to the fact that with UDP-
GlcNAc as the donor, doubly charged kaempferol-GlcNAc ([2(KMP-GlcNAc)-H+]-), 
with a MW of 979 Da might be observed. The scanning range for acceptor specificity 
screening was set at 100-2000 Daltons, as the MW of product vancomycin-Glc is 1611. 
‘Product ion’ mode, also known as MS/MS analysis, was then employed to fragment 
the potential glycosylated product. Since the newly-synthesised glycosidic bond was 
readily broken, the fragment with the MW of the aglycone minus one was expected. 
The collision energy should be suitable to break the newly synthesised glycosidic bond, 
thus confirming the glycosylated product. As this was a qualitative process, the 
collision energy was not optimised for each glycosylated product, but was set at 10 eV 
for all experiments in this mode. This level of collision energy ensured that the newly 
synthesised glycosidic bond would break, but was not so high that the glycosylated 
product would be fragmented into too small fragments that could not be attributed.  
3.1.2 Quantitative analysis for enzyme activity 
Quantitative analysis of enzyme activity delivers data of the initial rate of 
glycosylation at different substrate concentrations, from which the kinetics of an 
enzyme can be obtained. MRM mode was performed, which provided highly-targeted 
and accurate quantification analysis of the analyte. Two analytes were monitored: 
glycosylated product (Glycosylated-KMP) and internal standard quercetin (Que). The 
formation of glycosylated product was measured as a function of time. The details of 
the method development are discussed below. 
3.1.2.1 MS conditions (MRM parameters set up)  
To better monitor the Glycosylated-KMP and internal standard Que, their optimal 
MRM parameters were required, this included 1) optimal transition of analyte in MRM 
mode (precursor ions→ product ions) 2) optimal MS conditions applied (including 
fragmentor voltage (Frag), collision energy (CE) and acceleration voltage (CAV)).  
A standard sample was prepared by mixing the glycosylated product and the internal 
standard. The software ‘MassHunter Optimizer’ automatically initiated the injection 
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of the sample, showing the abundance of analytes at different MS conditions. Each 
injection was performed in a certain MS condition, showing the abundance of 
analyte’s transition in this MS condition. Finally, the optimal transition analyte was 
chosen (the one with highest abundance, highlighted characters in Table 3.1) and the 
corresponding MS condition was selected (highlighted characters in Table 3.1). These 
optimised MRM parameters were used to monitor analytes in the quantitative analysis. 
Table 3.1: MRM optimiser results of Glycosylated-KMP (KMP-3-O-Glc, KMP-GlcNAc, KMP-Rha) 
and internal standard (Que). The optimal transition analyte and condition are highlighted in yellow (the 
one with highest abundance). 
 
Compound  Exact MW 
(Dalton) 
Precursor 
ion 
Product 
ion 
Frag 
(eV) 
CE 
(eV) 
CAV 
(eV) 
Abundance 
(count) 
KMP-3-O-Glc 448.1 447.1 284.1 235 33 4 142114 
KMP-3-O-Glc 448.1 447.1 151.1 235 45 4 25369 
KMP-3-O-Glc 448.1 447.1 107.1 235 57 4 11794 
KMP-3-O-Glc 448.1 447.1 227.1 235 57 4 5576 
KMP-GlcNAc 489.0 488.0 285.0 200 24 4 5520 
KMP-GlcNAc 489.0 488.0 255.0 200 50 4 2063 
KMP-GlcNAc 489.0 488.0 227.0 200 50 4 1871 
KMP-GlcNAc 489.0 488.0 151.0 200 40 4 1238 
KMP-Rha 432.0 431.0 285.0 200 16 4 13323 
KMP-Rha 432.0 431.0 284.0 200 20 4 12757 
KMP-Rha 432.0 431.0 255.0 200 36 4 12401 
KMP-Rha 432.0 431.0 227.0 200 48 4 11221 
Que 302.0 301.0 151.1 170 17 4 60052 
Que 302.0 301.0 179.0 170 13 4 24715 
Que 302.0 301.0 121.1 170 25 4 16953 
Que 302.0 301.0 273.1 170 13 4 6243 
3.1.2.2 LC condition 
To measure the initial velocity of the enzymatic catalysed reaction, the quantity of 
Glycosylated-KMP was monitored as a function of time. Additionally, the quantity of 
the Que was also monitored, which was helpful to improve the accuracy and precision 
of the results in case that some unpredictable and uncontrollable errors of MS 
occurred133. Que was used as the internal standard in this section, due to its structurally 
similar to KMP and its consistent and stable ionisation in MS.  
A gradient condition was used as shown in Table 3.2. The sample volume injected was 
10 µL with a run time of 5.0 min. Glycosylated-KMP appeared at a retention time of 
~1.4 min. The internal standard Que appeared at a retention time of ~2.6 min. 
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Table 3.2: Gradient elution of mobile phase 
Time (min) Water (+0.1% FA) / ACN % Flow rate (mL/min) 
0.0 70.0/30.0 0.05 
1.0 55.0/45.0 0.05 
2.5 55.0/45.0 0.05 
5.0 70.0/30.0 0.05 
3.1.2.3 Calibration curve 
A calibration curve for Glycosylated-KMP was obtained to check the correlation of 
concentration and ion counts, using commercial KMP-3-O-glucoside as standard 
(Figure 3.2). Good linearity of KMP’s concentration (in the range of 0.001 μM – 0.500 
μM) and counts was achieved, with typical R2 values of 9.98E-01 (with internal 
standard) and 9.85E-01 (without internal standard) for three runs. The data showed 
that the internal standard increased the precision and ability of the analytical method, 
by reducing the possible influence of the fluctuation of ionisation caused by the 
environment. With the internal standard, the calibration curve yielded a line with an 
average slope of 1.64±0.03 and an intercept of 0.0004±0.0050, with a precision of 
1.83%. This calibration curve provided evidence of the precision of measurement of 
the tested analyte.  
 
Figure 3.2: Calibration curve of commercial KMP-3-O-Glc (with or without internal standard). This 
calibration curve shows the evidence of precise measurement of KMP-3-O-Glc. The internal standard 
method increases the precision and ability of the analytical method. 
However, MS is not a method without problems. For example, the system may drift 
from run to run134. Ion suppression effects may happen in every run and may vary as 
ions are accumulated in the instrument gradually135. Thus, the intra-day precision of 
MS may vary. To avoid this, a calibration curve was made along with each kinetic 
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measurement, thus ensuring the best correlation of the MS signal and the true 
concentration of products.  
3.1.2.4 Kinetic study of UGTs 
The LC-MS method developed above (Section 3.1.2.1 & 3.1.2.2) was used to 
quantitatively analyse enzyme kinetics by monitoring the formation of Glycosylated-
KMP as a function of time with Que as an internal standard. The initial rate of each 
enzymatic reaction was obtained using the d[product]/dt from the product formation 
curve at t=0 min. Mathematically, this method consists of approximating the slope 
(=first derivative) of the progressive curve at time t=0 by the average slope of the 
quasi-linear initial part136. Below, a few factors such as the kinetic model, buffer, 
temperature, concentrations of the enzyme and substrates are discussed. 
Kinetic model 
GTs’ Bi-Bi enzymatic reaction usually follows a Bi-Bi sequential mechanism, in 
which the EAB complex is formed in a catalytic process. This mechanism is either a 
Bi-Bi random sequential mechanism (if there is no compulsory order for substrates 
binding with enzymes) or a Bi-Bi ordered sequential mechanism (if there is a 
compulsory order for substrates binding with enzymes). A Bi-Bi Ping-pong 
mechanism is inferred when no substrate EAB complex is formed in the catalytic 
process, which is another possible but rather rare mechanism for GTs. 
In Bi-Bi enzymatic reactions, no matter ordered or random sequential, the kinetic 
parameters can be calculated by the same equation: 
 ! = #$%& ' [)]+,'+)-+) ' -+' ) - ' [)]																																																																																	Equation 3.1  
Where 
KIA: inhibitor parameter of enzyme-substrate A; 
KA: Michaelis parameter of substrate A; KB: Michaelis parameter of substrate B; 
Vmax: maximum velocity reaction. 
  Chapter 3 
 82 
In reciprocal form ([B] is varied at fixed [A]), 
/! = +)#$%& / + +,'' /) + /#$%& / + +'' 																																																											 Equation 3.2  
From this equation, it can be deduced that if 123	is very small compared to 13, the 
slopes of the plots become insensitive to the [A]. In addition, the [A] cannot greatly 
exceed	123, otherwise the slopes of 1 5 versus 1 [6] at different concentrations of 
A will be non-responsive (Figure 3.3). Consequently, the [A] in the experiments need 
to be kept in the low range compared to 123. 
 
Figure 3.3: Reciprocal form plots in the Bi-Bi sequential system, at fixed [A] and varying [B]. 
Kinetic models can be used not only to calculate kinetic parameters according to the 
equations above, but also, they can reveal more details of enzyme kinetic behaviour. 
For example, the relation between KIA and KA often suggests whether the already-
bound substrate promotes or prevents the binding of the co-substrate137. For a strict 
random mechanism, substrate A or B has exactly the same opportunity to bind the free 
enzyme E, or the enzyme-co-substrate complex, which means KIA=KA (or KIB=KB). In 
this case the family of plots will intersect on the x-axis. If the EA (or EB) complex 
prevents the co-substrate from binding towards the enzyme, a higher affinity will be 
required to bind the free enzyme. This will lead to KIA<KA (or KIB<KB), such that the 
family of reciprocal plots will intersect below the x-axis. Conversely, if the already-
bound substrate promotes the binding of the co-substrate, it will lead to an intersect 
point above the x-axis (KIA>KA or KIB>KB). The same logic can also be applied in the 
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ordered mechanism. The relation of KIA and KA can be obtained not only from the 
kinetic parameter calculation but also from the pattern of reciprocal plots. If	13 < 123, 
the ratio of 13 /123  will be below 1, causing the lines of the reciprocal plots to 
intersect above x-axis, and vice versa (Figure 3.3). 
Kinetic mechanisms and parameter calculations 
Reciprocal plots provide a convenient way to distinguish the kinetic mechanism, as 
the family of plots intersects in the sequential mechanism and appears parallel in the 
Ping-pong mechanism.  
However, the calculation of kinetic parameters from reciprocal form plots may not be 
precise as the reciprocal form model distorts the error structure of the data to some 
extent. For example, data points at high substrate concentrations are compressed into 
a small region, while data points at lower substrate concentrations are emphasised. 
Therefore, it is more precise to calculate the kinetic parameters by the original 
equation without reciprocal transformation (Equation 3.1). 
Based on the Equation 3.1, there are two independent variables ([A] and [B]) and four 
parameters (KA, KB, KIA, and Vmax) that need to be calculated. Therefore, the parameter 
calculation concerns the interpolation and approximation of data in three dimensions. 
Consequently the surface fitting model was used to fit the kinetic model in this 
research138. 
Kinetics conditions 
The buffer used for the kinetic study was the same as the qualitative analysis. However, 
the temperature used in this section was not 37oC, but room temperature instead 
(laboratory temperature controlled at 20oC by air conditioning). This is close to the 
plant's real environment, although plant UGTs probably have higher activity at 
37oC131,132. Room temperature was also frequently used in previous research for plant 
enzyme assays139,140. 
It should be noted that the use of room temperature means that the temperature is not 
vigorously controlled. Room temperature might be affected by many factors such as 
the condition of air conditioning, weather conditions and the room conditions. In order 
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to avoid the fluctuation, future optimisation includes a temperature control such as the 
use of a water bath to keep the temperature consistent.   
Selection of enzyme concentration ([E]) 
A kinetic study of an enzyme requires a suitable and known [E] because 1) based on 
a kinetic model assumption, [E] should be kept as low as possible but remain within 
the detectable range122, and the kinetic parameter kcat is calculated by dividing Vmax by 
[E]; 2) high [E] leaves a limited time to observe a progressive curve (the curve of 
product quantity Vs time) with a clear linear part, which is key to the calculation of 
the initial rate. The reaction rate will be very fast with a high [E] and the reaction will 
enter the equilibrium phase within a very short time period or even at the onset of the 
experiment122. Therefore, [E] in a kinetic study should be carefully considered, to 
produce a significant progressive curve of the reaction with a clear linear part. 
Experiments were designed to select the most suitable [E] for every tested UGT. 
Herein, the selection of [E] of 78D2 with UDP-Glc and KMP is exemplified. 
UDP-Glc (10 µM), KMP (10 µM) and 78D2 at a range of concentrations (0.0020, 
0.0010 and 0.0002 mg/mL) were mixed and incubated in the buffer (1 mM Tris, 1 mM 
MgCl2, pH 7.6). Aliquots were picked up at 5, 15, 30 and 50 min time intervals and 
treated as described in Chapter 2 to stop the reaction. Formation of the Glycosylated-
KMP was quantified by the MRM mode. Progressive curves with different [E] values 
were then obtained (Figure 3.4).   
 
Figure 3.4: Selection of [E] in the kinetic study of 78D2 with UDP-Glc and KMP. Different 
concentrations of 78D2 were used: 0.0020 (curve 1), 0.0010 (curve 2) and 0.0002 (curve 3) mg/mL. 
Substrates were fixed at 10 µM UDP-Glc and 10 µM KMP. As this step was a quick test to show the 
[E] values required approximately, it was performed only once and therefore no error bars were 
displayed. 
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As Figure 3.4 shows, progressive curves with different shape profiles were observed 
at different concentrations of 78D2 at 0.0020, 0.0010 and 0.0002 mg/mL (curve 1, 2, 
and 3 respectively). Curve 1 shows the initial rate period (the linear part of progressive 
curve) lasted less than 30 mins, and was followed by a plateauing of the curve, which 
indicated that the reaction entered the equilibrium phase. Curve 2 and 3 did not reach 
a plateau within the monitoring period and good linear responses were recorded 
(PMCCcurve 2=0.99 and PMCCcurve 3=0.96).  
For 10 µM UDP-Glc and 10 µM KMP, all three concentrations of 78D2 tested were 
suitable, as clear initial rate periods (the linear part of a progressive curve) were 
detected. However, a further full kinetic test was not limited to an [S] of 10 µM, but 
ranged from low [S] (e.g. 2 µM) to high [S] (e.g. 50 µM). In this case, [E]=0.0020 
mg/mL (curve 1) might be too high for experiments with a low [S], as the reaction 
might happen so quickly and might enter the equilibrium phase so quickly even at the 
onset of the experiment. On the other hand, [E]=0.0002 mg/mL (curve 3) might be too 
low for experiments with a low [S], as the reaction might happen so slowly that a low 
amount of product would be produced at the onset of the experiment, leading to a weak 
signal detection of the product. Besides, 0.0002 mg/mL (curve 3) might not be suitable 
for experiments with a high [S], as such a low [E] would probably become the reaction 
limiting factor, which would contradict the kinetic assumption that only [S] correlated 
with the velocity rate. Hence, medium [E] (0.0010 mg/mL, curve 2) was a good 
compromise to avoid possible problems and to be suitable in the full kinetic study of 
78D2. 
This step was carried out as a standard method to select the suitable [E] for the kinetic 
study of every enzyme. The concentration used for every enzyme is summarised in 
Chapter 2. 
Selection of substrate concentration ([S]) 
Enzyme kinetics is described by the relationship between [S] and its corresponding 
velocity. In a conventional enzyme assay, the selection of an [S] range is an iterative 
process, with an optimal [S] range covering 1/5-5 of the KM value141. To find the first 
estimation, a wide range of [S] values was used, and subsequent iterations were then 
performed, until an [S] range of 1/5-5KM was covered. However, in a Bi-Bi kinetic 
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reaction, the first estimation is hard to achieved approximately through a simple 
experiment due to the complexity of the Bi-Bi kinetic model (there are 10 parameter 
rates in the Bi-Bi ordered sequential model (Appendix, Figure A.1) and 18 parameter 
rates in the Bi-Bi random sequential model (Appendix, Figure A.2).  
Consequently, an empirical estimation based on the previous literature was necessary. 
From previous literature, it was found that [S] in the range of 1s-100s µM can cover 
KM values of many UGTs59,73,108,110,111,113,116-119,142-144. Hence, this [S] range was used as a 
first estimation in this project. Below, the rationality of 1s-100s µM [S] was examined 
from the aspects of the Bi-Bi kinetic model and MS practical considerations. 
The [S] cannot be too high 
According to Equation 3.2 and Figure 3.3, the slope of reciprocal plots depends on the 
ratio of KIA and [A]. If [A] is much larger than KIA, the variation in slopes of 1/v versus 
1/[B] is non-responsive to a change in [A] (Figure 3.5). Hence, for an enzyme with 
unknown kinetic parameters, [S] should be kept low. 
 
 
Figure 3.5: 3D plot of full kinetic simulation model (KA=10 µM, KB=10 µM, KIA=100 µM, Vmax=1E-04 
µM/min). This figure shows a reciprocal form of kinetics with [A] and [B] vary. Contour amber lines 
show the major level of the z axis, indicating that 1/v Vs 1/B became non-responsive in a high [A] 
range.  
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Apart from consideration of the kinetic model, the practical issues of ion suppression 
in the MS should be considered. Although an internal standard was added to minimise 
the impact of ion suppression, the impact of ion suppression might still have an adverse 
influence on the linear response of ESI-MS with increasing [S]145. 
In order to explore how ion suppression impacted the linear response of ESI-MS in 
this experiment, the counts of KMP-3-O-Glc/Que MRM were measured at different 
[KMP-3-O-Glc] with different [UDP-Glc]s added (Figure 3.6). It was observed that 
with an increasing [UDP-Glc], both R2 and PMCC in the curves that correlate MRM 
counts and concentration were decreased, indicating a decrease in a linear response of 
ESI-MS with increasing [S] in our experiment. 
 
Figure 3.6: Correlation Curve of commercial KMP-3-O-Glc and counts KMP-Glc/Que. This series of 
curves show that linear response of ESI-MS gradually decreases with increasing [UDP-Glc]. 
The [S] cannot be too low 
As discussed above, a high [S] range was not recommended, to avoid the non-response 
of the reciprocal kinetic form and the linear response decrease of ESI-MS. However, 
[S] cannot be too low, especially at the beginning of the reaction, as the product 
formation will fall below the detection limit of the MS. In the first few trials, we 
suggested keeping the [S] above 1 µM. 
Taking all of these factors together, [UDP-Glc] were set to 2, 5, 10, 20 and 50 µM, 
while [KMP] were set to 2, 5, 10 and 20 µM. As discussed above, we considered that 
the empirical estimation of [S] range was reasonable based on a previous study, the 
Bi-Bi kinetic model and practical considerations. Moreover, it had the advantage of 
simplifying the experimental design.  
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However, it cannot be ignored that an empirical estimation can bring some problems. 
Each enzyme has its own unique kinetic behaviour. And one enzyme may behave 
differently towards a different substrate. Consequently, if the same [S] range is used 
for all of the enzymes and all of the substrates, it may not be optimal for all, and the 
actual KM value may drop out of the uniform [S] range. Specifically, the imperfect [S] 
range may bring two major problems: 1) the error in the kinetic calculation may be 
big, although a surface fitting model can still be applicable even if the KM of the 
enzyme is out of the tested [S] range; 2) the reciprocal plots may not be clearly 
responsive, as KIA of a different enzyme varies and results in KIA/[A] not being high 
enough to make a clear responsive correlation of 1/v Vs 1/[B]. 
With the disadvantage of an empirical estimation of [S] range in this step, the data 
quality of the enzyme varied. This will be further discussed in section 3.3 depending 
on the specific data of each enzyme. 
Determination of enzyme full kinetics 
This project provided the full kinetics of 73B4, 73B5, 73C1, 73C5, 73C6, 76E11, 
76E12, 78D2 and 89B1 (acceptor: KMP; donor: UDP-Glc for all, UDP-Gal for 73C5 
and 78D2, UDP-GlcNAc for 73B4). Herein, 78D2 glycosylation towards UDP-Glc is 
exemplified as a representative to illustrate the workflow in obtaining full kinetics 
results. The general procedure is summarised in Figure 3.7. 
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Figure 3.7: Workflow of 78D2 full kinetics (donor: UDP-Glc). 1) KMP-Glc was monitored in MRM 
mode (447→284) and quantified at a fixed concentration of acceptor and donor. As a function of 
reaction time, the initial rate of enzymatic velocity was calculated in these conditions; 2) with the data 
of initial rate, the Michaelis-Menten curve was obtained fixing KMP at 20 µM but varying UDP-Glc at 
2, 5, 10, 20 and 50 µM; 3) Michaelis-Menten curves of fixing KMP at 2, 5, 10 and 20 µM were obtained 
in the same way as above. If needed, the reciprocal form of the Michaelis-Menten curve (Lineweaver-
burk plots) could be applied. 
The full kinetics of 78D2 were measured with varying both concentrations of KMP 
and UDP-Glc. The experiment was set up by a fixed [KMP] at 2, 5, 10 and 20 µM, 
and there were five samples of each with a [UDP-Glc] of 2, 5, 10, 20 and 50 µM. In 
total, 20 reaction samples with a volume of 150 µL for each were assembled. Enzyme 
was added in the last step to facilitate the reaction. 25 µL of solution from each reaction 
sample was extracted at 5, 15, 30 and 50 minutes after the start of the reaction and was 
transferred to a new Eppendorf tube, then acetonitrile was added to precipitate the 
enzyme therefore stopping any further reaction. 
KMP-Glc formation in all 80 samples (20 reaction samples x 4 time points) was 
monitored by the MRM mode. Figure 3.7 shows that the peak area of KMP-Glc 
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increased with a longer reaction time at specific [S]; thus, the velocity at this condition 
could be obtained with (v=d[P]/dt) (Step 1). Subsequently, the Michaelis-Menten 
curve of the enzyme’s velocity, with [KMP] fixed at 20 µM against different [UDP-
Glc] (varied at 2, 5, 10, 20 and 50 µM), was obtained (Step 2). Subsequently, the full 
set of kinetic results of the enzyme at different [KMP] was obtained following the 
same methodology (Step 3). Reciprocal plots provided a simple way to distinguish the 
enzymatic mechanism (Optional step): reciprocal plots intersected in the Bi-Bi 
sequential mechanism and were parallel in the Ping-pong mechanism. 
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3.2 Substrate specificity GAR screening 
Characterisation of 29 purified recombinant UGTs from group B (89B1 and 89C1), D 
(73B4, 73B5, 73C1, 73C2, 73C3, 73C4, 73C5, 73C6, 73C7 and 73D1), F (78D1 and 
78D2), H (76C2, 76C3, 76C4, 76C5, 76E3, 76E4, 76E5, 76E9, 76E11, 76E12, 76F1 
and 76F2) and L (74C1, 75C1 and 75D1) was conducted, along with their substrate 
specificities in this section.  
A sugar donor library was set up for donor specificity screening, containing eight 
nucleotide sugars (Figure 3.8): a-D-UDP-Glucose (UDP-Glc), a-D-UDP-Galactose 
(UDP-Gal), a-D-UDP-N-acetylglucosamine (UDP-GlcNAc), a-D-UDP-N-
acetylgalactosamine (UDP-GalNAc), b-L-UDP-Rhamnose (UDP-Rha), b-L-dTDP-
Rhamnose (dTDP-Rha), a-D-GDP-Glucose (GDP-Glc), and b-L-GDP-Fucose (GDP-
Fuc). The diverse combination of glycosyl parts and nucleoside parts offered a broad 
scope for donor screening of UGTs.  
 
Figure 3.8: Summary of donor structures. (A) α-D form sugars: the core sugar structure is Glc. Gal 
differs in the –OH orientation at C4 position of the Glc. GlcNAc replaces the –OH at C2 position of the 
Glc with an -NAc moiety. The nucleoside part can be replaced by UDP and GDP; (B) β-L form sugars: 
the core sugar structure is Rha. Fuc differs in the –OH orientation at C2 and C4 positions of Rha. The 
nucleoside part can be replaced by UDP, dTDP and GDP. 
The acceptor library mainly contained types of plant secondary metabolites, including 
anthraquinone, coumarin, alkaloid, saponin, flavonoid, cyanogenic and a plant 
hormone (structure shown in Chapter 2, Figure 2.7). These aglycones are frequently 
found as plant secondary metabolites and as hormone homeostasis metabolites. In this 
section, the experimental data are reported of UGTs’ activities towards 48 acceptors 
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in vitro, using UDP-Glc as the donor (with the exceptions that 78D1 and 89C1 used 
UDP-Rha as donor).  
3.2.1 Donor specificity 
Of the 29 UGTs, twelve of these were shown to be GlcTs (73B450,57,146, 73B550,147, 
73C157,148, 73C550,148-150, 73C650,151, 75C1152,153, 75D1154, 76C2148, 76E1150, 76E1250, 
78D250,146,152, and 89B150,146), whilst 78D1151 and 89C1155 were RhaTs. 
As discussed above, a sample was assembled with KMP (100 µM), donor (100 µM) 
and UGT (0.01~0.1 mg/mL) in the buffer (50 µL, 1 mM Tris with 1 mM MgCl2, pH 
7.6) and incubated at 37ºC overnight. Samples were analysed by ‘full scan’ mode and 
‘product ion’ mode of MS, providing the results of positive/ambiguous/no activity 
towards the tested donor and UGT. Results are summarised and displayed as Green-
Amber-Red, or ‘GAR’156, denoted as the colour red (no activity), colour amber 
(ambiguous activity), and colour green (positive activity) (Figure 3.9).  
             
 
Figure 3.9: GAR screening result of donor specificity (KMP as the sugar acceptor) (top). The activity 
of UGTs is denoted as green (positive), amber (ambiguous) or red (no activity). The phylogenetic tree 
to the left reveals the origin and homology of the tested enzymes. SDS-PAGE of the 11 UGTs (purified 
UGTs display MW around 75 kD, with a 26 kD GST tag) is displayed to show the existence of protein 
(bottom). 
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Experimental data in this research revealed that UGT 73B4, 73B5, 73C1, 73C5, 73C6, 
76E11, 76E12, 78D2 and 89B1 use UDP-Glc as their substrate, consistent with 
previous research. The confirmation of positive substrate specificity can be found in 
Appendix.  
Other known GlcTs 75C1152,153, 75D1154, 76C2148 did not show activity under current 
condition, probably because they could not use KMP as acceptor. Other UGTs (group 
D 73C2, 73C3, 74C4, 73C7 and 73D1; group H 76C2, 76C3, 76C4, 76C5, 76E3, 76E4, 
76E5, 76E9, 76F1 and 76F2; group L 74C1, 75C1 and 75D1) did not show detectable 
glycosyl transfer activities in the current conditions. 
In summary, the data shown in Figure 3.9 not only supports previous research, but also 
validates the methodology used. In addition, a broader donor range was revealed and 
is reported in this research for the first time: 73B4 and 78D2 with UDP-GlcNAc 
activity; 78D2 and 73C5 with UDP-Gal; 78D2 with GDP-Glc; 78D1 and 89C1 with 
dTDP-Rha. 
From this result, it was observed that UDP-Glc is the most frequently used donor for 
the tested UGTs. This result is consistent with previous research which found that 
most plant UGTs favoured UDP-Glc as the donor, whereas mammalian UGTs often 
used UDP-Glucuronic acid157. From the perspective of structure, the high selectivity 
and specificity of the enzymes may originate from their active sites158. Thus, the 
substrate specificity can be a reflection of the flexibility of the active site of the enzyme. 
As suggested by evolutionary theory, the more promiscuous the active sites are, the 
more they facilitate change159,160. In these results, 78D2 had the broadest range of 
donors among tested our UGTs. It can be suggested that the active site of 78D2 might 
be the most flexible in these enzymes, thus tolerating the most structural change and 
range of donors.  
Apart from an overall reflection of the flexibility of the active site, the different 
structures of the donors revealed some important information about the binding sites 
of the enzyme. For example, in the crystal structures of β4Gal-T1 (natural donor: 
UDP-Gal) complex with UDP-Glc and with UDP-Gal, a β4Gal-T1+UDP-Gal+Mn2+ 
complex was observed pointing towards the C4 position of Gal and forming a with 
D318. However, the β4Gal-T1+UDP-Glc+Mn2+ complex was observed pointing away 
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from the C4 position of Glc and no longer interacting with D318, due to the –OH 
orientation change at the C4 position161. This example revealed that the orientation of 
the –OH moiety at C4 position may influence the enzyme-substrate complex 
formation therefore influencing enzyme specificity. This is possibly why GlcTs cannot 
use UDP-Gal, even though there is only a subtle difference between Glc and Gal. 
Hence, according to the donor specificity results shown above, the active sites of 73B4, 
73B5, 73C1, 73C6, 76E11, 76E12 and 89B1 are sensitive to the orientation of the –
OH group at the C4 position, while the active sites of 73C5 and 78D2 can tolerate it. 
The tolerance of UDP-Gal for GlcTs was also observed in some studies, for example, 
ceramide GlcT showed dual activities of UDP-Glc and UDP-Gal, though the UDP-
Gal activity was just 10% (kcat/KM) of that compared to UDP-Glc activity162. 
Donor UDP-GlcNAc is a larger molecule than UDP-Glc, with an N-acetyl group rather 
than an –OH group at the C2 position. With the bulkier and more hydrophilic 
functional group, GlcNAc may make significant steric barrier in the place of Glc, thus 
most UGTs cannot accommodate UDP-GlcNAc and catalyse the reaction. In this 
project, only 73B4 and 78D2 showed UDP-GlcNAc activity, indicating that their 
active sites can tolerate the N-acetyl group at the C2 position of the sugar.  
Apart from the sugar part, UGTs showed a high specificity towards UDP, as their 
names indicate. However, some UGTs also showed tolerance of other nucleosides. In 
this project, dTDP and GDP were tested. dTDP has subtle structural differences as 
compared to UDP: an additional CH3 group attached at C5 of the uracil ring and the 
lack of an –OH at position C2’ of the ribose. These slight structural changes may not 
make any significant steric barrier to dTDP in the place of UDP, and to support this, a 
crystal complex of the SpsA+dTDP complex showed an identical binding pattern to 
the SpsA+UDP complex163. As experimental results showed, the compatibility of UDP 
and dTDP nucleosides was also suggested in the RhaTs 78D1 and 89C1. However, 
GDP was difficult for the UGTs to accommodate. GDP differs in many aspects 
compared to UDP, with an additional imidazole ring and an NH2 replacement at C2 
position of the nucleotide. With the big structural changes to the nucleotide, only 78D2 
showed tolerance towards the GDP base, which indicated the possible flexibility of 
the nucleotide binding region in the active site of 78D2. 
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The correlation between the enzyme active site structure and function is not 
straightforward. However, the amino acid sequence and structure of the enzymes may 
provide some useful insights. This will be presented in the next Chapter, providing 
some possible explanations as to why different UGTs showed different donor 
specificity.  
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3.2.2 Acceptor specificity 
3.2.2.1 Acceptor specificities – group D UGTs 
 
 
Figure 3.10: GAR screening results of acceptor specificities for the D group UGTs (UDP-Glc as donor) 
(top). The activity of UGTs is denoted as green (positive), amber (ambiguous) or red (no activity). A 
‘+’ in the amber circle means that the signal for the glycosylated product was very strong in the ‘full 
scan’ mode of MS, but was not detected in the ‘product ion’ mode of MS. The structures of the available 
acceptors are shown at the bottom.  
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From Figure 3.10, it was found that the group D UGTs can use many compounds and 
not only limited to flavonoids. Some new acceptor specificities of group D UGTs were 
discovered (with UDP-Glc as donor), including that 73B4 can use Esculetin, 7-
hydroxylcoumerin-3-carboxylic acid, and caffeic acid; 73C1 can use 2,5-
dihydroxylbenzoic acid with UDP-Glc as the donor; 73C5 had a broad acceptor 
specificity of aloe emodin, Esculetin, novobiocin (reported previously164), gossypol, 
3,4-dihydroxylbenzoic acid and 2,5-dihydroxylbenzoic acid.  
Additionally, flavonoid activities were varied for different UGTs. There were six 
flavonoids tested in this study: baicalein (No. 16), luteolin (No. 17), Que (No. 18), 
fisetin (No. 19), KMP (No. 20), and taxifolin (No. 21). The tested group D enzymes 
showed selectivity towards the six flavonoids. For example, 73C1 only exhibited 
positive activity towards flavonoids with an –OH group at the C3 position (Que, fisetin 
and KMP), probably as a 3-O-flavonoid GlcT. In addition, the presence of chirality of 
the flavonoid was also important. Among the tested UGTs, only 73C5 and 73C6 could 
use taxifolin, indicating their tolerance towards the presence of a chiral centre in 
taxifolin. 
3.2.2.2 Acceptor specificity screening – groups B, F, H and L UGTs 
UGTs from four other groups were also examined using UDP-Glc as a donor (except 
78D1 and 89C1, which used UDP-Rha) as the donor. Their activities are summarised 
below. 
 
Figure 3.11: GAR screening results of the acceptor specificities for the B group UGTs (89B1 with UDP-
Glc, 89C1 with UDP-Rha as donor). The activity of UGTs is denoted as green (positive), amber 
(ambiguous) or red (no activity). A ‘+’ in the amber circle means that the signal for the glycosylated 
product was very strong in the ‘full scan’ mode of MS, but not detected in the ‘product ion’ mode of 
MS. Structures of the available acceptors are shown in Figure 3.17 bottom. 
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Group B 89B1 and 89C1 can also use Esculetin (Figure 3.11). Furthermore, enzymes 
showed selectivity towards flavonoids. 89B1 did not tolerate the presence of chirality 
in taxifolin, whilst 89C1 did.  
 
Figure 3.12: GAR screening results for the acceptor specificities for the F group UGTs (78D1 with 
UDP-Rha, and 78D2 with UDP-Glc as donor). The activity of the UGTs is denoted as green (positive), 
amber (ambiguous) or red (no activity). The structures of the acceptors are shown in Figure 3.17 bottom. 
Group F 78D1 and 78D2 showed a narrow acceptor range (Figure 3.12). Both were 
sensitive towards the presence of chirality in taxifolin, as neither utilised taxifolin as 
a substrate in these conditions. 78D1 only exhibited positive activity towards 
flavonoids with an –OH group at the C3 position, possibly inferring that 78D1 is a 3-
O-RhaT, which is consistent with previous research151. 
 
Figure 3.13: GAR screening results of acceptor specificities for H group UGTs (UDP-Glc as donor). 
The activity of UGTs is denoted as green (positive), amber (ambiguous) or red (no activity). Structures 
of the acceptors are shown in Figure 3.17 bottom. 
Group H 76E11 and 76E12 also showed a narrow acceptor specificity (Figure 3.13). 
They could only use flavonoids as acceptors. Neither of them could tolerate the 
presence of chirality in taxifolin. 76E11 only displayed positive activity towards Que, 
fisetin and KMP, showing its possible characterisation as a 3-O-GlcT.  
Apart from the enzymes discussed above, group D 73C2, 73C3, 74C4, 73C7 and 73D1, 
group H 76C2, 76C3, 76C4, 76C5, 76E3, 76E4, 76E5, 76E9, 76F1 and 76F2, and 
group L 74C1, 75C1 and 75D1 were examined but did not show detectable 
glycosyltransfer activities (donor: UDP-Glc) in the current conditions. 
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Generally, the same group of UGTs show a very high amino acid (AA) percentage 
sequence identity, implying that they may be evolved from the same ancestor and can 
be expected to have similar functions. However, prediction from AA sequence identity 
is not always reliable. Many UGTs have different acceptor specificity systems even 
though their AA sequences are highly similar. 
For example, there are four UGTs belonging to group B (89A1P is the putative 
glycosyltransferase pseudogene) with an AA identity of approximately ~40%. Based 
on the phylogenetic tree, they are inferred to have evolved from the same ancestor and 
this would suggest a similar substrate specificity. This inference is true for 89B1 and 
89C1, which both had flavonoid activity. However, it was not the case for 89A2 in a 
previous study, which only used benzoates and not flavonoids146. These results 
suggested that the acceptor specificities for group B UGTs have commonalities to 
some degree, but vary depending on the specific enzyme.  
As mentioned above, an enzyme’s substrate specificity can originate from the active 
site of the enzyme. In UGTs, the acceptor binding region is located in the N-terminal 
domain and possesses relatively higher variations of AA sequence than that in the 
donor binding region (located in the C-terminal domain)19. Different UGTs have 
different AAs in their active sites to interact with different acceptors. Moreover, one 
UGT may have different AA in its active site to interact with similar acceptors. The 
comparison of crystal structures of the 72B1 complex with KMP (PDB: 4REL) and 
delphinidin (PDB: 4REM) is a good example to illustrate this phenomenon. Compared 
to KMP, delphinidin has additional –OH groups at C3’ and C5’ of ring B, but lacks a 
carbonyl group at C4 of ring C. These structure changes can shift their accommodation 
in 72B1, subsequently affecting some variations on specific sites: P78 bound to the –
OH group at C4’ of delphinidin, but not to the –OH group at C4’ of KMP; D181 
interacted with the –OH group at C7 of both delphinidin and KMP with different 
rotations that might result in a difference in the strength of the binding effect. This 
example clearly illustrated that different molecules have different ways of interacting 
with the same enzyme even though they have high similarities in structure. 
Consequently, any change of the acceptor structure may lead to the change of 
interaction and consequently affect the observed catalytic activity. This phenomenon 
was observed in the experimental data regarding the selectivity of flavonoids in this 
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section. Five flavonoids were tested and showed differential specificity towards 
different enzymes. This may be explained by differences in the active site of the 
specific enzyme from the perspective of a structure-based enzyme study.  
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3.3 Multi-substrate enzyme kinetics 
In this part, full kinetics of UGTs were examined under varying concentrations of both 
substrates. Compared to a simplified pseudo-Uni kinetic model, a more detailed 
picture of the reaction kinetics could be obtained. 
The full kinetics of nine active UGTs (73B4, 73B5, 73C1, 73C5, 73C6, 76E11, 76E12, 
78D2, and 89B1) were examined, with the acceptor as KMP and corresponding donors. 
3.3.1 Full kinetic study – Group D UGTs 
The reciprocal forms of plots are displayed to distinguish between sequential and Ping-
pong mechanisms (Figures 3.14-3.20). The kinetic parameters were calculated using 
Equation 3.1 by surface fitting model (Figure 3.21). 
 
Figure 3.14: Reciprocal form plots of 73B4 full kinetics (donor: UDP-Glc). Left: concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
 
Figure 3.15: Reciprocal form plots of 73B4 full kinetics (donor: UDP-GlcNAc). Left: concentration of 
KMP (B) is fixed at 2, 5, 10, and 20, with UDP-GlcNAc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
concentration of UDP-GlcNAc (A) is fixed, with KMP (B) varying. Their concentration range is the 
same as on the left. 
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Figure 3.16: Reciprocal form plots of 73B5 full kinetics (donor: UDP-Glc). Left: concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
 
Figure 3.17: Reciprocal form plots of 73C1 full kinetics (donor: UDP-Glc). Left: concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
 
Figure 3.18: Reciprocal form plots of 73C5 full kinetics (donor: UDP-Glc). Left: concentration of KMP 
(B) is fixed at 1, 2, 5, and 10, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: concentration 
of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same as on the left. 
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Figure 3.19: Reciprocal form plots of 73C5 full kinetics (donor: UDP-Gal). Left: concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Gal (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
concentration of UDP-Gal (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
 
Figure 3.20: Reciprocal form plots of 73C6 full kinetics (donor: UDP-Glc). Left: concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as in the left. 
 
 
Figure 3.21: 3D plot of full kinetics of 73B4 towards UDP-Glc. This Figure shows that the two 
concentrations of donor (A) and acceptor (B) vary. Full kinetic parameters are calculated by a nonlinear 
regression analysis that allows simultaneous fitting of the data. This is representative of the surface 
fitting model. 
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Table 3.3: Kinetic parameters of Group D UGTs. 
A: donor; B: acceptor (KMP)  
* means the data not converged in surface modelling, and their parameters were obtained from pseudo 
single calculation. 
 
The families of reciprocal plots intersect in both conditions that donor concentration 
was fixed (acceptor concentration was varied) and acceptor concentration was fixed 
(donor concentration was varied). These results reveal that group D UGTs follow a 
Bi-Bi sequential mechanism, ruling out the possibility of a Ping-pong mechanism.  
UDP-Glc activity in Group D UGTs 
As introduced in Chapter 1, KM values are the concentration of substrate at which half 
the active sites are filled and the requirement of significant catalysis to occur65. Thus, 
KA and KB of UGTs imply the substrate concentration required for significant 
glycosylation to occur. The KA of group D UGTs varies from 2 to 22 µM and KB varies 
from 1.8 to 110 µM. There are indeed big differences between individual GTs 
although they belong to the same group. From the KM data shown in Table 3.3, 73C1 
requires the smallest concentration (2.0E-06 M) of UDP-Glc for the significant 
catalysis, while of 73C6 requires 11-fold higher concentration (2.2E-05 M) of UDP-
Glc. For acceptor KMP, 73B4 requires the least (1.8E-06 M) while 73C6 needs 61-
fold higher concentration (1.1E-04 M).  
This fact more or less reflects the preference/sensitivity of an enzyme towards certain 
substrate, which can be a reference to some applications such as chemo-enzymatic 
synthesis. If the kinetic data are used to speculate enzyme in vivo activity, some 
Donor UGT KA (M) KB(M) KIA(M) Vmax(M/S) kcat(s-1) kcat/KA 
(s-1M-1) 
UDP-
Glc 
73B4 3.1E-06 
±1.9E-06 
1.8E-06 
±9.5E-07 
4.8E-05 
±3.1E-05 
1.6E-11 
±1.4E-12 
3.8E-04 
±3.2E-05 
1.2E+02 
±7.6E+01 
 73B5 4.0E-06 
±2.4E-06 
1.5E-06 
±5.3E-07 
2.4E-05 
±1.4E-06 
4.5E-13 
±5.5E-14 
1.8E-05 
±2.2E-06 
4.5E+00 
±2.8E+00 
 73C1* 2.0E-06 
±2.5E-06 
4.7E-05 
±5.2E-05 
- 7.3E-12 
±3.6E-12 
3.0E-04 
±1.5E-04 
1.5E+02 
±2.0E+02 
 73C5 3.9E-06 
±5.0E-06 
2.0E-06 
±1.2E-06 
1.6E-05 
1.3E-05 
1.9E-11 
±4.3E-12 
7.7E-04 
±1.8E-04 
2.0E+02 
±2.6E+02 
 73C6* 2.2E-05 
±1.1E-05 
1.1E-04 
±1.2E-04 
- 5.7E-10 
±4.0E-10 
2.3E-02 
±1.6E-02 
1.0E+03 
±9.4E+02 
UDP-
Gal 
73C5 4.1E-07 
±1.3E-07 
6.0E-07 
±1.2E-07 
3.3E-06 
±1.5E-06 
1.1E-13 
±2.5E-15 
1.6E-06 
±3.6E-08 
4.0E+00 
±1.3E+00 
UDP-
GlcNAc 
73B4* 1.1E-06 
±1.5E-07 
4.3E-05 
±6.8E-06 
- 4.3E-12 
±2.1E-13 
4.9E-05 
±2.4E-06 
4.6E+01 
±6.7E+00 
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considerations are required. For example, although 73B4 seems to facilitate 
glycosylation easier than 73C6 from the aspect of KM, it is not reasonable to infer that 
73B4 plays a better or more important role in vivo than 73C6 as they are expressed in 
different tissue (73B4 is expressed in roots147 while 73C6 was expressed in leaves and 
flowers151). To make the most use of kinetic data, specific considerations of further 
applications are required. 
In addition, KM values of UGTs can be used to suggest the Bi-Bi mechanism, i.e., 
whether it belongs to Bi-Bi ordered or Bi-Bi random mechanism119. A literature survey 
suggests that the KM ratio [KB/KA (when KB>KA) or KA/KB (KA>KB)] can be used as an 
evidence to identify random or ordered sequential mechanism. Random sequential 
displayed a ratio in the range 1.1~7.5, while ordered sequential showed a ratio in the 
range 7.4~485119. This method can be employed for a quick distinction between 
random and ordered mechanisms. Alternatively, product inhibition can be used, which 
is effort and chemical consuming. 
To validate the reliability of the method using KM ratio to distinguish Bi-Bi 
ordered/random mechanism, traditional product inhibition assay of 73C5 was 
performed (Figure 3.22).  
 
Figure 3.22: Product inhibition of 73C5. Mixed inhibition patterns are observed. 
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Product inhibition pattern of 73C5 showed all mixed patterns (Figure 3.22), indicating 
a Bi-Bi random sequential mechanism. This complies with the fact that the KM ratio of 
73C5 is 1.9 (±2.7) that is in the range of KM ratio range of Bi-Bi random mechanism. 
This experiment indicates that KM ratio is a convenient, reliable tool to determine the 
Bi-Bi mechanism.  
Following the same method, 73B4, 73B5, and 73C6 towards UDP-Glc are also 
suggested to follow a Bi-Bi random sequential mechanism as well, with KM ratio of 
1.7 (±1.4), 2.7 (±1.9) and 3.8 (±6.3) respectively. 
The turnover of an enzyme can also be reflected from the parameters such as Vmax and 
kcat65. It is the ability of an enzyme to convert the number of substrate molecules into 
product in a unit of time (typically second) in a saturated condition. However, Vmax is 
not frequently used as it is [E] dependent. Hence, kcat is introduced as it excludes the 
influence of enzyme concentration (by dividing Vmax to [E]). The values of kcat show 
that group D UGTs have different catalytic capability: 73B5 has the lowest catalytic 
capability (1.8E-05 s-1) while 73C6 has the highest (2.3E-02 s-1), which is 1300-fold 
higher. 
kcat/KM is typically used to measure the catalytic efficiency65 or catalytic performance  
towards certain substrate165. Using this criterion, 73C6 has the highest catalytic 
efficiency/performance using UDP-Glc (1000 s-1M-1), while 73B5 has the lowest 
catalytic efficiency/performance (4.5 s-1M-1) that is 222-fold smaller than 73C6. 
The KIA of 73B4, 73B5 and 73C5 are larger than their corresponding KA. The fact that 
KIA>KA indicates that the complex of donor-enzyme may promote KMP subsequent 
binding (as discussed in Section 3.3.1), which can be called as ‘donor-driven 
promotion of acceptor binding’166 that generally found in GT1 enzymes. 
UDP-Glc and UDP-GlcNAc activity of 73B4 
In addition to UDP-Glc, 73B4 also uses UDP-GlcNAc. KA comparison between UDP-
GlcNAc and UDP-Glc shows that a higher concentration of UDP-GlcNAc is required 
to facilitate significant catalysis (a 2.8-fold difference). The kcat suggests that the 
catalytic capability of 73B4 towards UDP-Glc is 7.8-fold higher than that towards 
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UDP-GlcNAc. The Kcat/KA highlights that 73B4 has a 2.6-fold greater catalytic 
efficiency/performance towards UDP-Glc than UDP-GlcNAc. Taking all parameters 
together, UDP-Glc is indicated as a better substrate for 73B4 compared to UDP-
GlcNAc.  
As for kinetic mechanism, it is suggested that 73B4 may facilitate UDP-GlcNAc 
transfer by the Bi-Bi ordered sequential mechanism, with KM ratio of 47 (±18). This is 
different from the kinetic mechanism by which 73B4 catalyses UDP-Glc, showing that 
73B4 may follow a donor-dependent kinetic mechanism. 
In previous studies, O-GlcNAc transferases (OGTs) were proposed to transfer UDP-
GlcNAc in a Bi-Bi ordered sequential mechanism as well. They were initially 
predicted to follow a Bi-Bi ordered sequential mechanism via kinetic experiments, 
with KM ratio of 18 (KUDP-GlcNAc = 6.0 μM and KCKII = 107 μM)167. This prediction from 
the perspective of kinetics was approved by the structure study with a substrates-
enzyme complex in catalytic process by a ternary complex crystal structure of human 
OGT-UDP-CKII168,169. UDP was bound firstly to human OGT, followed by its α-
phosphate binding to the backbone amide of serine of CKII, thereby aligning CKII in 
the correct position. Once CKII was attached to the binding pocket, access to the active 
site was blocked. After the formation of the ternary substrate complex, the side chain 
of CKII attacked the anomeric carbon and formed a β-glycosidic linkage. The 
glycopeptide product was then released, followed by UDP.  
In this research, 73B4 is also suggested to follow a Bi-Bi ordered sequential 
mechanism. The same Bi-Bi ordered mechanism might suggest the the co-evolution 
relationship of UGTs36 that with the same function (UDP-GlcNAc) but from different 
origins (plant and human).  
UDP-Glc and UDP-Gal activity of 73C5 
73C5 has dual donor activities towards UDP-Glc and UDP-Gal. KA reveals that 73C5 
requires an 11-fold higher concentration of UDP-Gal than UDP-Glc to facilitate 
significant catalysis. The values of kcat and kcat/KA indicate that 73C5 uses UDP-Glc 
with a 480-fold higher catalytic capability and 50-fold higher catalytic 
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efficiency/performance than that of UDP-Gal. These experimental data indicate that 
UDP-Glc acts as a better donor candidate for 73C5 than UDP-Gal.  
As for the kinetic mechanism, it is suggested that 73C5 uses the both donors in Bi-Bi 
random sequential mechanism with KM ratio towards UDP-Glc (1.9 (±2.7)) and UDP-
Gal (1.5 (±0.5)). 
As discussed above, the relation between KIA and KA often suggests whether the 
already-bound substrate promotes or prevents the binding of the co-substrate. The 
values of KIA of both UDP-Glc and UDP-Gal are larger than their corresponding values 
of KA. Consequently, it is suggested that when the donor binds the enzyme, a lower 
affinity is required for the acceptor to bind the free enzyme. 
3.3.2 Full kinetic study – Group B, F and H UGTs 
UGTs from group B (89B1), H (76E11 and 76E12), and F (78D2) were also examined 
using the same method. The results are displayed in Figures 3.23-3.27. 
 
Figure 3.23: Reciprocal form plots of 89B1 full kinetics (donor: UDP-Glc). Left: Concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
Concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
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Figure 3.24: Reciprocal form plots of 76E11 full kinetics (donor: UDP-Glc). Left: Concentration of 
KMP (B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
Concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
 
Figure 3.25: Reciprocal form plots of 76E12 full kinetics (donor: UDP-Glc). Left: Concentration of 
KMP (B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
Concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
 
Figure 3.26: Reciprocal form plots of 78D2 full kinetics (donor: UDP-Glc). Left: Concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Glc (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
Concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
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Figure 3.27: Reciprocal form plots of 78D2 full kinetics (donor: UDP-Gal). Left: Concentration of KMP 
(B) is fixed at 2, 5, 10, and 20, with UDP-Gal (A) varying at 2, 5, 10, 20, and 50 µM. Right: 
Concentration of UDP-Glc (A) is fixed, with KMP (B) varying. Their concentration range is the same 
as on the left. 
Table 3.4: Kinetic parameters of group B, H and F 
A: donor; B: acceptor (KMP) 
* means the data is not converged in surface modelling, and their parameters were obtained from 
pseudo-Uni calculation 
 
 
Donor UGT KA (M) KB(M) KIA(M) Vmax(M/S) kcat(s-1) kcat/ KA       
(s-1M-1) 
UDP-
Glc 
76E11 4.9E-06 
±9.8E-06 
6.3E-06 
±6.4E-06 
3.8E-05 
±4.4E-05 
2.3E-12 
±7.9E-13 
3.3E-05 
±1.1E-05 
6.7E+00 
±1.4E+01 
 76E12 6.9E-07 
±2.1E-07 
1.4E-06 
±4.0E-07 
5.9E-06 
±2.7E-06 
2.0E-10 
±9.5E-12 
7.9E-03 
±3.7E-04 
1.1E+04 
±3.5E+03 
 78D2 6.5E-06 
±2.1E-06 
9.1E-06 
±3.6E-06 
3.7E-05 
±1.4E-05 
2.5E-11 
±3.8E-12 
3.2E-03 
±4.8E-04 
4.9E+02 
±1.8E+02 
 89B1 3.1E-06 
±3.3E-06 
7.7E-06 
±3.7E-06 
1.0E-05 
±7.4E-06 
1.9E-10 
±3.5E-11 
4.7E-03 
±8.8E-04 
1.5E+03 
±1.6E+03 
UDP-
Gal 
78D2 3.7E-05 
±1.4E-05 
6.3E-06 
±3.2E-06 
1.1E-05 
±1.1E-05 
2.5E-13 
±5.5E-14 
6.3E-06 
±1.4E-06 
1.7E-01 
±7.5E-02 
 
UDP-Glc activity in group B, F and H 
As Figures 3.23-3.27 show, families of reciprocal form plots are intersected, indicating 
group B, F, and H UGTs follow sequential mechanisms. 
In four tested UGTs from these three groups, KA of UDP-Glc lies in a range of 6.9E-
07 M (76E12) ~ 6.5E-06 M (78D2), with a 9.4-fold difference. KB of KMP is located 
in a narrower range of 1.4E-06 M (76E12) ~ 9.1E-06 M (78D2), with a 6.5-fold 
difference. According to the result, 76E12 needs the lowest concentration of substrates 
to facilitate significant catalysis, while 78D2 requires the highest. 
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The values of kcat and kcat/KA indicate the catalytic capability and 
efficiency/performance of these tested UGTs. 76E12 has the highest catalytic 
capability and efficiency/performance, with kcat 7.9E-03 s-1 and kcat/KA 1.1E+04 s-1M-1, 
while 76E11 has the lowest with kcat 3.3E-05 s-1and kcat/KA 6.7E+00 s-1M-1. The KIA of 
these four enzymes are all larger than corresponding KA, suggesting that donor-enzyme 
binding may promote acceptor-enzyme binding.  
From KM ratios, 76E11, 76E12, 78D2 and 89B1 are suggested to follow Bi-Bi random 
sequential mechanism, with KM ratios as 1.3 (±2.9), 2.0 (±0.8), 1.4 (±0.7) and 2.5 (±2.8) 
respectively.  
UDP-Glc and UDP-Gal activity of 78D2 
For 78D2, UDP-Glc is believed to be a better substrate candidate than UDP-Gal in 
aspects of KA, KB, kcat and kcat/KA: The KA of UDP-Glc is lower than that of UDP-Gal 
(18-fold), showing that a lower concentration of UDP-Glc can facilitate the 
glycosylation. Besides, kcat and kcat/KA also reveal that 78D2 can transfer Glc with 510-
fold higher catalytic capability and 29,000-fold higher catalytic 
efficiency/performance than that of Gal.  
Notably, KIA of 78D2 towards UDP-Gal is smaller than its KA, consistent with the 
intersecting point below the x-axis in Figure 3.27. This result indicates that the binding 
of the donor-enzyme may prevent the binding of the acceptor-enzyme, rather than the 
‘donor-driven promotion of acceptor binding’166 that generally found in GT1 enzymes. 
From KM ratio, 78D2 is suggested to facilitate Gal transfer in the Bi-Bi random 
sequential mechanism with a ratio value of 5.9 (±3.7). The mechanism is the same as 
Glc transfer reaction of 78D2. 
So far, the full kinetics of nine active UGTs (group D 73B4, 73B5, 73C1, 73C5 and 
73C6; group H 76E11 and 76E12; group F 78D2, and group B 89B1) were examined. 
The in vitro kinetic study of UGTs can be used to not only describe the enzymatic 
process, but also shed light on many related research topics such as in vivo metabolism. 
Many plant GT researches showed the catalytic specificity of recombinant enzyme in 
vitro is the same/similar as that in vivo170,171. In addition, many experimental evidence 
  Chapter 3 
 112 
suggested KM provides an approximation of substrate in vivo65. Apart from the 
reference to in vivo metabolism, some other applications such as chemo enzymatic 
synthesis can use the information derived from kinetics, such as how to select a 
suitable UGT with desired substrate and optimise a reaction condition for maximum 
efficiency. Moreover, the kinetic data obtained in this chapter will be further discussed 
along with the active site analysis of enzymes (Chapter 4). 
3.3.3 Error analysis 
It cannot be neglected that there were errors in the full kinetic study of UGTs as 
displayed above, which were generally not low. In this section, possible origins of 
these error will be discussed mainly including two areas: data fitting and experimental 
design.  
Firstly, errors might originate from the process of data fitting mathematically. 
Compared to the single substrate kinetic model, the Bi-Bi mechanism kinetic model is 
multivariate hence very complicated (Section 3.1.2.4 and Appendix A.1). Regression 
analysis of such a complicated mathematic equation (Equation 3.1) requires a large 
amount of preciously measured data. However, the data amount was limited due to 
MS being used. Therefore, the regression could produce mathematical fittings with 
large error.  
In addition, the MS method itself can contribute to error. The process of MS 
fragmentation can reduce some sensitivity of MS although MRM can help increase a 
confident detection, however, the error might be big especially at the initial rate stage 
where not many products were formed. Although measures that minimise the possible 
errors had been taken such as using internal standard, systematic errors can occur 
including 1) MS system may drift from run to run in many aspects such as sensitivity134. 
This happens particularly for long time experiments. In a full kinetic experiment, 80 
samples plus a calibration curve were measured, which lasted around 8 hours. 
Although the error from system drift could be reduced by using internal standard 
method, it could happen and be accumulated; 2) Ion suppression frequently occur and 
may vary during each experiment134. This error was minimised by using internal 
standard and avoiding using a high concentration of substrates (discussed in Section 
3.1.2). However, it is hard to be fully eliminated; 3) Measurement of a signal intensity 
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always carries a minimal intrinsic error134. This error is inversely proportional to the 
square root of the number of ions detected for that signal. This error is relatively large 
in the quantification of a small amount of analyte and cannot be reduced by using an 
internal standard (Discussed in Section 3.1.2); 4) Contaminating substances may 
generate ion signals that interfere with the quantification of analyte ion134. Although 
MRM mode can recognise an analyte specifically by its specific MRM transition, 
contamination might associate with analyte thus resulting in the change of MRM 
transition of analyte. The contamination is hard to be avoided in a shared laboratory, 
though a one-hour cleaning program was performed before each time; 5) Sample 
handling of MS by autonomous injection might cause unpredictable random errors172.  
Although there are many other methods to test UGT kinetics, such as coupled assay 
and fluorescent-based UGT assay, they all have different limitations. For example, 
coupled assay requires additional coupled enzymes with 2 steps to turn into UV/VIS 
signal, which probably influence the kinetics of tested enzyme. A few trials were 
conducted using this method but it was decided not to go further due to various 
practical limitations. Finally, the MS was adopted in this research with several 
advantages especially on direct monitoring of the reaction without any modification 
and was proved as a robust method previously.  
Another possible error might come from the experimental design – [S] range used in 
an experiment. With the complexity of a full kinetic model, it is hard to estimate a 
rough KM experimentally then designing a [S] range of 1/5-5KM. Hence, an empirical 
estimation (with considerations previous studies, kinetic model and practical problems) 
of [S] range was performed (discussed in Section 3.1.2). Although kinetic parameter 
calculation is not affected by imperfect [S] range mathematically, the imperfect [S] 
range may affect the optimal performance of experiments and lead to large errors. 
According to the data generated above, some enzyme kinetics probably need to be 
double checked with the new 1/5-5KM [S] range to obtain the best quality data (Table 
3.5). This will be done as one of the future works.  
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Table 3.5: 1/5-5KM [S] range based on the full kinetic experimental KM value 
Donor UGT Range [A] (µM) Range [B] (µM) 
UDP-Glc 73B4 0.6-16 0.4-9.0 
 73B5 0.8-20 0.3-7.5 
 73C1 0.4-10 9.4-240 
 73C5 0.8-20 0.4-15 
 73C6 4.4-110 22-550 
 76E11 1.0-25 1.3-32 
 76E12 0.1-3.5 0.3-7.0 
 78D2 1.3-33 1.8-46 
 89B1 0.6-16 1.5-39 
UDP-Gal 73C5 0.1-2.1 0.1-3.0 
 78D2 7.4-190 1.3-32 
UDP-GlcNAc 73B4 0.2-5.5 8.6-220 
Table 3.5 gives the optimal [S] range according to traditional kinetic theory. This 
guides the [S] range applied in future experiments, however, careful consideration 
should be taken: 1) As discussed in Section 3.1, too low [S] might not be enough to 
produce detectable signal of products especially at the onset of the experiment. For 
example, in the 73C5 catalysed UDP-Gal reaction, signal counts of KMP-Gal in MRM 
were 146 counts at 2 µM UDP-Gal and 2 µM KMP at time point 5 minutes. If [S] is 
re-designed according to Table 3.5, signal counts of KMP-Gal in MRM would be 
estimated (based on kinetic equation with 73C5 UDP-Gal kinetic parameters obtained 
above) only 1 count at 0.1 µM UDP-Gal and 0.1 µM KMP. Such low signal count is 
not acceptable due to MS detection limit (discussed in Section 3.1). Hence, the [UDP-
Gal] concentration range cannot reach as low as 0.1 µM. To avoid problem of 
detection limit, [S] concentration is recommended not below 1 µM to ensure that 
enough signal ions can be detected. Hence, UDP-Gal concentration range for 73C5 
UDP-Gal kinetic test should be adjusted to 1.0-2.1 µM rather than 0.1-2.1 µM; 2) 
Concentration of KMP cannot be too high due to its poor solubility in buffer. The 
precipitate was observed when the concentration near 200 µM. Hence, the range of 
KMP concentration should always be below 200 µM. 
All in all, all kinetic results above were reported with final errors from experimental 
design and data fitting, which was not low indeed. For cases where the error was larger 
than the data itself, it is recommended to repeat the experiment for a better result. 
It should be noted that enzyme activity can be influenced by manifold factors. 
Different enzymes show their highest activities under different optimum conditions. 
Any deviation from the optimum conditions leads to the reduction of enzyme activity 
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that may be relatively subtle or crucial. Hence, enzyme activity reported in this project 
is only applied to the conditions clarified. 
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3.4 Conclusions 
In this study, 29 recombinant UGTs from group B (89B1 and 89C1), D (73B4, 73B5, 
73C1, 73C2, 73C3, 73C4, 73C5, 73C6, 73C7 and 73D1), F (78D1 and 78D2), H (76C2, 
76C3, 76C4, 76C5, 76E3, 76E4, 76E5, 76E9, 76E11, 76E12, 76F1 and 76F2), and L 
(74C1, 75C1, and 75D1) were examined in the aspects of substrate specificities, 
kinetic mechanism and parameters.  
Donor library (UDP-Glc, UDP-Gal, UDP-GlcNAc, UDP-GalNAc, UDP-Rha, dTDP-
Rha, GDP-Glc and GDP-Fuc) and acceptor library (48 acceptors included) were set 
for the substrate specificity screening of UGTs, and displayed as a GAR figure (Green: 
positive activity; Amber: ambiguous activity; Red: no activity). The product formation 
was detected by a combination of the ‘full scan’ mode and ‘product ion’ mode of MS. 
Nine out of these 29 UGTs (except 78D1 and 89C1) used UDP-Glc, while 78D1 and 
89C1 used UDP-Rha. Some new donor activities of these UGTs were discovered, 
including 73C5 and 78D2 with UDP-Gal, 73B4 and 78D2 with UDP-GlcNAc, 78D2 
with GDP-Glc, 78D1 and 89C1 with dTDP-Rha. As for acceptor specificities, all of 
these 11 UGTs utilised flavonoids (UDP-Glc as the donor, with the exceptions that 
78D1 and 89C1 used UDP-Rha). Additionally, coumarins were used in 73B4 
(Esculetin, 7-hydroxylcoumerin-3-carboxylic acid), 73C5 (Esculetin), 89B1 
(Esculetin), and 89C1 (Esculetin). Caffeic acid could be used for 73B4. Aloe-emodin, 
gossypol and benzoic acid derivatives (3,4-dihydroxylbenzoic acid and 2,5-
dihydroxylbenzoic acid) could be used for 73C5. 
Full kinetics of nine UGTs (73B4, 73B5, 73C1, 73C5, 73C6, 76E11, 76E12, 78D2 
and 89B1) were examined with KMP as the acceptor and their available donors. MRM 
mode of MS was performed to quantify the accumulated glycosylated product as a 
function of the reaction time. The study revealed the kinetic parameters of each UGT. 
Towards donor UDP-Glc, Michaelis parameter (KA) lay in the range 10-7~10-5 M. 
Catalytic capability was in the range 10-5~10-2s-1. Catalytic efficiency (for donor UDP-
Glc) varied in the range of 1~102 M-1s-1.  
Intersecting Reciprocal form plots and the KM ratio illustrated further mechanism of 
kinetics (validated by product inhibition assay of 73C5). UGTs generally mediated 
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glycosylation by Bi-Bi random sequential mechanism, however, exception was 
discovered such as 73B4 facilitated UDP-GlcNAc glycosylation via a Bi-Bi ordered 
mechanism. 
In summary, we demonstrated an in vitro characterisation of UGTs in terms of 
substrate specificity, kinetic mechanism and parameters, shedding light on the 
understanding of UGT metabolism in vivo and potential applications such as an 
alternative approach for synthesis of valuable glycans. 
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Chapter 4 Identification of catalytic key amino acids 
(ckAAs) in UGTs 
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In an enzymatic reaction, the substrates are accommodated into the active site of the 
enzyme and undergo chemical reactions. The active site of an enzyme can be divided 
into the binding site and catalytic site. AAs in the binding site (binding AAs, bAAs) 
can interact with the substrate to make an enzyme-substrate complex such as by 
forming temporary bonds (e.g. hydrogen bond89) or non-covalent interactions (e.g. van 
der Waals90). AAs in the catalytic site (catalytic AAs, cAAs) can catalyse a reaction 
such as acting as a Brønsted base to activate the substrate for nucleophilic attack91. 
Both bAAs and cAAs are key for an enzymatic reaction, and are frequently named as 
catalytic key amino acids (ckAAs)92,93. 
This chapter aims to identify ckAAs in target UGTs that showed positive activities in 
Chapter 3 (73B4, 74B5, 73C1, 73C5, 73C6, 76E11, 76E12, 78D2 and 89B1 all showed 
UDP-Glc activity. Additionally, 73B4 and 78D2 also showed UDP-GlcNAc activity. 
73C5 and 78D2 showed UDP-Gal activity), using the multiple sequence alignment 
(MSA)-based method. 
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4.1 Method development 
A crystal structure of an enzyme can provide the most direct and reliable evidence to 
identify ckAAs, by providing insight into the essence of a protein’s structure and 
interactions with other molecules directly173. However, obtaining a protein crystal can 
be a very difficult and expensive process174. For examples, proteins must be produced 
in a relatively large amount with a high level of purity and the conditions for 
crystallization need to be optimized for each enzyme. In addition, crystals, even after 
they have been obtained, must diffract well to produce an electron density map with 
sufficiently high resolution174. Thus, attempts to elucidate the molecular basis of 
proteins by crystallization frequently fall short even with much effort and time. 
Without crystal structures, rational MSA-based methods are usually adopted and 
shown to be efficient tools to identify ckAAs in enzymes93,103,175-178. Previously solved 
crystal structures of homologous proteins, in particular the complex of an enzyme-
substrate, can be used as evidence to predict potential ckAAs in other homologous 
proteins. Further experimental data from site-directed mutagenesis (SDM) can provide 
experimental evidence to identify whether potential ckAAs (inferred from MSA) play 
a significant role in enzyme activity/performance, by checking whether mutation of 
potential ckAAs have an effect on enzyme activity/performance. 
The MSA-based methodology has been widely used and acknowledged as a reliable 
experimental approach to identify ckAAs in UGTs. For example, the Thorsøe group 
identified ckAAs in UGT85B1 by using an MSA-based method with GtfA and GtfB 
as templates93. At equivalent sites of ckAAs that were located in GtfA and GtfB, AAs 
in 85B1 were inferred as ckAAs. For instance, GtfA E318 and GtfB D332 were 
observed interacting with sugar in the crystal. At the equivalent site, E410 appeared in 
85B1, thus to be inferred as a potential ckAA in 85B1 that might bind sugar as has 
been observed in GtfA and GtfB (also shown in homology modelling). Subsequently, 
alanine mutation in E410 was carried out by SDM. UDP-Glc activity of E410A 
showed a 225-fold decrease compared to the wild type (WT), thus substantiating the 
results from the MSA-based inference that E410 was a ckAA. Additionally, further 
research conducted by Osmani used the same method to identify ckAAs in 94B1 using 
71G1 and VvGT1 as templates92. N123 and D152 were inferred as ckAAs in 94B1 by 
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binding to the acceptor according to the MSA results. Subsequently, experimental data 
from SDM agreed with the significant role of these potential ckAAs by detecting that 
mutants N123A and D152A had less than 15% of activity when compared to the WT. 
In this Chapter, MSA was used to identify ckAAs in target UGTs. By comparing AA 
sequences of seven template plant UGTs whose crystal structures were already known, 
with target UGTs of 73B4, 74B5, 73C1, 73C5, 73C6, 76E11, 76E12, 78D2 and 89B1 
that were to be tested in this project, potential ckAAs in target UGTs involved in 
binding could be predicted. Then, mutations of potential ckAAs were performed by 
SDM and the activities of the mutants were compared to their corresponding WT 
enzymes. The results of the comparison of activity between mutants and WT will show 
whether the predicted important roles of those potential ckAAs are correct (general 
Scheme in Figure 4.1). This methodology provides a reliable identification of ckAAs 
from known crystal structures and avoids the structure distorting prediction from 
computational method by using experimental data (experimental data of mutants) 
instead179.  
  
Figure 4.1: General scheme of Chapter 4.  
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4.1.1 Template UGTs and MSA 
4.1.1.1 Template UGTs 
MSA was performed on nine UGTs and seven crystal-structure-known template plant 
UGTs (VvGT135, 78K679,80, 71G176, 72B181, 78G178, 85H277 and OS7982). For example, 
one of the important template UGTs used was the red grape Vitis vinifera flavonoid 3-
O-GT VvGT135, whose crystal structure was revealed with the substrates [kaempferol 
(KMP) and UDP-2-deoxy-2-fluoro-Glc (U2F)] presented in the active centre. This is 
one of the important templates that can provide valuable interaction information for 
enzymes and substrates, which makes it as the most frequently used template in many 
UGT researches180-185. In VvGT1, eight ckAAs were key to binding the donor (Figure 
4.2): W332 and E358 bound to uridine via a pi-pi bond with the uracil ring and a 
hydrogen bond with ribose respectively; T19, T280 and H350 were responsible for 
binding phosphate via hydrogen bonds; D374, Q375 and T141 were involved in 
binding Glc by forming hydrogen bonds towards O3/O4, O2/O3 and O6 of Glc 
respectively. 
 
Figure 4.2: ckAAs in VvGT1: D374, Q375 and T141 bind to Glc (Glc-O3 and Glc-O4, Glc-O2 and Glc-
O3, and Glc-O6, respectively); T19, T280 and H350 bind to phosphate; W332 and E358 bind to uridine 
(the uracil ring and ribose respectively). 
In other template UGTs, some of their ckAAs were also observed at equivalent sites 
of where the eight ckAAs in VvGT1 are listed above. For example, the D-Q (D374-
Q375 VvGT1 numbering) motif was highly conserved among template UGTs. In those 
crystal complex structures of the enzyme-substrate (72B1, 71G1 and OS79), the D-Q 
motif was also conserved to bind the –OH at the C2-C4 positions of the sugar in the 
same manner as what observed in VvGT1. In those crystal enzyme structures without 
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substrates (78G1 and 85H2 and 78K6), the D-Q motif was predicted to interact with 
donors (from crystal-based docking experiments) in the same pattern as for VvGT1. 
However, a few exceptions exist. These exceptions were ckAAs that were located at 
the N-terminal: VvGT1 T19 that bound to phosphate and T141 that bound to the Glc-
O6. Conversely the equivalent sites of VvGT1 T141, 72B1 and 85H2 did not show 
corresponding ckAAs towards the Glc-O6. At the equivalent site of VvGT1 T19, no 
corresponding AAs that bound to phosphate were observed in 72B1, 71G1, 85H2 and 
OS79. These facts showed that ckAAs in UGTs towards a donor molecule followed a 
conserved fashion in general, but with some variations. Therefore, the ckAAs in 
individual UGT need to be investigated and identified specifically. 
4.1.1.2 MSA 
MSA was performed by Clustal Omega186. This is the most recent algorithm in the 
Clustal family and enables aligning any number of AA sequences quickly and 
accurately187. Once the FASTA format of UGTs (template and target) were inputted 
into the Clustal Omega website, the software would output a result of MSA by running 
the following procedures: 1) A MSA was produced by pairwise alignments using the 
k-tuple method; 2) The sequences were clustered using the mBed method followed by 
the k-means clustering method; 3) The guide tree was constructed using the UPGMA 
method; 4) The final MSA result was produced using the HHAlign package, which 
aligns two profile-hidden Markov models (HMM)188. 
After MSA, the result was generated in Clustal w/o numbers format while the 
sequences were compared according to their similarities (Figure 4.3). Gaps were 
introduced so that the optimal MSA score was achieved. From the resulting MSA, 
sequence homology can be inferred. The signature motif of UGTs, the PSPG motif 
was observed (highlighted in the amber rectangle in Figure 4.3) in both the template 
and target UGTs. Moreover, the potential ckAAs in the target UGTs (highlighted in 
the green rectangle in Figure 4.3) were found at the equivalent site of where ckAAs in 
the template UGTs were located.  
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Figure 4.3: MSA among seven template UGTs and nine target UGTs. Potential ckAAs are highlighted 
in the green rectangle and the PSPG motif is highlighted in the amber rectangle. 
Although MSA has been acknowledged as a method to infer the potential ckAAs in 
an unknown enzyme, the level of accuracy and reliability should be considered 
according to specific UGTs189. This is due to there being an important assumption 
underlying MSA in that protein structure is related to AA sequences190. Additionally, 
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MSA can only infer and exploit the relationships of UGTs based on existing sequences, 
but the ancestral sequences and the level of evolution might differ in different UGTs190. 
Thus, further experiments (e.g. SDM) are required to validate the actual role that 
potential ckAA play in different UGTs.  
4.1.2 Mutants 
In this project, SDM was carried out to mutate each potential ckAAs inferred from the 
MSA. Mutant plasmids were transformed to XL-1 blue competent cells and mutant 
proteins were produced following the same procedures as for the WT. 
4.1.2.1 Mutant plasmids  
SDM was performed using the Q5® SDM kit (NEB) (Figure 4.4). Three steps were 
included: 1) exponential amplification; 2) treatment and enrichment; 3) transformation. 
 
Figure 4.4: Schematic diagram of SDM. SDM undergoes exponential amplification, treatment and 
enrichment, and transformation (manual of Q5® SDM kit, NEB). 
Exponential amplification (EA) 
EA in SDM is based on the principle of a polymerase chain reaction (PCR), but with 
primers incorporating the desired mutation. After the process of EA, plasmids (both 
mutant and WT) were amplified and therefore the plasmid concentration increased. 
The results of EA can be analysed by agarose gel (Figure 4.5). Agarose gel provides 
a verification of successful EA at this stage, which is crucial to ensure the success of 
subsequent procedures and to avoid the propagation of errors. 
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Figure 4.5: Agarose gel of WT 73C5 and its mutants. 1: DNA ladder; 2: Plasmid of 73C5 WT before 
EA; 3~5: EA product in SDM experiments 73C5 D397A, D397E and Q398A. This Figure is a 
representative of other experiments with successful amplification of the plasmid after the EA step. 73C5 
WT before EA could not be observed on the agarose gel due to its low concentration, however, EA 
increased the concentration of the plasmid, thus making them visible in the gel (the band appears at 
approximately 6.0 kb compared to the DNA ladder). 
In Figure 4.5, no band is shown in lane 2, as the concentration of plasmid was so low 
that it was out of the detection range of the SYBR® Safe DNA stain (500 pg/band) 
(manual of SYBR® Safe DNA stain, Thermo Fisher Scientific). After EA, a band 
around 6.0 Kb was observed in lanes 3-5 (the size of recombinant 73C5: 6.4 Kb), 
indicating that the concentration of the plasmid had increased after EA.  
It is noteworthy that in some SDM kits, such as the Agilent Quickchange® SDM kit, 
agarose gel is not required as a band may or may not be visualized at this stage191. This 
is due to the amplification being linear but not exponential in these kits, thus the 
concentration increase of plasmids after amplification is not significant to be detected 
in agarose gel. The underlying reason for the linear amplification in these kits is the 
design of the overlapping primer: the entire plasmid with overlapping primers is 
amplified and generates a nicked circular DNA that cannot take part in the next cycle 
as a DNA template191,192 (Figure 4.6). However, back-to-back primer design was used 
in this experiment. Linear DNA was generated with a back-to-back primer, thus 
allowing exponential amplification of the plasmid (Figure 4.7) 193. Such amplification 
has many advantages: it makes the product verified at this stage, to ensure the success 
of further experimental steps and to avoid error propagation; also, it enables a high 
yield of products, increasing the proportion of mutant plasmids and decreasing the WT 
background. 
 
 
                                                           Chapter 4 
 127 
 
Figure 4.6: Schematic diagram of SDM using overlapping primers. Nicked (represented by red cross) 
circulated daughter plasmids are produced in the amplification and cannot be involved in the next cycle 
as template DNA. Thus, this amplification is a linear process. 
 
Figure 4.7: Schematic diagram of SDM using a back-to-back primer. Linear DNA is produced in the 
amplification and will be involved in the next cycle as template DNA. Thus, the amplification is an 
exponential process.  
Treatment and enrichment 
EA products existed as linear DNAs which could not be transformed into competent 
cells directly and contained WT. Therefore, EA products were incubated with the KLD 
mix (kinase, ligase and DpnI), with the aim of cyclising the DNA and removing the 
WT background.  
After incubating with KLD mix, linear EA products were cyclised therefore could be 
transformed into competent cells. The cyclisation of EA products was accomplished 
by kinase and ligase in the KLD mix. Kinase is responsible for DNAs phosphorylation 
and then ligase can ligate and cyclise phosphorylated linear DNAs.  
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After cyclisation of linear DNAs, the next step was template removal. There are two 
types of WT plasmids that should be avoided: 1) ‘original WT plasmids’ that were 
extracted from cells and used as initial template plasmids at the outset of EA; 2) 
‘obtained WT plasmids’ that were produced during EA when the silent primer was 
used as the template for DNA replication. Among which, the former (‘original WT 
plasmids’) could be digested by DpnI in the KLD mix, as they were methylated 
(plasmids amplified in vivo were methylated) but the EA products were not. However, 
the latter (‘obtained WT plasmids’) could not be recognized and digested by KLD mix 
as they were also amplified in vitro. Although this might be a problem of the SDM 
experiment, it could be omitted as the proportion of ‘obtained WT plasmids’ was 
negligible. As shown above (Figure 4.7), the amplification of mutant plasmids with 
respect to cycle (n) was shown by the equation ‘2n-(n+1)’, while the amplification of 
‘obtained WT plasmids’ with respect to cycle (n) was shown by the equation ‘n-1’. 
After 25 cycles in EA, ‘obtained WT plasmids’ were overwhelmed in terms of 
numbers by the millions of mutant plasmids (24/3.36E+07=7.45E-07). 
Transformation 
After treatment and enrichment, cyclised mutant plasmids were transformed into XL-
1 blue competent cells, following the same procedures of WT plasmid transformation. 
Mutant plasmid verification 
Mutant plasmids were sent to the Source Biosource Company for verification using 
the Sanger sequencing method194. A typical sequencing result with mutant 78D2 
Q381E is shown in Figure 4.8. 
 
Figure 4.8: DNA sequencing results of 78D2 Q381E. At site 381 of 78D2, CAG (coding Q) was 
replaced by GAG (coding E) after SDM, indicating that 78D2 Q381 was successfully mutated by E. 
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In Figure 4.8, it is observed that GAG (E) replaced the original CAG (Q) at site 381 
in 78D2 after SDM, showing that Q was successfully switched to E. 
As a large number of mutants (106) was produced in this project, sequencing for all 
plasmids would be costly and time consuming. Hence, a few representative mutant 
plasmids were selected for verification. These mutant plasmids were 73C6 Q398A, 
78D1 N374Q, 78D2 Q381E and the double point mutant 78D2 C357A-C374A. Sanger 
sequencing showed that all of these selected mutant plasmids were constructed 
correctly, indicating the reliability of the method. In addition, the same sequence 
checking was carried out by another PhD student's project in our group and the results 
showed that the mutant plasmids were constructed correctly, which demonstrated the 
robustness, reliability and reproducibility of our method.   
In some previous studies195-197, the plasmid verification step was also omitted in the 
SDM experiment when using NEB Biolabs Q5 SDM kit as its highly efficient, reliable 
and robust (discussed above)193.  
Despite the low probability of wrong mutant plasmids produced by the NEB Biolabs 
Q5 SDM kit, it was possible that mutants might not be correctly constructed. An 
unsuccessful SDM may cause the same activity detected between the WT and mutant 
enzyme in the next step. This could lead to a confusion about the reason for unchanged 
activity which could be due to the failure of the mutation or due to the insignificant 
role the potential ckAA plays, which gives a wrong indication to the identification of 
ckAAs. Thus, the sequence should be double-checked, especially for those mutants 
with unchanged activity compared to the WT, in the future. 
4.1.2.2 Production of mutant protein  
The production of mutant proteins followed the same procedure of that for the WT 
(c.f. Chapter 2): mutant proteins were induced by IPTG, purified by a GST tag column 
and verified by SDS-PAGE. 
Although previous research has shown a general trend that proteins manifested a 
robustness towards point mutations198,199, It is possible that SDM may lead to 
instability of protein folding and the change of overall conformation, resulting in the 
malfunction of a protein200. This can lead to a confusion as to whether the change of 
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activity was due to the mutation of potential ckAAs or the possible improper folding 
and conformation of the protein.  
Thus, there is an important assumption in this research that point mutagenesis did not 
change the stability and overall conformation of proteins in this project. This 
assumption has also been widely used in UGT research, such as in the study of VvGT1 
(mutants: T141A, D374A, Q375H and Q385N), Caenorhabditis elegans (a 
xylosyltransferase)201, LgtC from Neisseria meningitides202 and human Gb3/CD77 
synthase (α1,4-GalTs)203.  
In addition, a ‘Site Directed Mutator’ program (developed by the University of 
Cambridge) (http://131.111.43.103) was used to provide computational data to 
indicate whether point mutagenesis would affect protein stability. This program is 
based on a statistical potential energy function, to predict the effects of mutations on 
protein stability200. By giving the stability score DDG (PSEUDO Delta Delta G), the 
program indicates how mutants affect the stability of the protein with six classes: 
neutral (-0.5≤DDG≤0.5), slightly destabilizing (-1.0≤DDG<-0.5), slightly stabilizing 
(0.5<DDG≤1.0), destabilizing (-2.0≤DDG<-1.0), stabilizing (1.0<DDG≤2.0), highly 
destabilizing (DDG<-2.0) and highly stabilizing (DDG>2.0)200. This program has been 
used in many studies204-206. 
This program was firstly used in some template UGTs with mutagenesis data (Table 
4.1). It showed that point mutagenesis may affect the stability of a protein to some 
extent, but no ‘highly destabilizing’ was observed.  
Table 4.1: Mutations on protein stability of some template UGTs (predicted by SDM program) 
 
 
 
 
WT Mutants DDG Class 
VvGT1 H20A -0.91 Slightly destabilising 
 T141A -0.62 Slightly destabilising 
 D374A -0.21 Neutral 
 Q375H -0.15 Neutral 
 Q375N -1.49 Destabilising  
71G1 Y202A -1.19 Destabilising 
78G1 H26A -0.7 Slightly destabilising 
 E192A 0.52 Slightly stabilising 
 D376A -0.21 Slightly destabilising 
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Subsequently, the program was run with 73B4 as an example to predict whether point 
mutagenesis affected the stability of 73B4 (WT 73B4 was modelled using 71G1 as the 
template) (Table 4.2). 
Table 4.2: Mutations on protein stability of 73B4 (predicted by SDM program) 
 
Mutants DDG Class 
S270A 0.96 Slightly stabilising 
W331A 8.95 Highly stabilising 
H349A -0.75 Slightly destabilising 
E357A 0.96 Slightly stabilising 
E373A 1.76 Stabilising 
E373D 1.32 Stabilising 
E373Q 0.28 neutral 
E373K -1.28 Destabilising 
Q374A 2.81 Highly stabilising 
Q374N -0.65 Slightly destabilising 
Q374H 0.15 neutral 
Q374E 1.08 Stabilising 
As Table 4.2 shows, point mutants of 73B4 maintained the stability of the protein at 
different levels but there was no ‘highly destabilizing’ level. Therefore, it can 
reasonably be assumed that point mutagenesis of 73B4 does not disrupt the stability 
of protein.  
Although there is computational evidence to support the point mutagenesis does not 
significantly destabilise target UGTs, experimental result is required to improve the 
reliability of the research. Consequently, technology such as circular dichroism (CD) 
could be used as one of the optimisations in future work, to provide solid experimental 
evidence that point mutagenesis may be benign or harmful to protein function. 
4.1.3 Mutant activity 
Activities of mutants were checked both qualitatively and quantitatively (if active) 
with the MS method described in Chapter 3. Qualitative analysis checked the activities 
of mutants against sugar donors in the donor library (c.f. Chapter 3) with KMP as the 
acceptor. This qualitative analysis could lead to two discoveries 1) whether mutants 
lost/retained original activities and 2) whether mutants obtained new activities. Once 
mutants retained the original activities, the quantitative analysis then checked how 
much of the original activity was reduced/increased compare to WT.  
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The activity comparison was carried out between the mutant and WT (as the control) 
using a fixed substrate condition. Glycosylated-KMP counts in the MRM mode (c.f. 
Section 3.1.2) at different time intervals in the control (WT enzyme) and experimental 
groups (mutant enzyme), progressive curves (a function of MRM counts of 
glycosylated product/internal standard Vs time) of WT and mutant enzymes, were 
obtained and initial rates were compared. 
As the equation of initial rate 89 = (;<=> 1?) ∗ ( B C ) indicates, the direct initial 
rate comparison of WT and mutant enzymes in a closed system reflects their kcat/KM 
(unit: s-1M-1) comparison ([E] and [S] are fixed and the same)65. As a higher kcat/KM 
indicated better enzyme activity/performance generally, kcat/KM can be used as an 
index to give an indication of the functional effects of enzyme mutations165. Although 
separate kcat and KM provide more kinetic details of a mutant, the combination index 
kcat/KM would summarise the net advantage or disadvantage of a mutation to the 
enzyme in one constant. Hence, the interpretation of changes in enzymatic 
activity/performance by the kcat/KM index is straightforward and has a longstanding 
tradition in biochemistry practice, especially to guide directed mutagenesis research. 
Thus, this criterion was used in much research such as the enzyme 
activity/performance comparison between lipase and α-chymotrypsin207 and the 
comparison between p120GAP with the GTP-bound WT hERas and WT HRas208. 
4.1.4 Determination of ckAAs in UGTs 
Summarising steps above, the ckAAs in target UGTs were determined by 1) to infer 
potential ckAAs using MSA. The ckAAs in target UGTs were inferred at the 
equivalent site of the ckAAs in the template UGTs; 2) to obtain mutants (mutation to 
alanine or an AA with a similar character) at sites of those potential ckAAs using SDM; 
3) to analyse the mutants' activities by comparing the initial kinetic rates of WTs.  
If the mutant loses its activity entirely, it is possible that the mutated AA is significant, 
i.e. the mutated AA is a ckAA. If the original activity is retained, activity comparison 
between WT and mutant enzymes was carried out. In this project, five levels were set 
up to distinguish how significant a role the potential ckAA plays in enzyme 
activity/performance: Level  0 – mutants showing no activity (‘Very Strong’ effect 
in enzyme activity/performance); Level 1 – mutants retain <20% original activity 
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(‘Strong’ effect in enzyme activity/performance); Level 2 – mutants retain 20~50% 
original activity (‘Medium’ effect in enzyme activity/performance); Level 3 – mutants 
retain 50~80% of original activity (‘Weak’ effect in enzyme activity/performance) and 
Level 4 – mutants retain >80% original activity (‘Very Weak/No’ effect in enzyme 
activity/performance). 
As introduced above, the specific roles of ckAAs included acting as either bAA 
(binding AA) or cAA (catalytic AA) or both. Initial rate comparison between WT and 
mutants in this Chapter might not provide enough evidence to distinguish the specific 
role of that potential ckAAs play. However, it is valuable to consider investigating 
ckAAs in this Chapter as bAAs for two main reasons 1) these ckAAs in target UGTs 
were found at the equivalent site of bAAs in template UGTs; 2) cAAs of UGTs are 
frequently act as a Brønsted bases that activate the acceptor for nucleophilic attack by 
deprotonation209. This means that cAAs are likely to be located in a region that stacks 
the acceptor molecule, such as VvGT1 H20-D12135, CalG3 H11-E115210. However, 
this Chapter focuses on the donor region, where cAAs are unlikely to be located. 
Although ckAAs studied in this Chapter are more likely to act as bAAs rather than 
cAAs, the method of comparing kcat/KM between WT and mutant alone is not sufficient 
to provide solid evidence to confirm that they are bAAs. As the criterion of kcat/KM 
reflects the net effect of a mutation on the enzyme, the specific binding effect of a 
mutation on the enzyme is not accurately obtained. In order to confirm the specific 
role of potential ckAAs (cAAs or bAAs), further experiments should be done such as 
1) measurement of detailed kinetic parameters (e.g. KM). For example, UGT1A6 H371 
was identified as a bAA with the evidence of kinetic parameters that KM values of 
mutant H371A towards the acceptor (scopoletin) and donor (UDP-GA) increased by 
4- and 11-fold respectively and Kd values for the enzyme+UDP-GA complex increased 
9- fold211. These detailed kinetic values implied that the mutation severely impaired 
substrate-enzyme binding. Therefore, H371 was identified as a bAA rather than a 
cAA211. 2) Isothermal Titration Calorimetry (ITC). For example, the functional role of 
R135, D246 and R293 in α1,4-N-acteylhexosaminyltransferase (EXTL2) were 
investigated by ITC: the alanine mutations at the sites decreased Kd values 2.25-, 5.43- 
and 3.87-fold respectively and increased KM values 2.32-, 2.97- and 1.78-fold 
respectively compared to the WT (at pH 7.5), which confirmed the binding effect of 
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these three AAs212. 3) Saturation transfer difference NMR (STD NMR). As STD NMR 
can measure the affinity KD, it can be used to detect the binding. For instance, the 
binding kinetics of disaccharides trehalose and trehalose-6-phosphate to repressor 
protein TreR were determined by STD NMR213. 4) Molecular docking and dynamic 
simulation studies. For example, molecular docking and dynamic simulations were 
conducted to investigate the interaction of kinase inhibitors (KIs) with peroxisome 
proliferator-activated receptor gamma (PPARγ). By analysing the energy contribution 
for 270 (207-476) AAs in the PPARγ complex with KIs and specifically orsiglitazone, 
seven AAs (C285, R288, E295, I326, L330, I341 and S342) showed a binding free 
energy contribution of more than -2.0 kcal/mol. The seven AAs were supposed as to 
be energetically important for ligand binding in the active site via hydrophobic or 
hydrogen bond interactions214. 
The work in this Chapter will not only contribute valuable information to the 
understanding of ckAAs in the active site of UGTs, but also shed light on further 
applications of UGTs such as active site manipulation. 
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4.2 Identification of ckAAs – sugar moiety 
In this section, the potential ckAAs towards the C2, C3, C4 and C6 positions of the 
sugar moiety in UGTs were investigated using the methodology discussed above. 
4.2.1 ckAAs towards C2 and C3 positions of the sugar moiety (the AA 44 within 
the PSPG motif) 
Previous studies showed that the AA 44 within the PSPG motif (a conserved motif for 
the donor binding in plant UGTs, c.f. Chapter 1) was responsible for binding the –OH 
at the C2 and C3 positions of the Glc moiety via hydrogen bonds. At this site, Q was 
highly conserved in template UGTs (Table 4.3). 
Table 4.3: ckAAs that bind the –OH of the C2 and C3 positions of the sugar moiety in solved crystal 
structures 
Plant UGT ckAAs Result origin  
VvGT135 Q375 PDB (2C1Z) 
UGT 72B181 Q389 PDB (2VCE) 
UGT 71G176 Q382 PDB (2ACW) 
UGT 78G178 Q377 Docking 
UGT 85H277 Q403 Docking 
UGT 78K6 (Ct3GT-A)79,80 Q368 Overlay on VvGT1 
OS7982 Q390 PDB (5TMD) 
 
4.2.1.1 MSA 
MSA was performed on the template UGTs (Figure 4.9, top) and the nine target UGTs 
(Figure 4.9, bottom) to indicate the potential ckAAs in target UGTs towards the C2 
and C3 positions of the sugar moiety.  
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Figure 4.9: MSA of potential ckAAs towards C2 and C3 positions of the sugar moiety. The colours of 
residues represent their different properties: small and hydrophobic AAs AVFPMILW are coloured red; 
acidic AAs DE are coloured blue; basic AAs RK are coloured magenta; hydroxyl/sulfhydryl/amine 
AAs STYHCNGQ are coloured green. Symbols in the last line denote the degree of conservation: 
conserved (*), conserved mutations (:), semi-conserved mutations (.), and non-conserved mutations (). 
This Figure demonstrates that the potential ckAAs towards the C2 and C3 positions of the sugar moiety 
are highly conserved as Q. 
In similarity to template UGTs, Q is conserved in all target UGTs.  
4.2.1.2 SDM 
Alanine scanning 
Alanine is widely used to replace an original AA in SDM with its characteristics as 
non-bulky, inert, and containing a methyl side chain215. Alanine mutants mimic AA 
deletion by eliminating the side chain, but maintaining the primary secondary structure 
of the protein. Consequently, alanine screening can be used as an initial step to 
determine the contribution of a specific AA in an enzyme215. 
The potential ckAAs in the target UGTs were mutated to alanine firstly. The relative 
activities of alanine mutants (compared to the WT) were examined followed by and 
shown in Figure 4.10, along with the donor screening result. 
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Figure 4.10: Relative activities of mutations (WT activity set as 100%) of ckAAs towards C2 and C3 
positions of the sugar moiety (alanine scanning). The green rectangle depicts that original activities 
were retained at level 4 (>80%); the light green rectangle means that original activities were retained at 
level 3 (51%-80); the yellow rectangle shows original activities were retained at level 2 (20%-50%); 
the red rectangle depicts original activities were retained at level 0 (no activity). The olive green ‘WT’ 
indicates positive activity was detected in the WT (data from Chapter 3). 
Alanine mutants: UDP-Glc activity 
Results showed that UGT 73C1 Q394A, 73C5 Q398A, 73C6 Q398A, and 76E11 
Q374A lost all their UDP-Glc activities, indicating Q is highly important in these 
enzymes for enzymatic activity/performance. The side chain elimination of Q 
probably removed the binding to the Glc-O2 and Glc-O3 in the WT, thus leading to 
the absence of activities. To better visualise the interaction between Q and UDP-Glc, 
73C1 (as a model) was used as an example to show the interaction of Q and UDP-Glc 
by overlaying the template VvGT1 (Figure 4.11). The side chain atom NE2 of 73C1 
Q394 interacts with Glc-O2 and Glc-O3 in the same manner as that of VvGT1 Q375. 
Following the same inference, it can be inferred that Q is a ckAA in 73C1 (numbering 
394), 73C5 (numbering 398), 73C6 (numbering 398) and 76E11 (numbering 374) by 
a possible role of binding Glc-O2 and Glc-O3 (based on MSA result). This result also 
complied with some previous reports that Q played a significant role in UGTs. For 
example, mutations of UGT2B7 at Q (Q399A and Q399L) abolished morphine 
glucosidation and glucuronidation activities completely216. 
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Figure 4.11: ckAA (Q) towards Glc-O2 & Glc-O3 in modelled 73C1 (cornflower blue) overlaying on 
the crystal VvGT1 complex U2F (UDP-2-deoxy-2-fluoro-Glc) (PDB: 2C1Z). The interactions of 
VvGT1 and 73C1 towards U2F are represented by a solid and dashed line, respectively. This Figure 
demonstrates that 73C1 Q394 binds Glc-O2 & Glc-O3 in the same manner as does VvGT1 Q375. 
However, Q does not show a similar significance in some other target UGTs. For 
example, 73B4 Q374A (57%) and 78D2 Q381A (58%) still retained >50% original 
activities, which suggested that Q probably is not key in the enzyme and is not 
contributing to binding a Glc significantly. Especially in 73B5 and 89B1, the majority 
of original activities were retained (>80%, level 4), indicating that the elimination of 
the side chain Q was not sufficient to attenuate their activities. It is likely that Q in 
these enzymes is remote from the active site where the substrate is bound. 
Alanine mutants: UDP-GlcNAc activity 
As UDP-GlcNAc activity indicated, 73B4 and 78D2 had a region to accommodate 
UDP-GlcNAc and ckAAs to help binding and using UDP-GlcNAc. In crystal results 
of template GlcTs binding UDP-Glc35,76-82,217, MurG binding UDP-GlcNAc218 and 
many UGTs binding nucleotides (e.g. SpnP binding TDP219, LanGT1 binding TDP220, 
SnogD binding dUDP221 and OleI binding UDP222), the sugar donors were observed in 
a similar region of the UGTs. Thus, it was presumed that UDP-GlcNAc was located 
in the similar region where UDP-Glc is located in 73B4 and 78D2. The potential 
ckAAs towards UDP-Glc might be also important for 73B4 and 78D2 with UDP-
GlcNAc activity. 
As Glc and GlcNAc differ in the C2 position (with an –OH and N-Acetyl functional 
group respectively) structurally, ‘Q’ site attracted much attention as it was located in 
the vicinity of C2 and C3 positions of Glc and bound the –OH groups in template 
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GlcTs. As our study showed, alanine mutation of ‘Q’ site in 73B4 and 78D2 retained 
0% and 22% original UDP-GlcNAc activity respectively (Figure 4.10), which 
indicated the significant role of ‘Q’ in UDP-GlcNAc activity. As suggested by 
template GlcTs, ‘Q’ site was probably located in the vicinity of C2 and C3 positions 
of GlcNAc. Then, 73B4 Q375 and 78D2 Q381 were possible to bind –OH groups at 
C3 position of GlcNAc, explaining why the alanine mutation of ‘Q’ site reduced UDP-
GlcNAc activity. However, as GlcNAc has an N-acetyl group instead of –OH group 
at C2 position, ‘Q’ might not have the same interaction with N-acetyl group as that 
with –OH group of Glc. In the previous study of MurG+UDP-GlcNAc complex, the 
interaction equivalent to that of 73B4 Q375/78D2 Q381 was performed in MurG by a 
similarly located Q289218. Q289 was observed interacting with –OH at C3 position of 
GlcNAc but not interacting with the N-acetyl group at C2 position, moreover, no AA 
was observed interacting with the N-acetyl group via hydrogen bond at C2 position of 
GlcNAc218. Besides, another GlcNAc transfer enzyme UGT3A1 also showed Q394 
(the equivalent site of 73B4 Q375 and 78D2 Q381) was responsible for GlcNAc-O3 
binding (docking data)223. Based on these previous studies, 73B4 Q375 and 78D2 
Q381 were likely to be in close proximity to the C2 and C3 positions of the sugar and 
bind GlcNAc-O3 in the same fashion to that of template GlcTs and GlcNAcTs (MurG 
and UGT3A1).  
Although previous studies showed that there was no specific binding between C2 
position of UDP-GlcNAc and enzyme, one would be interested in that what makes 
UDP-GlcNAc rarely used in most GlcTs. A previous research provided the clue: they 
observed that analogues with bulkier substitutions at C2 position of UDP-GlcNAc 
could not be used by human short OGT224, indicating that steric occlusion at C2 
position might be the interaction pattern of GlcNAc. Thus, it was suggested that the 
interaction between target UGTs (73B4 and 78D2) and C2 position of GlcNAc was 
simple steric occlusion.  
A further question is what kind of ‘steric occlusion’ can accommodate the N-acetyl 
group at C2 position of UDP-GlcNAc, and why only the active sites of 73B4 and 78D2 
in all target UGTs can accommodate the N-acetyl group at C2 position. A close 
observation and comparison between GlcTs and GlcNAcTs was conducted 
subsequently. 
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In the previous study of MurG+UDP-GlcNAc crystal complex218, an ‘HEQN’ 
structure was observed to directly crossed from the hexose-binding site and provided 
the space to accommodate GlcNAc. This ‘HEQN’ AA sequence was conserved in 
target UGTs (Figure 4.12) and VvGT135 (a template GlcT with weak UDP-GlcNAc 
activity): H (AA 19 within the PSPG motif) – E (AA 27 within the PSPG motif) – Q 
(AA 44 within the PSPG motif) – N (AA 3 outside of the PSPG motif). The presence 
of ‘HEQN’ AA sequence provided the basic primary structure of active sites of UDP-
GlcNAc in 73B4 and 78D2. However, as only 73B4 and 78D2 could use UDP-
GlcNAc in tested UGTs, it was inferred that the secondary structure of ‘HEQN’ 
structure might vary in target UGTs and only ‘HEQN’ of 73B4 and 78D2 could form 
the conformation that provided the enough space to accommodate GlcNAc. 
 
Figure 4.12: MSA of HEQN structure. HEQN sequence is shown conserved in both GlcTs and 
GlcNAcTs. The AA sequence (HKD) for an inserted extension in ‘C2 loop’ is observed in GlcNAcT 
MurG. 
A further close look at the structure comparison between VvGT1 and MurG showed 
that the HEQN structure in MurG contained a longer loop (280-287: VPFQHKDR) 
surrounded the C2 position of hexose (named ‘C2 loop’ in this section) prior to the 
subsequent helix and provided more space to accommodate the N-acetyl group than 
that in VvGT1 (Figure 4.13). The longer ‘C2 loop’ in MurG resulted from an extended 
AA insertion HKD (284-286 Figures 4.12 and 4.13). As VvGT1 did not have such AA 
insertion, its ‘C2’ loop (369-374: RPFFGD) was shorter and provided less space. This 
was why its UDP-GlcNAc activity was much weaker (4%) than UDP-Glc in VvGT1, 
though the short ‘C2 loop’ could still provide the steric occlusion of N-acetyl group. 
This fact indicated one of reasons of why 73B4 and 78D2 could use UDP-GlcNAc: 
their HEQN structures contained ‘C2 loop’ that provided a space to accommodate N-
acetyl group at C2 position of GlcNAc. It is tempting to speculate that an insertion of 
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‘C2 loop’ in 73B4 and 78D2 might improve the UDP-GlcNAc activity, as the insertion 
might provide more space to accommodate N-acetyl group.  
 
Figure 4.13: HEQN structure and ‘C2 loop’ comparison between GlcNAcT (MurG, light yellow) and 
GlcT with weaker UDP-GlcNAc activity (VvGT1, navy blue). The AA sequence for ‘C2 loop’ was 
written below respective loop (MurG: amber; VvGT1: navy blue). It is shown that MurG has an 
extended insertion in ‘C2’ loop, which might provide more space to N-acetyl group at C2 position. 
Notably, it was thought that the AA constitution of the ‘C2 loop’ was not related to 
the secondary structure of ‘C2 loop’, i.e. the primary structure in this loop was not 
related to the secondary structure. 73B5 had almost the same AA sequence of ‘HEQN’ 
structure (27 out of 29 AAs are the same) as that of 73B4, especially they have the 
exactly the same AA sequence PMGAE (73B4 369-373 numbering; 73B5 395-397 
numbering) in possible ‘C2 loop’. However, UDP-GlcNAc activity was detected in 
73B4 but not in 73B5 in the same condition, which suggested that AA sequence in 
73B5 might not form a ‘C2 loop’ with proper secondary structure that is enough to 
accommodate N-acetyl group of GlcNAc while 73B4 could. The contrast example is 
73B4 and 78D2: their AA sequences of the ‘C2 loop’ were very different (73B4 
PMGAE 369-373 numbering; 78D2 PFFGD 364-380 numbering), however, it was 
inferred the secondary structure of their ‘C2 loops’ can provide the space to 
accommodate N-acetyl group of GlcNAc as they all possess UDP-GlcNAc activity 
Apart from the ‘C2 loop’ discussed above, we are interested in whether there is an AA 
that discriminates Glc and GlcNAc specificity might be located at other sites. For 
example, a detailed analysis of the AA sequence of UGT3A1 (an GLCNACT) 
suggested that N391 might act in GlcNAc recognition of an AA223. The idea came 
from the observation that F was conserved in all GlcTs in the same family whilst N 
was observed in 3A1 (GlcNAcTs) at the equivalent site. Further mutation of N391F 
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successfully enhanced UDP-Glc activity but decreased its UDP-GlcNAc activity223. 
Interestingly, at the equivalent site of 3A1 N391, G371 and F378 were found in 73B4 
and 78D2 respectively, but not the ‘N’ that potentially specifically recognised UDP-
GlcNAc. This may explain why 73B4 and 78D2 do not recognize UDP-GlcNAc 
specifically and prefer UDP-Glc as their native donor rather than UDP-GlcNAc. 
Alanine mutants: UDP-Gal activity 
The 73C5 Q398A mutant showed the absence of UDP-Gal activity (Figure 4.10). This 
indicated that Q398 is probably a ckAA in 73C5 when using UDP-Gal. This result is 
consistent with the suggestion from MSA that Q398 may locate near the sugar C2 and 
C3 positions, as the mutant abrogated both UDP-Gal and UDP-Glc activities.  
Contrary to 73C5, Q381 in 78D2 behaved differently towards UDP-Glc and UDP-Gal 
(Figure 4.10). 78D2 Q381A retained 58% of the original UDP-Glc activity but 0% 
original UDP-Gal activity. This may simply result from UDP-Glc being the main 
substrate for activity of 78D2 and being more resilient to mutation. Kinetic results 
showed that kcat and kcat/KM of UDP-Gal were 510-fold and 29,000-fold lower than 
those of UDP-Glc (c.f. Chapter 3). Consequently, UDP-Glc is the main substrate with 
activity for 78D2. As previous studies suggested, the main activity of an enzyme is 
‘robust’ towards mutation, whereas promiscuous activities are more ‘plastic’ from the 
aspect of evolution225. Therefore, UDP-Gal activity may show less tolerance to the 
introduction of a variance in the enzyme. 
The only difference between Glc and Gal is in the orientation of the –OH group at the 
C4 position. However, it was reported that ‘Q’ (the AA binding for the C2 and C3 
positions) may differentiate Glc and Gal94. Much research has indicated that Q 
recognised Glc specifically whilst H recognised Gal specifically103. Recently, an 
analysis of UGT8A1 (a GalT with ‘H’) gave the possible explanation of why ‘Q’ had 
a weaker binding with Gal but ‘H’ had a much stronger binding with Gal226. In their 
research, UDP-Gal was docked into the donor binding region of a UGT8A1 model. 
MD simulations of the full-length UGT8 model (with VvGT1 as the template) showed 
that ‘H’ formed a salt-bridge with its adjacent ‘D’, which acted by ‘locking’ the D-H 
dipeptide in the ligand free structure of UGT8A1. This might influence the spatial 
requirement for the preferential binding of Gal over Glc. The fact that UDP-Glc was 
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the main activity observed in 78D2 in this project might be aligned with the fact that 
‘Q’ appears in this site of 78D2. 
However, there are exceptions that ‘Q’ does not relate to or distinguish UDP-Glc and 
UDP-Gal specificities. For example, VvGT6 could use these two donors with Q373, 
and even displayed a slightly higher UDP-Gal activity against quercetin (1.4-fold and 
3.7-fold higher compared to UDP-Glc in kcat and kcat/Kdonor, respectively)104. This raised 
a speculation that Q might not be the only AA to recognise Glc. This speculation was 
supported by the Pramod research group recently. They proposed that the AA 22 
within the PSPG motif might be a potential AA to recognise the orientation of the –
OH at the C4 position specifically. W was conserved as the AA 22 within the PSPG 
motif in UGT 2B7, 2A3 and 8A1 (all are GlcTs), and the backbone –NH of W was 
observed only to recognise the specific orientation of O4 sugars such as UDP-GlcUA, 
UDP-Glc, and UDP-Xyl and interacts with the sugar ring with an hydrophobic effect226. 
At the equivalent site of target UGTs, W was also observed, which possibly explained 
why target UGTs recognised UDP-Glc specifically rather than UDP-Gal (with the 
exception that 73C5 and 78D2 have UDP-Gal activity but with a much lower 
preference).  
Effect on Q/N swap and Q/H swap 
The detailed functional roles of Q were examined by replacing Q with AAs with 
similar properties – N (Figure 4.14). 
 
 
 
 
 
 
 
                                                           Chapter 4 
 144 
Q→N 
 
Figure 4.14: Relative activities of mutations (WT activity set as 100%) of ckAAs towards the C2 and 
C3 positions of sugar moiety (Q/N swap). The green rectangle depicts that original activities were 
retained at level 4 (>80%); the yellow rectangle indicates original activities were retained at level 2 
(20%-50%); the pink rectangle indicates original activities were retained at level 1 (<20%); the red 
rectangle indicates original activities were retained at level 0 (no activity). The olive green ‘WT’ 
indicates positive activity was detected in the WT (data from Chapter 3).  
N is very similar to Q in chemistry, but with one CH2 of side chain being shorter. The 
mutant will best maintain the environment as well as the structure. This is why Q→N 
mutants relatively restored more original activity than Q→A mutants generally. 
However, a Q/N swap shortens the side chain of the AA, potentially increasing the 
distance between the enzyme and substrate therefore reducing the interaction. Hence, 
the retained activities for Q/N swap mutants might suggest the distance between the 
enzyme and substrate. 
Q/N swap mutants: UDP-Glc activity 
The Q/N swap resulted in a significant UDP-Glc activity loss in the following enzymes: 
73C6 (1%) and 76E11 (7%) retained <10% of the original activity and 73C1, 73C5, 
and 76E12 lost all of UDP-Glc activity (Figure 4.14). The significant activity loss 
implied that 73C6 Q398, 76E11 Q394, 73C1 Q394, 73C5 Q398, and 76E12 Q376 may 
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be positioned in a place where a longer distance between the enzyme and the substrate 
cannot be tolerated. Similar results were found in previous research. For example, 
VvGT1 Q375 showed a distance of 3.0 Å and 2.9 Å between Q and Glc-O2 and Glc-
O3 respectively in the WT. This distance is classified as a ‘moderate, mostly 
electrostatic’ hydrogen bond distance227. Q/N swap of VvGT1 resulted in only 1% of 
original activity (kcat/KM) being retained. Among all possibilities, it was very likely that 
the shorter side chain of N led to a greater distance between N and Glc in the mutant: 
with VvGT1 Q375N as the model (VvGT1 WT as the template), distances between 
N375 and Glc-O2 and Glc-O3 were changed to 3.5 Å (weak, mostly electrostatic 
hydrogen bonding) and 4.2 Å (out of the hydrogen bonding distance) respectively. 
However, 78D2 Q381N (82%) and 89B1 Q390N (88%) retained >80% of the original 
activities, showing that the shortening of the side chain from Q to N can be tolerated. 
Unexpectedly, 73B4 Q374N and 73B5 Q398N showed that original activities were 
enhanced (110% and 110%, respectively). This is not consistent with the hypothesis 
that the shorter side chain of the AA will increase the distance from the AA to the 
substrate therefore reducing the original activity.  
To explain this observation, it was considered that the mutation may be helpful to 
UDP-Glc activity. Figure 4.15 shows the possibility raised to explain how the mutant 
probably enhances UDP-Glc activity. The side chain atom of NE2 in the WT 73B4 
Q374 and 73B5 Q398 interacted with the Glc-O2 and Glc-O3 originally. When Q was 
mutated to N, the distance between the side chain atom of NE2 in Q and Glc did indeed 
increase, however, the distance between the side chain atom of OD1 in N and Glc 
decreased. Thus, N might bring an additional atom (OD1) into the interaction, which 
compensated for the loss of activity caused by the longer distance. In 73B4 Q374N 
and 73B5 Q398N, the compensation of a binding effect became even stronger than 
previous binding, showing an enhanced activity. Additionally, protein may have 
enough flexibility that would allow site to change its conformation and distinguish 
changes due to the shorter side chain of N. 
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Figure 4.15: Overlay of modelled WT and Q→N mutants. Left: Overlay of 73B4 WT (cyan) and 73B4 
Q374N (yellow). Right: Overlay of 73B5 WT (pink) and 73B5 Q398N (yellow). This Figure 
demonstrates that the OD1 of N in 73B4 Q374N and 73B5 Q398N exert additional binding to Glc-O3. 
Q/N swap mutants: UDP-GlcNAc activity 
Q/N swap in 73B4 decreased the original UDP-GlcNAc activity to 12%, implying that 
the longer distance between the AA and GlcNAc can be tolerated partially.   
In 78D2, it was unexpected to find Q381N led to enhanced activity. This was possibly 
achieved if N could better bind UDP-GlcNAc with a strengthened hydrogen bonding 
(discussed above).  
Q/N swap mutants: UDP-Gal activity 
Q/N swap of 73C5 and 78D2 lost all UDP-Gal activities (Figure 4.14). This indicated 
that Q in 73C5 (numbering 398) and 78D2 (numbering 381) might interact with Gal 
with a limit of hydrogen bonding distance so that the longer distance between N and 
Gal cannot be tolerated. 
Q/H swap 
Apart from a potential role of binding the –OH at C2 and C3 positions of the sugar, Q 
was previously proposed to act as a UDP-Glc recognition AA (discussed above) and 
new activities might be conferred by point mutagenesis at this site. Some previous 
studies showed that a Q/H swap might switch the activity. For example, the point 
mutant H374Q of Aralia cordata UDP-Gal anthocyanin GalT successfully conferred 
new UDP-Glc activity103. UGT8-Q383H decreased its original UDP-Glc activity by 
50% to all bile acids but enhanced UDP-Gal activity228. However, there has always 
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been the debate whether point mutagenesis by a Q/H swap can surely switch Glc or 
Gal transfer activity. Unsuccessful cases have been observed as well. 71G1 
Q382H76,229 and flavonoid GlcT UBGT Q382H103 did not acquire UDP-Gal activity by 
point mutagenesis. This paradox might be due to the set of sugar recognition AAs 
being difficult to be substituted thoroughly during the evolution process, as many 
ckAAs are evolved to stay conserved in the active site230. 
Herein, Q/H swap was subjected in some of the target UGTs, to investigate whether 
new donor specificity would be conferred in these UGTs (Figure 4.16). 
 
Figure 4.16: Relative activities of mutations (WT activity set as 100%) of ckAAs towards the C2 and 
C3 positions of the sugar moiety (Q→H). The pink rectangle indicates original activities were retained 
at level 1 (<20%); the red rectangle means original activities were retained at level 0 (no activity). The 
olive green ‘WT’ indicates positive activity was detected in the WT (data from Chapter 3). 
Although original UDP-Glc activities were greatly decreased, the Q/H swap did not 
confer any new activity. For 73C5 and 78D2 with UDP-Gal activity originally in the 
WT, a Q/H swap did not enhance their UDP-Gal activity but abrogated it conversely. 
The hypothesis that a Q/H swap leading to Glc/Gal specificity swap has not been 
demonstrated in 73B4, 73C1, 73C5, 73C6 and 78D2 in the current conditions. 
4.2.2 ckAAs towards the C3 and C4 positions of the sugar moiety (the AA 43 
within the PSPG motif) 
According to previous studies in template UGTs, the AA 43 within the PSPG motif 
was responsible for binding –OH groups at C3 and C4 positions of Glc via hydrogen 
bonds (Table 4.4). A negatively charged AA (D/E) was conserved at this site. 
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Table 4.4: ckAAs that bind –OH of C3 and C4 positions of the sugar in solved crystal structures 
 
Plant UGT ckAAs Result origin  
VvGT135 D374 PDB (2C1Z) 
UGT 72B181 E388 PDB (2VCE) 
UGT 71G176 E381 PDB (2ACW) 
UGT 78G178 D376 Docking 
UGT 85H277 D402 Docking 
UGT 78K6 (Ct3GT-A)79,80 D367 Overlay on VvGT1 
OS7982 D389 PDB (5TMD) 
 
4.2.2.1 MSA 
With the seven template UGTs, MSA was generated on the nine target UGTs (Figure 
4.17), to indicate the potential ckAAs towards C3 and C4 of the sugar moiety in target 
UGTs.  
 
Figure 4.17: MSA of potential ckAAs towards C3 and C4 positions of the sugar moiety. The colours of 
residues represent their different properties: small and hydrophobic AAs AVFPMILW are coloured red; 
acidic AAs DE are coloured blue; basic AAs RK are coloured magenta; hydroxyl/sulfhydryl/amine 
AAs STYHCNGQ are coloured green. The last line symbols denote the degree of conservation: 
conserved (*), conserved mutations (:), semi-conserved mutations (.), and non-conserved mutations (). 
This Figure demonstrates that the potential ckAAs towards C3 and C4 positions of the sugar moiety are 
highly conserved as D/E. 
From the MSA result, it was observed that a negatively charged AA (D/E) is conserved 
as the AA 43 within the PSPG motif in target UGTs. With the exceptions of 73B4 and 
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73B5 showing E, the remaining target UGTs show D. Both D and E are negatively 
charged, only differing in structure that the side chain of E has one more CH2 group. 
4.2.2.2 SDM 
Alanine scanning 
The potential ckAAs associated with the C3 and C4 positions of the sugar moiety in 
target UGTs were replaced by alanine individually. Their relative activities compared 
to the WT were examined and summarised in Figure 4.18. 
 
Figure 4.18: Relative activities of mutations (WT activity set as 100%) of ckAAs towards C3 and C4 
positions of the sugar moiety (alanine scanning). The green rectangle indicates original activities were 
retained at level 4 (>80%); the pink rectangle shows original activities were retained at level 1 (<20%); 
the red rectangle means original activities were retained at level 0 (no activity). The olive green ‘WT’ 
indicates positive activity was detected in the WT (data from Chapter 3).  
Alanine mutants: UDP-Glc activity 
As shown above, the alanine mutation caused 73C1, 73C5, 73C6, 76E11, and 76E12 
to lose their UDP-Glc activities completely. In addition, 89B1 (<1%), 73B4 (6.5%), 
and 73B5 (16%) retained their original activities <20% (level 1). Taking the MSA 
results together, the devoid or great decrease of activities by mutation can be explained 
by D/E→A preventing the hydrogen bonding between the D/E and Glc-O3 and Glc-
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O4 (Figure 4.19). Thus, D/E are inferred as ckAAs in 73B4 (numbering 373), 73B5 
(numbering 397), 73C1 (numbering 393), 73C5 (numbering 397), 73C6 (numbering 
397), 76E11 (numbering 373), 76E12 (numbering 375) and 89B1 (numbering 389). 
 
Figure 4.19: ckAA (D/E) towards Glc-O3 & Glc-O4 in modelled UGTs and crystal VvGT1 complex 
with U2F (PDB: 2C1Z). Left: Overlay of modelled 73B4 (cyan) E373 and crystal VvGT1 (tan) D374; 
Right: Overlay of modelled 73C1 (cornflower blue) D393 and crystal VvGT1 (tan) D374. The 
interaction of VvGT1 and model UGTs towards U2F is represented by a solid and dashed line, 
respectively. This Figure demonstrates that 73B4 E373 and 73C1 D393 bind Glc-O3 and Glc-O4 in the 
same manner as does VvGT1 D374. 
However, one exception was observed – 78D2. 78D2 D380A showed no significant 
change in UDP-Glc activity (92%), which meant that the elimination of the side chain 
of D/E was not sufficient to reduce the UDP-Glc activity of 78D2 significantly. Thus, 
D380 is not inferred as a ckAA in 78D2, though the MSA result indicated that it may 
be involved in binding the substrate. It is suggested that D380 may be remote from the 
active site where the substrate is bound. 
Alanine mutation at the D/E site revealed that D/E plays an important role as a ckAA 
in target UGTs with UDP-Glc activity (except for 78D2). Apart from the target UGTs 
above, previous studies also revealed the significant role of D/E. For example, UGT 
73A5 E378175 and 85B1 E41093 showed they were responsible for Glc-O3 and Glc-O4 
binding and their alanine mutants significantly reduced their UDP-Glc activities. 
Apart from plant UGTs, similar observations were also found in bacterial UGTs (e.g. 
GtfA, GtfB)231,232 and human UGTs211. For example, the alanine mutation of UGT1A6 
(originating from humans but has a distant homologous relationship to the GT1 class) 
resulted in E379 retaining only 14% of its original activity211. 
Alanine mutants: UDP-GlcNAc activity 
Mutant 73B4 E373A had a dramatic effect on UDP-GlcNAc activity (0% activity 
retained), indicating E373 may be a ckAA in 73B4 with UDP-GlcNAc activity. Taking 
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the MSA result together with this finding, it indicated that E373 is probably located in 
proximity to C3 and C4 positions of the sugar and interacts with the sugar.  
Reviewing data in the previous section, it is observed that the alanine mutation of 
73B4 at site 373 had a different effect on UDP-Glc and UDP-GlcNAc: 6.5% and 0% 
retained respectively. This difference indicated that E373 can be more helpful in 
binding UDP-GlcNAc. A further hypothesis is that the UDP-GlcNAc activity is the 
promiscuous activity of 73B4 and therefore the activity is not as robust as the main 
activity (UDP-Glc), as discussed above. 
78D2 D380A had a significantly different effect on UDP-Glc and UDP-GlcNAc 
activities: 92% and 10% respectively. This result suggests that the role of D380 in 
78D2 is dependent on substrate. It is suggested that D380 may be remote from the 
active site where UDP-Glc is bound but be in close proximity to where UDP-GlcNAc 
is bound. Although the two substrates are very likely to be orientated in the same donor 
binding region as discussed above, the detailed orientation of UDP-Glc and UDP-
GlcNAc in the region may have a shift, leading to the distance between D380 and Glc 
being out of the range that a hydrogen bond can form but that between D380 and 
GlcNAc is within the range that a hydrogen bond can form. The orientation shift of 
different substrates in the same region was observed in previous research. For example, 
in the UGT3A1 docking experiment, the distances between H35 to C1 position of 
UDP-Glc and UDP-GlcNAc were different (4.02 Å and 6.21 Å respectively), though 
the two donors were located in the same region223.  
In comparison with other GlcNAcTs, AAs located at the equivalent site of 73B4 E373 
and 78D2 D380 in GlcNAcTs were also observed to bind GlcNAc-O3 and -O4. For 
example, the crystal structure of the complex of MurG-UDP-GlcNAc (PDB: 1NLM) 
showed that polar residues in MurG anchored the –OH groups of C3 and C4 of 
GlcNAc, with Q288 specifically interacting with GlcNAc-O3 and-O4 by forming a 
hydrogen bond218. Another example was UGT3A1, which showed an interaction 
between D393 and GlcNAc-O3 and-O4 (docking experiment)223. These studies 
indicated that 73B4 E373 and 78D2 D380 might also be in close proximity to C3 and 
C4 positions of GlcNAc and acted as ckAAs to help bind GlcNAc. 
Alanine mutants: UDP-Gal activity 
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Mutant 73C5 D397A retained no UDP-Gal activity, implying that D397 is crucial to 
UDP-Gal activity. Based on the results from MSA, 73C5 D397 is proposed to be 
located in the vicinity of the C3 and C4 positions of the sugar. The interaction of 73C5 
D397 with Gal might be an analogous to the D interaction with sugar hydroxyls seen 
in GlcTs, which was observed in the docking experiment of UGT8A1 that D382 
interacted with Gal-O3 and Gal-O4226. However, as the UDP-Gal activity is much 
weaker than UDP-Glc activity (The values of kcat and kcat/KA of UDP-Gal is less than 
that of UDP-Glc with 480-fold and 50-fold respectively), the binding between D397 
and Gal-O4 might be very weak as the orientation of –OH at C4 position varies in 
UDP-Gal compared to UDP-Glc.  
Alanine mutation of 78D2 D380 showed that less than 1% original UDP-Gal activity 
was retained. It is possible that 78D2 D380 interacted with UDP-Gal in the same 
pattern as that for 73C5 D397, thus playing a catalytic key role in UDP-Gal activity. 
Or, the great reduction of UDP-Gal activity by alanine mutation was due to UDP-Gal 
being a promiscuous substrate (reflected in kinetics, in Chapter 3) and being ‘plastic’ 
towards mutation from the aspect of evolution (discussed above). This suggestion was 
inferred from the different effect of 78D2 D380A towards UDP-Glc and UDP-Gal (92% 
and <1% original activity retained). 
In other GalTs, D has been found to be highly conserved as the AA 43 within the 
PSPG motif, such as Petunia hybrida GalTs (Accession No. AF165148), Rattus 
norvegicus ceramide GalTs (Accession No. L21698), and Homo sapiens ceramide 
GalTs (Accession No. U62899). The invariant ‘D’ indicated its conserved catalytic 
key role in Gal transfer activity. 
Effect on D/E swap 
A swap between D and E was tested (Figure 4.20). The two AAs have similar 
properties with negatively charged side chains. The only structural difference between 
these two AAs is the length of the side chain, as E has a longer side chain with one 
additional CH2. It was expected that the D/E swap might restore some original activity 
and more than alanine mutation. The result of the D/E swap might indicate the distance 
between D/E and substrate by checking whether the shorter/longer distance between 
the AA and the substrate can be tolerated. 
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Figure 4.20: Relative activities of mutations (WT activity set as 100%) of ckAAs towards the C3 and 
C4 positions of sugar moiety (D/E swap). The green rectangle means original activities were retained 
at level 4 (>80%); the light green rectangle indicates original activities were retained at level 3 (51%-
80); the yellow rectangle shows original activities were retained at level 2 (20%-50%); the pink 
rectangle means original activities were retained at level 1 (<20%); the red rectangle indicates original 
activities were retained at level 0 (no activity). The olive green ‘WT’ indicates positive activity was 
detected in the WT (data from Chapter 3). 
D/E swap mutants: UDP-Glc activity 
73B4 E373D and 73B5 E397D lost UDP-Glc activity partially (30% and 35%, 
respectively), probably due to the longer distance between the AA and Glc caused by 
the shortening of the side chain. Combining the previous inference that E may be one 
of the ckAAs in 73B4 and 73B5 by binding Glc-O3 and Glc-O4, the D/E swap result 
indicated that E of 73B4 and 73B5 might interact with Glc closely and the interaction 
is strong so that the longer distance can be tolerated (Figure 4.21, left). 
D/E swap of 89B1, 73C1, and 73C5 completely or significantly reduced their UDP-
Glc activities. This result suggested that D in 89B1, 73C1, and 73C5 are located very 
close to Glc so that no additional place could tolerate one additional CH2. Thus, when 
D was replaced by E, the extended side chain might be too long and too flexible in the 
active site, causing steric hindrance and inhibiting the interaction with UDP-Glc. By 
comparing the 89B1 WT (model) and 89B1 D389E (model) (Figure 4.21, right), it was 
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observed that the side chain bond CB-CG of E in the mutant did not position in the 
same way as the side chain bond CB-CG bond of D in the WT, but rotated to another 
direction with an actual increasing distance towards the donor (which may be due to a 
repulsive effect produced by the longer side chain). This explains why the extended 
side chain did not decrease the distance to enhance the activity as expected, but instead 
caused the reduction of activity.   
 
Figure 4.21: Overlay of modelled WT UGTs and D/E swap mutants. Left: Overlay of 73B4 WT (cyan) 
and 73B4 E373D (yellow). Right: Overlay of 89B1 WT (purple) and 89B1 D389E (yellow). This Figure 
demonstrates 1) In 73B4, the shorter chain of D causes a longer distance towards Glc-O3 and Glc-O4, 
thus reducing activity; 2) In 89B1, the longer chain of E has a rotation of CB-CG bond and removes the 
binding effect towards Glc-O3 and Glc-O4 as WT, thus destroying the activity. 
However, the mutation of D was not fatal for all UGTs, as 73C6 D397E (35%), 76E11 
D373E (57%), and 76E12 D375E (28%) still retained partial activities. This indicated 
that the distance between D in 73C6, 76E11 and 76E12 and Glc was not close as the 
UGTs above (89B1, 73C1, and 73C5), which had space to tolerate one additional CH2. 
D/E swap mutants: UDP-GlcNAc activity 
73B4 E373D lost all UDP-GlcNAc activities. Taking the data above that mutation of 
E→A also lost UDP-GlcNAc activity, E373 is inferred as crucial to 73B4 towards 
UDP-GlcNAc activity. Even with this data, still 30% of UDP-Glc activity was retained 
for mutant E373D, it is therefore suggested that the distance between E373 and 
Glc/GlcNAc differ. It is possible that E373 is located closer to Glc compared to 
GlcNAc, thus the longer distance caused by mutation D was tolerated in UDP-Glc 
activity but not in UDP-GlcNAc activity.  
78D2 D380E mutant retained 52% of its original UDP-GlcNAc activity. It is 
suggested that D380 interacts with GlcNAc with a tolerance for an additional CH2 
chain length. 
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D/E swap mutants: UDP-Gal activity 
Neither 73C5 D397E nor 78D2 D380E showed positive UDP-Gal activity. It is 
suggested that D in 73C5 and 78D2 interact with UDP-Gal within a close distance, 
thus, the mutation of E caused steric hindrance and inhibited the interaction with UDP-
Glc. Alternatively, the lack of UDP-Gal activity is simply due to promiscuous activity 
of enzymes being more "plastic" for mutants as discussed above. 
4.2.3 ckAAs towards C6 position of sugar moiety 
Compared to the high level of conservation of ckAAs at the C2-C4 positions of the 
sugar moiety, the ckAAs towards the C6 position of the sugar shows more variations 
in crystal structures (summarised in Table 4.5). In VvGT1, T141 interacted with Glc-
O6 spatially by crossing the N-terminal domain. At the equivalent site of VvGT1 T141, 
ckAAs towards Glc-O6 were also observed in 71G1 and OS79. However, unlike most 
ckAAs towards the donor concentrating in the C-terminal of UGT, the ckAAs towards 
the C6 position are located in the N-terminal of UGT where most ckAAs towards the 
acceptor are located. As a consequence of this, more variability happens. Some crystal 
structures did not show a clear indicator ckAA which is responsible for binding the –
OH at the C6 position, such as 72B1 and 85H2.   
Table 4.5: ckAAs that bind the –OH of C6 position of the sugar moiety in solved crystal structures 
Plant UGT ckAAs Result origin  
VvGT135 T141 PDB (2C1Z) 
UGT 72B181 No AAs near Glc-O6 PDB (2VCE) 
UGT 71G176 T143 PDB (2ACW) 
UGT 78G178 T141 Docking 
UGT 85H277 No data report - 
UGT 78K6 (Ct3GT-A)79,80 N137 Overlay on VvGT1  
OS7982 S142, Q143 5TMD 
 
4.2.3.1 MSA 
As above, MSA was performed on the seven template UGTs and the nine target UGTs 
(Figure 4.22), to evaluate which of the potential ckAAs in the target UGTs may be 
involved in binding the –OH group at the C6 position of the sugar. 
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Figure 4.22: MSA of potential ckAAs towards the C6 position of the sugar moiety. The colours of 
residues represent their different properties: small and hydrophobic AAs AVFPMILW are coloured red; 
acidic AAs DE are coloured blue; basic AAs RK are coloured magenta; hydroxyl/sulfhydryl/amine 
AAs STYHCNGQ are coloured green. This Figure demonstrates that the potential ckAAs towards the 
C6 position of the sugar moiety are not conserved. 
In template UGTs, ckAAs that interacted with Glc-O6 are not highly conserved. Polar 
uncharged AA T or S (T has an additional CH3 group) are present in most template 
UGTs. 72B1 and 78K6 display P at the equivalent site, however, P is hardly involved 
in directly binding of the substrate via a hydrogen bond233.  
In target UGTs, 76E11, 76E12, and 78D2 show T at position 134, 135, and 145, 
respectively. Group D UGTs (73B4, 74B5, 73C1, 73C5, and 73C6) are conserved to 
show G and 89B1 shows P.  
4.2.3.2 SDM 
SDM was performed to mutate potential ckAAs and the activities of the mutants were 
examined (Figure 4.23).  
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Figure 4.23: Relative activities of mutations (WT activity set as 100%) of ckAAs towards the C6 
position of the sugar moiety (alanine scanning). The green rectangle indicates original activities were 
retained at level 4 (>80%); the light green rectangle means original activities were retained at level 3 
(51%-80); the yellow rectangle demonstrates original activities were retained at level 2 (20%-50%); the 
pink rectangle means original activities were retained at level 1 (<20%); the red rectangle indicates 
original activities were retained at level 0 (no activity). The olive green ‘WT’ indicates positive activity 
was detected in the WT (data from Chapter 3). 
Figure 4.23 shows that 76E11 T134A and 76E12 T125A retained no UDP-Glc activity, 
indicating the significant role of T. Based on the MSA result above, it is inferred that 
76E11 T134 and 76E12 T125 are ckAAs that may interact with Glc-O6. Reviewing 
previous literature, similar results can also be found. 76E1, a UGT belonging to the 
same group of 76E11 and 76E12, showed a significant role of T134 with the 
experimental data that T134A abrogated all UDP-Glc activity and inferred the binding 
of Glc-O6 based on the MSA result234.  
78D2 T145 did not show its significant role in UDP-Glc and UDP-GlcNAc activity as 
T145A retained most activity. As the functional group of C6 positions at the hexoses 
of UDP-Glc, UDP-GlcNAc, UDP-Gal and GDP-Glc are the same, the potential ckAA 
towards C6 positions of the four donors are expected to be the same. However, the 
experimental result did not come out as expected but 78D2 T145A lost the original 
GDP-Glc and UDP-Gal activities while retained most UDP-Glc and UDP-GlcNAc 
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activities. This confusing result might be explained by comparing the crystal 
complexes of β4Gal-T1+UDP-Glc+Mn2+ and β4Gal-T1+UDP-Gal+Mn2+161. The 
research observed that when UDP-Glc was bound, Glc-O4 was pointing away from 
the side chain of D318, resulting in a space between the C4 position of Glc and the 
side chain of D318, which was filled by the –OH group at C6 position of Glc. However, 
if –OH group was in axial orientation as in Gal, it would be pointing towards the side 
chain of D318, not leaving enough space between Gal-O4 and D381. Thus, the –OH 
group at C6 position must orient away from D318. As indicated, the allocation of C6 
positions of Glc and Gal might be different in the active site of 78D2 thus mutation 
might affect the activity differently.  
Additionally, another possible explanation is that the overall binding of UDP-Gal is 
very weak (kinetic results shown in Chapter 3), causing the activity to be too plastic 
to tolerate any change of protein. For GDP-Glc, as the GDP has many differences with 
UDP, GDP-linked nucleotides may have different accommodation in enzyme as 
discussed above. Thus, the mutagenesis can cause different activity change.  
G is conserved to appear at the equivalent site that may be responsible for binding the 
C6 position in 73B4, 73B5, 73C1, 73C5, and 73C6. The alanine mutations of these 
UGTs at this site varied: 73C1 G148A, 73B5 G154A, 73B4 G127A, 73C5 G150A, 
and 73C6 G151A retained 110%, 66%, 25%, 37%, and 28%, of activities respectively. 
These variable results may due to the complexity of G function and its characteristics. 
The side chain of G just has a hydrogen atom, which is predicted not to be involved in 
substrate binding via a hydrogen bond. This might be the reason why 73C1 G148A 
did not show any significant activity change. However, G plays a significant role in 
providing conformational flexibility that may be required in an enzyme-catalysed 
reaction235, as an enzyme action generally follows an ‘induced fit’236. A closer look at 
the crystal structure of template UGTs found that the ckAAs of Glc-O6 in both VvGT1 
(T141) and OS79 (S142) were located in a linker between β5 and α535. Moreover, 
VvGT1 H150 that is located at the α5 helix interacted with the acceptor molecule 
(KMP) directly via a hydrogen bond. Consequently, the point mutation of G in a linker 
might not only affect the flexibility of the linker thereby affecting the twisting and 
rotating of the connected domains nearby, but also, the effect of some other ckAAs in 
connected domains might be affected, therefore changing the enzyme activity. For 
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example, 73B4 G127A only retained 25% of UDP-Glc activity. At the equivalent site 
of VvGT1 H150 (ckAA that interacts with KMP, located in the α5 helix that is 
connected by the linker with T141 on), 73B4 S136 was observed and its alanine 
mutation retained only 32% activity (data not shown). Consequently, the mutation of 
73B4 G127 might affect the connected helix with 73B4 S136 on, thus reducing the 
activity of UDP-Glc.  
However, MSA may not provide highly accurate and reliable potential ckAAs 
information concerning the C6 position, as potential ckAAs at the C6 position are 
located in the N-terminal that has a low level of conservation. For example, 78K6 
shows P136 from the MSA at the equivalent site, however, its adjacent N137 is 
observed to bind Glc-O6 by overlaying its apo crystal structure on the crystal structure 
of VvGT179,80. In addition, the possible ckAA at C6 position of glucuronic acid in 
VvGT5 was approved as R140 (via a docking experiment)104, which was located at the 
equivalent site of VvGT1 W140 rather than T141. 
Consequently, more tests on the adjacent AAs in this region are required to provide 
more information of the ckAAs involved at the C6 position of the sugar moiety in an 
individual enzyme. 
4.2.4 Cysteines in the PSPG motif – disulphide bridge 
In enzyme catalysed reactions, AAs might act as spectator residues to stabilise the 
conserved motif of enzymes for the proper accommodation of a substrate237. The 
crystal structure of 85H2 showed two cysteines (Cs) within the PSPG motif forming 
a disulphide bridge to stabilise the PSPG motif. Herein, the study of the disulphide 
bridge is presented, which indicates the potential role of Cs within the PSPG motif in 
UGTs. 
A disulphide bond is defined as a functional group with an R-S-S-R structure, 
stabilising the structures of enzymes in a great array of enzymatic processes238. Each 
disulphide bond may stabilise folded conformation by 2-5 kcal/mol239. Thus, it can not 
only reinforce local stability, but also create a suitable condition for local 
conformational changes relating enzymatic function240. Among 20 AAs, only two AAs 
incorporate sulphur elements - cysteine (C) and methionine (M). However, M never 
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takes part in a disulphide bridge formation because it comprises a methyl group bound 
with sulphur that results in more hydrophobic and is sterically larger. 
MSA was performed (Figure 4.24) between template UGTs and target UGTs. The two 
Cs in 85H2 appear at the 20th and 37th position within the PSPG motif. At the 
equivalent site, the two Cs are also observed in template UGT VvGT1 and target UGTs 
76E11, 76E12, and 78D2. 
 
Figure 4.24: MSA of the PSPG motif. The 20th and 37th sites are highlighted, with the possibility of 
forming a disulphide bridge. The colours of residues represent their different properties: small and 
hydrophobic AAs AVFPMILW are coloured red; acidic AAs DE are coloured blue; basic AAs RK are 
coloured magenta; hydroxyl/sulfhydryl/amine AAs STYHCNGQ are coloured green.  
SDM was used to produce the double mutant 78D2 C357A-C374A. From the activity 
comparison test, C357A-C374A retained 28% (±15) of the original UDP-Glc activity 
and no original UDP-GlcNAc, UDP-Gal, and GDP-Glc activities. This result indicated 
the significance of Cs in 78D2: they are very likely to form a disulphide bridge to 
stabilize the PSPG motif and to aid glycosylation. Thus, when the Cs were mutated, 
i.e. the disulphide bridge was abrogated, the PSPG motif could not form a stabilised 
conformation to support the glycosylation.  
However, the presence of these two Cs within the PSPG motif cannot be regarded as 
the sole evidence for disulphide bridge formation. If the distances of these two Cs are 
too far apart, it is hard to build such a ‘bridge’. For example, C351 and C368 in VvGT1 
were also found in the PSPG motif. However, their distance apart in the crystal 
structure was ~3.4 Å, making it hard to form a disulphide bridge35.  
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Reviewing past literature, the significance of the disulphide bridge has been widely 
emphasised. Even an engineering called ‘disulphide engineering’ was applied to 
increase the stability of proteins241. For example, Perry and Wetzel mutated I3 to C in 
T4 lysozyme. Mutant I3C then formed a disulphide with C97, leading to an increased 
stability of the T4 lysozyme in oxidizing conditions242. 
4.2.5 Summary –ckAAs in UGTs (sugar moiety) 
UDP-Glc activity 
The potential ckAAs in nine target UGTs towards the sugar moiety are summarised in 
Figures 4.25, 4.26 and 4.27. The potential ckAAs were deduced from MSA. The level 
of significance of the potential ckAAs in specific UGTs is indicated by the percentage 
of the retained original activities in the alanine mutants. The distance between ckAAs 
and substrates was suggested from the similar AA-swapped mutants (D/E and Q/N 
swap). 
 
 
                                                           Chapter 4 
 162 
 
 
 
Figure 4.25: Potential ckAAs in UGTs towards UDP-Glc. The level of significance of potential ckAAs 
(from MSA) is based on the experimental results of alanine scanning and indicates in colour: Level 0, 
Very Strong (alanine mutants retained original activity 0%, in red); Level 1, Strong (alanine mutants 
retained original activity <20%, pink); Level 2, Medium (alanine mutants retained original activity 
20~50%, in yellow); Level 3, Weak (alanine mutants retained original activity 51~80%, in light green); 
Level 4, Very Weak/No (alanine mutants retained original activity >80%, in green). The diameter of 
the dotted circle suggests the distance (longer/shorter) between potential ckAAs and substrate based on 
the structure of D/E or Q/N swap.  
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As Figure 4.25 shows, potential ckAAs D/E-Q play different roles in different target 
UGTs, although they are conserved in MSA. For example, D/E was predicted to bind 
Glc-O3 and Glc-O4 in most UGTs, but the experimental results showed that not to be 
the case in 78D2 as 78D2 D380A retained UDP-Glc activity at level 4. Furthermore, 
although Q was highly conserved and proposed to bind Glc-O2 and Glc-O3, the 
elimination of its side chain did not lead to a significant loss of the original activity in 
73B5 and 89B1. 
Apart from alanine scanning, D/E and Q/N swap showed relatively modest activity 
loss due to their similarity in the structure. D/E and Q/N swap provided a possible 
estimation on the tolerance of the distance between AAs and a substrate. For example, 
73C1 D393-Q394 showed no tolerance of the distance change from the D-Q motif to 
the substrate as any longer/shorter side chain of AA caused the absence of activity. 
However, 73B4, which is from the same group, showed tolerance of the distance 
change from the D-Q motif to the substrate as its D/E and Q/N swap restored partial 
original activity.  
Unlike a relative clear picture of potential ckAAs towards the C2-C4 positions of the 
sugar, ckAAs towards the C6 position of the sugar were not highly conserved and 
remained obscure. At the equivalent site of ckAAs in template UGTs (e.g. VvGT1 
T141), only 76E11, 76E12, and 78D2 showed an identical AA (T) at 134, 135, and 
145, respectively, and the SDM result substantiated only that T134 and T135 were 
potential ckAAs in 76E11 and 76E12 respectively. Besides, not all targeted UGTs 
showed AAs with active side chains (e.g. 73B4 G127 and 89B1 P147) that could be 
supposed to have a direct binding effect towards the donor via a hydrogen bond. This 
might suggest that the binding at the C6 position was not necessary or that the ckAA 
towards the C6 position was not at the equivalent position as in VvGT1. It is 
recommended that future work should focus on probing the adjacent AAs in this region 
for individual enzymes. 
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UDP-GlcNAc activity 
The ckAAs in 73B4 and 78D2 towards UDP-GlcNAc is summarised in Figure 4.26. 
 
Figure 4.26: Potential ckAAs in UGTs towards UDP-GlcNAc. The level of significance of potential 
ckAAs (from MSA) is based on the experimental results of alanine scanning and is indicated by colour: 
Level 0, Very Strong (alanine mutants retained original activity 0%, in red); Level 1, Strong (alanine 
mutants retained original activity <20%, pink); Level 2, Medium (alanine mutants retained original 
activity 20~50%, in yellow); Level 3, Weak (alanine mutants retained original activity 51~80%, in light 
green); Level 4, Very Weak/No (alanine mutants retained original activity >80%, in green). The 
diameter of the dotted circle suggests the distance (longer/shorter) between potential ckAAs and the 
substrate is based on the structure of D/E or Q/N swap. 
73B4 and 78D2 had UDP-GlcNAc activity. The prediction from MSA was that D/E-
Q bound to the C2-C4 positions of GlcNAc. SDM of 73B4 approved the significant 
role of D/E-Q as alanine mutations of E-Q abolished original activity. However, 
mutations of D-Q in 78D2 did not show the same level of activity loss, especially 
Q381A still retained the original activity at level 2. This data indicated the significance 
of potential ckAAs that varied in the different enzymes. 
The study of ckAAs in 73B4 and 78D2 towards UDP-GlcNAc is important as GlcNAc 
transfer activity is important in plants. For example, GlcNAc transfer activity is 
involved in the gibberellin (GA) response pathway and takes part in regulating plant 
hormones such as the control of many plant processes like germination, growth, 
flowering, and seed development243. For example, some Arabidopsis thaliana 
GlcNAcTs mediate GlcNAcylation using UDP-GlcNAc as a donor to viral capsid 
proteins when infected by the Plum Pox virus244.  
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UDP-Gal activity 
 
Figure 4.27: Potential ckAAs in UGTs towards phosphate, UDP-Glc (left, c.f. section 4.1), or UDP-
GlcNAc (right, c.f. section 4.1). The level of significance of potential ckAAs (from MSA) is based on 
the experimental results of alanine scanning and is indicated by colour: Level 0, Very Strong (alanine 
mutants retained original activity 0%, in red); Level 1, Strong (alanine mutants retained original activity 
<20%, pink); Level 2, Medium (alanine mutants retained original activity 20~50%, in yellow); Level 
3, Weak (alanine mutants retained original activity 51~80%, in light green); Level 4, Very Weak/No 
(alanine mutants retained original activity >80%, in green). The diameter of the dotted circle suggests 
the distance (longer/shorter) between potential ckAAs and the substrate is based on the structure of D/E 
or Q/N swap.   
As shown in Figure 4.27, the D-Q motif of 73C5 and 78D2 showed significance in 
UDP-Gal activity: only 78D2 Q380A retained the original activity at level 1 (<1%), 
while alanine mutations of D-Q in 73C5 and D in 78D2 completely abrogated original 
activity. As suggested by the MSA result, Q was located in the proximity to the C2 
and C3 positions of the sugar, suggesting that it might interact with Gal-O2 and Gal-
O3 as well. D was likely to be positioned in the vicinity of the C3 and C4 positions of 
the sugar, however, as the orientation of the –OH at the C4 position in Gal is different 
to that of Glc, the interaction effect of 73C5 D397 and 78D2 D380 binding Gal-O4 
might vary.  
Generally, UDP-Gal activity was shown to be easier to be reduced by mutation 
compared to UDP-Glc (e.g. 78D2 Q381A retained 58% original UDP-Glc activity but 
<1% original UDP-Gal activity), probably resulting from the observation that UDP-
Gal was promiscuous activity with 73C5 and 78D2 (kinetic data in Chapter 3). As 
previous research suggested, promiscuous activity of an enzyme is more ‘plastic’ 
conferred by the mutation than the main activity of enzyme225. 
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4.3 Identification of ckAAs – phosphate moiety 
The phosphate moiety is a common part of nucleoside sugar donors. Consequently, 
ckAAs for phosphate are expected to be highly conserved in UGTs. Previous research 
showed that T19 (VvGT1 numbering), T280 (VvGT1 numbering), and H350 (VvGT1 
numbering) were three ckAAs that bind phosphate, however, T19 showed the least 
level of conservation (Table 4.6). 
Table 4.6: ckAAs that bind the phosphate moiety in solved crystal structures 
Plant UGT ckAAs Result origin  
VvGT135 T19, T280, H350 PDB (2C1Z) 
UGT 72B181 S277, H364 PDB (2VCE) 
UGT 71G176 S285, H357 PDB (2ACW) 
UGT 78G178 T25, S282, H352 PDB (3HBF) 
UGT 85H277 S304, H378 Docking 
UGT 78K6 (Ct3GT-A)79,80 S16, T273, H343 PDB (4WHM) 
OS7982 T291, H361  5TMB 
 
4.3.1 MSA 
Based on the AA sequence of template UGTs, ckAAs in the target UGTs towards 
phosphate were inferred from MSA (Figure 4.28).  
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Figure 4.28: MSA of potential ckAAs towards the phosphate moiety. The colours of residues represent 
their different properties: small and hydrophobic AAs AVFPMILW are coloured red; acidic AAs DE 
are coloured blue; basic AAs RK are coloured magenta; hydroxyl/sulfhydryl/amine AAs STYHCNGQ 
are coloured green. This Figure demonstrates the degree of conservation of three main ckAAs towards 
phosphate binding follow the sequence as H250 (VvGT1 numbering), T280 (VvGT1 numbering), and 
T19 (VvGT1 numbering). 
Figure 4.28 shows the degree of conservation of potential ckAAs relating to binding 
diphosphate. VvGT1 T19 is the least conserved. In the 16 UGTs displayed in Figure 
4.28, only five UGTs (VvGT1, 78K6, 78G1, OS79, and 78D2) show T or S. The 
remaining ten UGTs (except 73B4 showing R) display G that is unlikely to be involved 
in direct binding via a hydrogen bond. 
At the equivalent site of VvGT1 T280, a higher level of conservation was observed. 
At this site, only T and S were observed. These two AAs have similar properties with 
a polar uncharged side chain but with the subtle variation that T has an additional CH3 
group compared to S. As S is the fastest-evolving AA245, it is probably that the 
variability at this site is a consequence of evolution. 
VvGT1 H380 is located in the 19th position within the PSPG motif and highly 
conserved: all UGTs show H in corresponding sites. 
4.3.2 SDM 
Potential ckAAs towards phosphate in 73B4 (R7, T270, and H349) and 78D2 (T22, 
T286, and H356) were mutated to alanine and their activities were examined (Figure 
4.29).  
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Figure 4.29: Relative activities of mutations (WT activity set as 100%) of ckAAs towards phosphate 
(alanine scanning). The green rectangle means original activities were retained at level 4 (>80%); the 
light green rectangle indicated original activities were retained at level 3 (51%-80); the yellow rectangle 
showed that original activities were retained at level 2 (20%-50%); the pink rectangle indicates that 
original activities were retained at level 1 (<20%); the red rectangle means original activities were 
retained at level 0 (no activity). The olive green ‘WT’ indicates positive activity was detected in the 
WT (data from Chapter 3). 
At the equivalent site of VvGT1 T19, 73B4 R7A did not display much activity change 
(88% activity retained towards UDP-Glc, and 82% activity retained towards UDP-
GlcNAc). This result suggested that 73B4 R7 might not be a ckAA in 73B4 and did 
not participate directly in binding the phosphate as inferred from the MSA result. On 
the contrary, 78D2 T22A only retained original activities of UDP-Glc and UDP-
GlcNAc with 20% and 5%, respectively, and activities of UDP-Gal and GDP-Glc were 
completely abrogated. Therefore, it could be suggested that T22 is more likely to be a 
ckAA in 78D2 and probably binds to the phosphate moiety inferred by MSA. 
At the equivalent site of VvGT1 T280, S and T appear in site 270 and 286 in 73B4 and 
78D2, respectively. The SDM result substantiates that S or T plays a significant role 
in enzyme activity, as most original activities were reduced: 73B4 S270A retained 26% 
original UDP-Glc activity and 0% original UDP-GlcNAc activity. 78D2 T286A 
retained 15% original UDP-Glc activity and 19% original UDP-GlcNAc activity. 
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Based on the MSA result, it may be inferred that the reason for the significant activity 
loss resulted from 73B4 S270 and 78D2 T286 binding phosphate, however, alanine 
mutants prevent the hydrogen bond between the enzyme and phosphate.  
The AA 19 within the PSPG motif, H350 (VvGT1 numbering), shows a high degree 
of conservation in MSA. The subsequent SDM test substantiated the significance of 
this site: 73B4 H349A only retained 3% and 0% of activities towards UDP-Glc and 
UDP-GlcNAc respectively; 78D2 H356A retained 51% and <1% of activities towards 
UDP-Glc and UDP-GlcNAc respectively. Accordingly, H can be inferred as a ckAA 
for 73B4. However, H might not play a crucial role in 78D2 towards UDP-Glc, as >50% 
of the original activity was retained in the alanine mutant.  
Phosphate binding is important in all UGTs, as it is the common component of a 
nucleoside sugar donor. Apart from plant UGTs, UGTs with other origins also showed 
a high level of conservation towards phosphate binding at the equivalent site of VvGT1 
T280 and H350, such as GtfA (PDB: 1PN3) S230 and H293231, GtfD (PDB: 1RRV) 
S246 and H309246, and UDP-GlcNAc 2-epimerase H242 (PDB:3BEO)247. Furthermore, 
SDM showed that UDP-GlcNAc 2-epimerase H242A only retained 3% of the original 
UDP-GlcNAc activity. As the N-terminal domain of UGTs is variable, the role of T19 
(VvGT1 numbering) located in the N-terminal was less conserved and less reported in 
the literature, however, examples can still be found. At the equivalent site VvGT1 T19, 
S was conserved in human UGTs and showed a similar binding pattern towards 
phosphate as T19 in VvGT1 (e.g. the crystal structure of UGT2B7 showed S34 
interacted with the phosphate part of UDP-glucuronic acid248).  
4.3.3 Summary – ckAAs in UGTs (phosphate moiety + sugar moiety) 
Until now, potential ckAAs in UGTs towards the phosphate moiety of 73B4 and 78D2 
were identified and summarised in Figure 4.30, along with our previous study on 
ckAAs towards the sugar moiety. 
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Figure 4.30: Potential ckAAs in UGTs towards phosphate, UDP-Glc (top, c.f. section 4.2), or UDP-
GlcNAc (bottom, c.f. section 4.2). The level of significance of potential ckAAs (from MSA) is based 
on the experimental results of alanine scanning and is indicated by colour: Level 0, Very Strong (alanine 
mutants retained original activity 0%, in red); Level 1, Strong (alanine mutants retained original activity 
<20%, pink); Level 2, Medium (alanine mutants retained original activity 20~50%, in yellow); Level 
3, Weak (alanine mutants retained original activity 51~80%, in light green); Level 4, Very Weak/No 
(alanine mutants retained original activity >80%, in green). The diameter of the dotted circle suggests 
the distance (longer/shorter) between potential ckAAs and the substrate is based on the structure of D/E 
or Q/N swap. 
Figure 4.30 demonstrates potential ckAAs towards the phosphate of 73B4 and 78D2 
along with the ckAAs towards the sugar moiety as discussed in Section 4.2. They 
generally followed the similar interaction pattern as the template UGTs, but with some 
variations (e.g. 73B4 R7 was not a ckAA as the mutation of R did not show much 
effect on the enzyme activity, although MSA result indicated its potential role as a 
ckAA). 
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Phosphate is a common moiety both in UDP-Glc and UDP-GlcNAc, so it was 
expected that the mutation of potential ckAAs played an equal role in affecting enzyme 
activity/performance towards UDP-Glc and UDP-GlcNAc, however, the UDP-
GlcNAc activity seemed to be more readily reduced by mutations in both 73B4 and 
78D2. The possible explanation of this data is that UDP-GlcNAc activity is 
promiscuous activity (the kinetic data to support this is discussed in Chapter 3) but 
UDP-Glc activity is the main activity of 73B4 and 78D2. As discussed above, 
promiscuous activities of enzymes result from greater "plasticity" from the aspect of 
evolution225, therefore UDP-GlcNAc seemed to be affected by enzyme mutation more 
easily (this reason could be the explanation of why GDP-Glc and UDP-Gal activities 
of 78D2 were so easily affected). 
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4.4 Identification of ckAAs – uridine moiety 
As the name indicates, the uridine moiety is the common part of a nucleoside sugar 
donor, and consequently one would suppose that the UDP binding pattern is highly 
conserved. This hypothesis has been supported by solved crystal structures where the 
AA 1 (generally W, except F in OS79) and AA 27 (E) within the PSPG motif were 
conserved and interacted with uridine by pi-pi interaction and hydrogen bond 
respectively (Table 4.7).  
Table 4.7: ckAAs that bind uridine moiety in solved crystal structures 
Plant UGT ckAAs Result origin  
VvGT135 W332, E358 PDB (2C1Z) 
UGT 72B181 W346, E372 PDB (2VCE) 
UGT 71G176 W339, E365 PDB (2ACW) 
UGT 78G178 W334, E360 PDB (3HBF) 
UGT 85H277 W360, E386 Docking 
UGT 78K6 (Ct3GT-A)79,80 W325, E351 PDB (4WHM) 
OS7982 F343, E369 5TMB 
 
4.4.1 MSA 
MSA was used to demonstrate the ckAAs in the target UGTs that might bind uridine 
(Figure 4.31). 
Figure 4.31: MSA of potential ckAAs towards the uridine moiety. The colours of residues represent 
their different properties: small and hydrophobic AAs AVFPMILW are coloured red; acidic AAs DE 
are coloured blue; basic AAs RK are coloured magenta; hydroxyl/sulfhydryl/amine AAs STYHCNGQ 
are coloured green. This Figure demonstrates the two potential ckAAs towards uridine are located in 
the 1st and 27th position within the PSPG motif with a high degree of conservation. 
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MSA revealed that potential ckAAs towards uridine in targeted UGTs are highly 
conserved, with W and E as the 1st and the 27th AA within the PSPG motif. 
4.4.2 SDM 
SDM was performed on 73B4 W331 and E357, as well as 78D2 W338 and E364 
(Figure 4.32). 
 
Figure 4.32: Relative activities of mutations (WT activity set as 100%) of ckAAs towards uridine 
(alanine scanning). The yellow rectangle shows original activities were retained at level 2 (20%-50%); 
the pink rectangle indicates original activities were retained at level 1 (<20%); the red rectangle means 
that original activities were retained at level 0 (no activity). The olive green ‘WT’ indicates positive 
activity was detected in the WT (data from Chapter 3). 
As Figure 4.32 shows, alanine mutations of W and E significantly reduced original 
activity, with the only exception that 78D2 W338A retained above 20% of the original 
UDP-Glc activity (32%). The possible explanation why 78D2 W338A did not 
significantly reduce UDP-Glc activity is probably due to the region in 78D2 that stacks 
uridine being very stable. As shown in previous studies, the first six AAs within the 
PSPG motif were an important loop to stack the uracil ring in the hydrophobic 
platform. For example, in 71G1, the 339-344 loop region (WAPQVE) helped W339 
form a hydrophobic platform to stack uridine. E356P abolished all UDP-Glc activity 
by disturbing the loop using P mutation229. Thus, it is possible that uridine binding is 
not only due to the pi-pi interaction formed by W, but may relate to the stability of the 
hydrophobic platform that the loop provided. Based on the fact that 78D2 W338A did 
not affect UDP-Glc activity significantly, it is suggested that the loop stacking of UDP 
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in 78D2 (WAPQVE) is extremely stable, therefore destruction of pi-pi interaction is 
not enough to result in a significant activity loss. 
Reviewing previous studies, the critical role of W and E being responsible for 
interacting with uridine has been widely accepted. For example, SDM of UGT2B7 
W356A and W356H resulted in attenuated activity towards UDP-glucuronic acid, 
although the modelling experiments showed that W356 did not interact with uracil248. 
The inconsistency of SDM and molecular modelling probably results from the 
conformational change of W in the apo form of UGT to the complex form of 
UGT+UDP-sugar (observed in VvGT1), which also indicated a disadvantage of 
molecular modelling and an advantage of SDM. Apart from W, the role of E was 
conserved throughout the UGT family, such as UGT2B7 E382226.  
4.4.3 Summary – ckAAs in UGTs (uridine moiety + phosphate moiety + sugar 
moiety) 
The potential ckAAs that might be involved in binding uridine in active sites of 73B4 
and 78D2 were identified (Figure 4.33). Along with the potential ckAAs towards the 
phosphate and sugar moieties discussed in Sections 4.3 and 4.2, overall pictures of 
ckAAs at the active sites of 73B4 and 78D2 were speculated. 
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Figure 4.33: Potential ckAAs in UGTs towards uridine, phosphate, UDP-Glc (top, c.f. section 4.2), or 
UDP-GlcNAc (bottom, c.f. section 4.2). The level of significance of potential ckAAs (from MSA) is 
based on the experimental results of alanine scanning and is indicated by colour: Level 0, Very Strong 
(alanine mutants retained original activity 0%, in red); Level 1, Strong (alanine mutants retained 
original activity <20%, pink); Level 2, Medium (alanine mutants retained original activity 20~50%, in 
yellow); Level 3, Weak (alanine mutants retained original activity 51~80%, in light green); Level 4, 
Very Weak/No (alanine mutants retained original activity >80%, in green). The diameter of the dotted 
circle suggests the distance (longer/shorter) between potential ckAAs and the substrate is based on the 
structure of D/E or Q/N swap.  
Figure 4.33 shows potential ckAAs towards uridine of 73B4 and 78D2 along with the 
potential ckAAs towards the sugar and phosphate moieties as discussed above. 
Specifically, 73B4 W331 was inferred as a ckAA (by SDM data) probably interacting 
with the uracil ring via a pi-pi bond (by MSA data). 73B4 E357 and 78D2 E364 were 
identified as ckAAs (by SDM data) that might interact with ribose via a hydrogen bond 
(by MSA data). Again, mutation had a general stronger influence on UDP-GlcNAc 
activity than that of UDP-Glc activity, which probably could be explained from the 
aspect of evolution as discussed above. 
Until now, the identification of potential ckAAs in nine target UGTs have been 
revealed by MSA and SDM. No crystal structures of target UGTs have been solved 
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successfully. Thus, MSA and SDM provide the best and fastest approach currently 
available to identify the potential ckAAs in UGTs. 
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4.5 Homology model validation 
Although molecular modelling was not applied to guide the experiments presented 
here, it can give a useful way to visualise the interaction mentioned in the discussion. 
Consequently, homology modelling was inevitably used to construct models of UGTs 
without crystal structures.  
Target UGTs in this section (73B4, 73B5, 73C1, 73C5, 73C6, 76E11, 76E12, 78D2, 
and 89B1) were constructed individually with their corresponding template UGTs (the 
one with the highest percentage of identical AAs) by the SWISS-MODEL program249. 
Notably, only the C-terminal of these UGTs was constructed as this research focused 
on donor binding and most ckAAs towards the donor were concentrated in the C-
terminal of UGTs. The characteristic fold of UGT structure indicates the two terminal 
domains as independent halves226. C-terminal domain modelling can be accurate as no 
biasing would be introduced from the N-terminal domain that has a lower degree of 
homology. 
According to the theory that Rost derived for a precise limit for homology modelling 
(Figure 4.34), two proteins that were practically guaranteed to adopt a similar structure 
the homology modelling could be applied, as long as the length of the two sequences 
and the percentage of the identical AAs fall in the ‘safe homology modelling zone’250. 
Taking the number of aligned AAs and the highest percentage of identical AAs with 
the template UGT together, all target UGTs were located in the ‘safe homology 
modelling zone’ and homology modelling was used to provide a reliable model 
(Figure 4.34) 
 
 
. 
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Figure 4.34: Homology modelling zone validation of target UGTs. (A): Limit for the homology 
modelling defined by Rost (1999). The location of ‘X’ means the point of the modelling zone where 
different target UGTs are located. They are represented by different colours corresponding to the name 
of the UGT shown in the right Table (B). All target UGTs are located in the safe homology modelling 
zone. (B): The percentage of identical residues between target and template UGT and the number of 
aligned residues of target UGT. (C): A representative homology model of the C-terminal of 73B4 
(purple, model) overlaid on its template 71G1 (grey, crystal).  
After cycles of energy minimisation, the final UGT models (C-terminal) were 
constructed and the model qualities were assessed (results are listed in Table 4.8). This 
comprehensive scoring indicated the level of confidence of the constructed models. 
The model quality can be estimated by QMEAN. QMEAN acts as a scoring function 
for global and local model quality estimation251,252. It consists of four structural 
descriptors: local geometry, all-atom interaction, C-beta interactions, and burial status 
of residues. Furthermore, the model structures were examined using a Ramachandran 
map to reveal the rotations of the polypeptide backbone around the bonds between N-
Ca (Phi, j)and Ca-C (Psi, y)253. The map may find the torsion angles in disallowed 
regions and indicate any problems with the structure. 
Table 4.8: Scoring of model quality validation 
Model Template QMEAN Residues in outlier region (Ramachandran plots) 
73B4 71G1  -2.30 G241, K399  
73B5 71G1 -3.33 K423 
73C1 78G1 -3.10 V413, E415, V429 
73C5 78G1 -3.79 E418, E427, V431 
73C6 78G1 -2.71 S303, S339, W423, V431, L432, V433, D434, K435 
76E11 OS79 -1.72 - 
76E12 72B1 -1.31 - 
78D2 VvGT1 -0.57 E315 
89B1 85H2 -2.80 I296 
 
Table 4.8 shows that all constructed models presented a QMEAN in the range of -
3.33~-0.57. In the Swiss-Model program, a value between -4.00~+4.00 was 
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recommended, which indicated the reliability of the constructed models. In addition, 
more than 96% of all AAs were located in the allowed regions of the Ramachandran 
plots. Every potential ckAAs (C-terminal) in this project was in the allowed area of 
the Ramachandran plots. Therefore, the location of the ckAAs in the models displayed 
above are reliable. In summary, the scoring of model quality elucidates the reliability 
of the constructed model and the potential ckAAs in this Chapter. Consequently, the 
overlaying of the target UGTs on the template UGTs would be reasonable and could 
provide a useful interpretation of SDM data.  
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4.6 Conclusions 
By combining MSA and SDM, potential ckAAs in the target UGTs were inferred and 
substantiated/disapproved. Potential ckAAs towards sugar, phosphate, and uridine 
moieties of an individual enzyme were summarised in Sections 4.2.5, 4.3.3 and 4.4.3, 
respectively. A general summary of the ckAAs towards different portions of the donor 
molecule is shown in Figure 4.35. A general summary of ckAAs towards different 
sugars is shown in Figure 4.36.
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Figure 4.35: Summary of MSA, SDM, and potential ckAAs towards UDP-Glc. 
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Figure 4.36: Summary of SDM and potential ckAAs towards Gal and GlcNAc moiety.
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For potential ckAAs towards the C2 and C3 positions of the sugar, MSA showed that 
Q was highly conserved as the AA 44 within the PSPG motif. By SDM, 73C1 Q394, 
73C5 Q398, 73C6 Q398, and 76E11 Q374 were inferred as potential ckAAs (alanine 
mutants retained original activity at 0/1), probably by orientation on the Glc-O2 and 
Glc-O3 positions (based on MSA result).  
For potential ckAAs towards the C3 and C4 positions of the sugar, MSA showed that 
a negatively charged AA (D/E) was conserved as the AA 43 within the PSPG motif. 
Along with the result of alanine scanning, 73B4 E373, 73B5 E394, 73C1 D393, 73C5 
D397 and 73C6 D397, 76E11 D373, 76E12 D375 and 89B1 D389 were inferred as 
potential ckAAs (alanine mutants retained the original activity at 0/1) probably by 
binding the Glc-O3 and Glc-O4 positions (based on MSA result).  
Potential ckAAs towards the C6 position of the sugar moiety showed the least level of 
conservation: 76E11, 76E12, and 78D2 showed T; 73B4, 73B5, 73C1, 73C5, and 
73C6 showed G; and 89B1 showed P. 76E11 T134 and 76E12 T135 were proposed as 
ckAAs (based on SDM result).  
The phosphate binding site study was focused on the equivalent site of VvGT1 T19, 
T280, and H350. T19 (VvGT1 numbering) was the least conserved: 78D2 with T, 
73B4 with R, and the remaining target UGTs with G. T280 (VvGT1 numbering) was 
semi-conserved as all target UGTs showed a polar uncharged AA (S/T). H350 (VvGT1 
numbering) was the highest conserved as all target UGTs showed the same AA (H). 
SDM indicated that 78D2 T22, 78D2 T286 and 73B4 H349 were crucial for UDP-Glc 
activity and were proposed to be ckAAs. 
Identification of ckAAs towards the uridine moiety included two AAs: the AAs 1 and 
27 within the PSPG motif. They were all highly conserved as W (AA 1) and E (AA 
27). SDM suggested that 73B4 W331, 73B4 E357, and 78D2 E364 were key for 
enzyme activity and could be inferred as potential ckAAs. 
Apart from UDP-Glc, ckAAs towards other sugar donors were investigated. CkAAs 
towards other sugar donors generally followed the same fashion to those of UDP-Glc. 
However, there were some variations in details. For example, Q was inferred to be 
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involved in binding Glc-O2 and Glc-O3 moieties, which might not be applied directly 
to UDP-GlcNAc due to the N-acetyl group at the C2 position of GlcNAc might not be 
involved in the interaction via forming a bond as previous GlcNAcT studies indicated. 
Thus, Q was inferred to bind only the C3 position of UDP-GlcNAc rather than both 
the C2 and C3 positions. In addition, it was generally observed that the activities of 
other donors were more sensitive towards mutation compared to the activity of UDP-
Glc. This probably could be explained from the aspect of evolution that promiscuous 
activity of an enzyme was not as ‘robust’ as the main activity, but appeared to be 
‘plastic’ towards mutation. 
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Chapter 5 Rhamnosyltransferases 78D1 and 89C1 
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Many rhamnose (Rha)-containing natural compounds are present in both plants and 
bacteria. For example, L-Rha is a key component of rhamnogalacturanan I and II that 
are the primary constituents of pectins (mainly responsible for cell wall extension and 
plant growth) in the plant cell wall254. Further, L-Rha can be a part of O-linked 
glycoproteins (e.g. O-glycan chains of arabinogalactan proteins) that control many 
biological activities, such as growth, morphogenesis, and adaptation to stress255. In 
bacteria, several types of O-antigens containing Rha can be covalently linked to 
lipopolysaccharides in the outer leaflet of the outer cell membrane (e.g. the 
Pseudomonas aeruginosa core oligosaccharide of the lipopolysaccharide), which can 
facilitate bacterial evasion of the immune system defences256. 
Rhamnosyltransferases (RhaTs) are enzymes involved in the synthesis of Rha-
containing compounds. They catalyse the transfer of Rha from NDP-Rha to the 
acceptors. Thus far, sequences of over 3000 RhaTs have been deposited in the UniProt 
database; they originate from various organisms, such as Arabidopsis thaliana (At), 
Escherichia coli (strain K12), Citrus maxima, and Mycobacterium tuberculosis257.   
Functions of some RhaTs have been characterised. For example, two RhaTs in citrus 
species (pomelo and grapefruit) determine the flavour of a plant: 1,2-RhaT, for the 
synthesis of the bitter flavanone-7-O-neohesperidoside, and 1,6-RhaT, for the 
synthesis of the tasteless flavanone-7-O-rutinoside258. Glycine max (soybean) 
UGT79A6 is a flavonol-3-O-glucoside (1→6) RhaT, which uses b-L-UDP-Rha and a 
flavonol 3-O-b-D-Glc (kaempferol or quercetin) to synthesise flavonol 3-O-(a-L-Rha-
(1→6)-b-D-Glc)259. GmSGT3 (soybean) can convert soyasaponin III to soyasaponin I 
by using UDP-b-L-Rha as the sugar donor 260.  
Although the functions of some RhaTs have been identified, the number of available 
RhaTs crystal structures is limited. Currently, only two crystal structures of RhaTs 
from bacteria, b-1,2-RhaT WsaF (PDB: 2X0D, APO structure of WsaF; 2X0E, 
complex structure of WsaF with dTDP; 2X0F, complex structure of WsaF with dTDP-
b-L-Rha)261,262 and Saccharopolyspora spinosa SpnG (PDB: 3TSA, APO structure of 
SpnG; 3UYK, complex structure of SpnG with spinosyn aglycone; 3UYL, complex 
structure of SpnG with dTDP)263 have been solved, and provide molecular-level 
insights into the understanding of RhaTs.  
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WsaF belongs to the GT4 family in the CAZy database. It is a b-retaining RhaT, 
responsible for the formation of b-1,2-linkage during the polyrhamnan biosynthesis 
for the S-layer protein SgsE in Geobacillus stearothermophilus NRS 2004/3a264. The 
growing Rha chain is used as a substrate by accepting the sugar from dTDP-b-L-Rha. 
WsaF adopts a GT-B fold with two Rossmann-fold domains (b/a/b). A cavity in the 
cleft between the N-terminal and C-terminal domains is responsible for substrate 
accommodation. In the complex structure of WsaF with dTDP-b-L-Rha, the thymidine 
moiety forms polar interactions with the side-chain of K302 and the main-chain atoms 
of L303; O3 of the 2-deoxyribose interacts with E333 by hydrogen bonds; Rha sugar 
forms hydrophobic interactions with Y329, hydrogen bond with N227 (-OH groups at 
C2 and C3 positions), and hydrogen bond with K225 (-OH groups at C3 and C4 
positions) (Figure 5.1, left).  
Figure 5.1: Some key AAs in the active sites in WsaF (left) and SpnG (right). 
Another RhaT whose crystal structure had been solved is SpnG. It belongs to the GT1 
family and catalyses 9-OH rhamnosylation to spinosyn by using dTDP-Rha as the 
sugar donor. Similar to WsaF, the architecture of SpnG also adopts a GT-B fold and 
contains two domains with two Rossmann-fold domains. The dTDP-binding pocket is 
composed of AAs that are mostly located in the C-terminal domain, i.e. A255–P257, 
S276–L279, and S295–T297. For example, thymine interacts with L279 (O2 of 
thymine) and V277 (N3 and O4 of thymine) via hydrogen bonding, and P257 (methyl 
of thymine) and L279 (the ring of thymine) by hydrophobic interactions (Figure 5.1, 
right). Because of a lack of the complex structure of SpnG with dTDP-b-L-Rha, dTDP-
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Rha was docked along with the crystal research. The docking of dTDP-Rha into the 
crystal structure of SpnG revealed that D316–Q317 interact with C2–C4 positions of 
Rha. The D316–Q317 motif is also conserved in plant UGTs, as the last two AAs 
within the PSPG motif, and interacts with the C2–C4 positions of the sugar moiety as 
discussed in Chapter 4. 
This chapter focuses on RhaTs 78D1 and 89C1, detailing kinetic study and the 
identification of catalytic key AAs (ckAAs). The methodology was the same as 
described in the previous chapters: the kinetic study was performed using multiple 
reaction monitoring (MRM) mode of mass spectrometry (MS) by monitoring the 
formation of kaempferol-rhamnose (KMP-Rha) as a function of time (c.f. Chapter 3). 
The ckAAs of enzymes were identified by multiple-sequence alignment (MSA)-based 
methodology (c.f. Chapter 4). This study expands the understanding of 78D1 and 
89C1, shedding light on related research, such as the biological role of RhaTs, 
synthesis of Rha-containing glycoconjugates, and active site manipulation. 
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5.1 In vitro characterisation of 78D1 and 89C1 
5.1.1 Donor specificity of 78D1 and 89C1 
The donor specificities of UGT78D1 and 89C1 were examined using the donor library 
mentioned in Chapter 3 (with KMP as the acceptor), namely, a-D-UDP-Glc, a-D-
UDP-Gal, a-D-UDP-GlcNAc, a-D-UDP-GalNAc, b-L-UDP-Rha, b-L-dTDP-Rha, a-
D-GDP-GDP-Glc, and b-L-GDP-Fuc. Experimental data revealed that 78D1 and 89C1 
are able to transfer the Rha moiety from both UDP-Rha and dTDP-Rha to KMP (see 
GAR results in Chapter 3). The glycosylated product KMP-Rha was expected to show 
a peak at 431 in the ‘full scan’ mode of MS in the negative-ion mode ([MW-H+]-). The 
subsequent ‘product ion’ mode of MS fragmented the KMP-Rha to KMP with a peak 
at 285 ([MW-H+]-), with the collision energy of 10 eV (See MS figure in Appendix, 
Figure A.7 and A.8). The experimental conditions were clarified and discussed in 
Chapter 3, including the buffer, temperature, MS, and LC conditions. 
In our research, both 78D1 and 89C1 exhibited dual activities of UDP-Rha and dTDP-
Rha. In previous studies, only UDP-Rha activity was reported151,155. The dTDP-Rha 
activity had been predicted previously but never experimentally confirmed. In a 
previous in silico screening, 78D1 showed a dTDP-6-deoxytalose activity265, which 
indicated the tolerance of the dTDP nucleoside base in the active site of 78D1 and was 
consistent with the results of the current study.  
With respect to the chemical structure, dTDP has an additional CH3 group at C5 of 
uracil and lacks an –OH group at 2¢ of ribose (Figure 5.2). The structural difference of 
UDP and dTDP is tolerated by some enzymes, such as VvGT135, while some enzymes 
show strict selectivity towards specific donors, such as trehalose 6-phosphate synthase 
(Sco), which transfers Glc only from UDP-Glc but not dTDP-Glc266. The selectivity 
for UDP-sugar and dTDP-sugar donors might be associated with the active site of 
enzymes, which will be discussed below.  
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Figure 5.2: Structures of β-L-UDP-Rha (left) and β-L-dTDP-Rha (right).  
Apart from the difference in structure, UDP-Rha and dTDP-Rha are different with 
respect to their distribution in nature. UDP-Rha is found in plants267, while dTDP-Rha 
is found in bacteria268. Although 78D1 and 89C1 show dual activities, they are only 
found in plants: 78D1 is produced in leaves, flowers, siliques, and stems151; 89C1 is 
highly produced in floral buds, but also produced in roots, stems, and leaves155. Thus, 
dTDP-Rha cannot be the natural substrate of 78D1 and 89C1 in vivo. However, the 
newly reported dTDP-Rha activity may broaden the available materials in potential 
applications, such as synthesis of Rha-containing glycoconjugates.  
5.1.2 Kinetic study 
Rhamnosylation reactions catalysed by 78D1 and 89C1 are Bi-Bi enzymatic reactions, 
with two reactants and two products. A pseudo-Uni system was generated with a high 
fixed concentration of KMP (100 µM) with varied UDP-Rha/dTDP-Rha 
concentrations. The KM of KMP was fixed as this part of investigation mainly focused 
on the kinetic parameters of the donor molecule. According to previous studies (c.f. 
Chapter 3), most KM values of KMP are below 10 µM (except that for 73C1, which 
was 47 µM), thus 100 µM was estimated as the saturation level of KMP. The 
Michaelis-Menten curves (Figures 5.3 and 5.4) were used for the calculation of kinetic 
constants, based on the equation ! = #$%&∗()*+( . Other experimental conditions have been 
already discussed in Chapter 3, including, the buffer, temperature, MS, and LC 
conditions, and selection of enzyme concentration.  
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Figure 5.3: Michaelis-Menten curve of 78D1 kinetics towards UDP-Rha and dTDP-Rha. 
 
Figure 5.4: Michaelis-Menten curve of 89C1 kinetics towards UDP-Rha and dTDP-Rha. 
Table 5.1: Kinetic parameters of 78D1 and 89C1 
 Donor KM (M) Vmax (M/s) kcat (s-1) kcat/KM 
78D1 UDP-Rha 7.0E-05 
(±1.6E-05) 
8.1E-11 
(±1.3E-11) 
2.0E-03 
(±3.3E-04) 
2.9E+01 
(±8.1E+00) 
 dTDP-Rha 3.3E-05 
(±7.2E-06) 
2.8E-12 
(±5.5E-13) 
7.0E-05 
(1.4E-05) 
2.1E+00 
(±6.2E-01) 
89C1 UDP-Rha 4.5E-06 
(±5.1E-07) 
9.0E-13 
(3.3E-14) 
2.2E-05 
(8.3E-07) 
5.0E+00 
(±6.1E-01) 
 dTDP-Rha 1.4E-05 
(±1.7E-06) 
2.2E-13 
(±9.5E-15) 
5.5E-06 
(±2.4E-07) 
3.9E-01 
(4.9E-02) 
For 78D1, the KM value indicated that a higher concentration of UDP-Rha is required 
to fill half of the active sites and for significant catalysis to occur than that of dTDP-
Rha (2.1-fold). The values of kcat and kcat/KM indicated that 78D1 transfers Rha from 
UDP-Rha with a higher catalysis capability (29-fold) and higher catalysis efficiency 
(14-fold) compared to dTDP-Rha. Thus, UDP-Rha is a better substrate candidate for 
78D1 than dTDP-Rha. 
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For 89C1, the KM value for UDP-Rha was 3.1-fold smaller than that for dTDP-Rha. 
This suggested that a lower concentration of UDP-Rha is required to fill half of the 
active sites of 89C1 and for significant catalysis to occur. In addition, the values of kcat 
and kcat/KM indicated that UDP-Rha is a better substrate candidate of 89C1, with a 4-
fold higher catalysis capability and a 13-fold higher catalysis efficiency compared to 
that of dTDP-Rha. 
The comparison of 78D1 and 89C1 revealed that a lower concentration of UDP-Rha 
is required for a significant reaction to occur with 89C1 (16-fold lower than that of 
78D1). However, the catalysis capability (kcat) and efficiency (kcat/KM) of 89C1 were 
weaker than those of 78D1, by 91-fold and 6-fold, respectively. Reactions with the 
donor dTDP-Rha followed the same trend. Smaller concentrations of dTDP-Rha were 
required for significant reactions to occur with 89C1 (2.4-fold lower than that of 78D1). 
However, 78D1 had a 13-fold higher catalysis capability (kcat) and a 5.4-fold higher 
efficiency (kcat/KM) than that of 89C1. These comparative results indicated that 78D1 
is a more efficient enzyme facilitating the Rha transfer reaction than 89C1 in vitro. 
Thus far, limited kinetic data have been obtained for RhaTs, and no kinetic data have 
been reported for 78D1 and 89C1. For some other RhaTs, the KM values of donor are 
in the 1–100 µM range, as also observed for 78D1 and 89C1. For example, WbbL 
(catalysing Rha transfer from dTDP-Rha to decaprenyl-pyrophosphoryl-GlcNAc) 
exhibits KM of 35 µM for dTDP-Rha269. C. maxima C12RT1 (catalysing Rha transfer 
from UDP-Rha to prunin and hesperetin-7-O-glucoside) showed KM values of 1.3 and 
1.1 µM for UDP-Rha with prunin and hesperidin-7-O-glucoside as acceptors, 
respectively270. 
The detailed in vitro kinetic study of 78D1 and 89C1 presented in this Chapter may 
be useful for several fields, e.g. 1) the kinetic data of UDP-Rha can be indicative of 
the biological function of 78D1 and 89C1 in vivo, as KM value may provide an 
approximation of substrate concentration in vivo65. 78D1 and 89C1 are thought to play 
significant roles in hormone regulation during plant development, by flavonoid 
glycosylation. For example, 78D1 was relatively abundant at the shoot apex in 
Arabidopsis. It affects the growth of the plant by taking part in the synthesis of KMP-
3-O-Rha-7-O-Rha that modulates auxin transport and affects the shoot phenotype271. 
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Similarly, 89C1 indirectly induces auxin concentration change. It facilitates flavonol 
glycosylation, which would increase the concentration of auxin precursors and auxin 
metabolites272. 2) as mentioned above, dTDP-Rha may broaden the array of materials 
available for such potential applications as the synthesis of Rha-containing 
glycoconjugates, although dTDP-Rha activity does not inform any biological 
functions of these enzymes as the compound is not present in plants. The significant 
role of flavonol rhamnosides has been emphasised in many studies. For example, 
quercetin-3-O-Rha might be an antimicrobial agent blocking the replication of the 
influenza virus273,274. However, obtaining flavonol-Rha compounds is not easy: they 
were originally isolated from plants, which was followed by several complex 
purification steps and was limited by the supply of plant material37. Thus, the in vitro 
activity and kinetic study of 78D1 and 89C1 may suggest an alternative method (e.g. 
a chemo-enzymatic method) for generation of such compounds.  
5.1.3 Experiment optimisation 
As discussed in Chapter 3, an accurate range of substrate concentration ([S]) can result 
in an improved experimental performance and smaller error; however, the [S] range 
used in this part of the investigation was not optimal. Thus, the kinetic study should 
probably be double-checked using the new 1/5–5KM [S] range to obtain data of the 
best quality (Table 5.2). This will be performed as part of the future studies.   
Table 5.2: 1/5-5KM [S] range based on the full kinetic experimental KM value 
UGT Donor Range [S] (µM) 
78D1 UDP-Rha 14-350 
 dTDP-Rha 7-165 
89C1 UDP-Rha 1-23 
 dTDP-Rha 3-70 
Table 5.2 provides the theoretical optimal [S] range. It guides the [S] range for future 
experiments; however, these concentrations cannot be implemented directly without 
practical consideration. For example, if the [UDP-Rha] or [dTDP-Rha]>100 µM, MS 
ion suppression may occur, leading to the loss/decrease of a linear response of ESI-
MS (discussed in Chapter 3). Thus, [UDP-Rha] or [dTDP-Rha] above 100 µM is not 
recommended for the MS approach. 
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5.2 Identification of catalytic key amino acids (ckAAs) in 78D1 and 
89C1 
Using the same MSA-based methodology as the one in Chapter 4, ckAAs in the active 
sites of 78D1 and 89C1 were identified. The rationality, accuracy, reliability, 
assumptions, and limitations of the methodology were discussed in Chapter 4.1. 
First, selection of suitable enzymes as templates was required to predict the potential 
ckAAs in the active sites of 78D1 and 89C1. The plant template UGTs (VvGT135, 
72B181, 71G176, 78G178, 85H277, 78K679,80, and OS7982) used in Chapter 4 could have 
provide useful information for the prediction of the potential ckAAs in the active sites 
of 78D1 and 89C1 on account of their relatively high sequence identities, plant origins, 
and similar function of the UDP-linked sugars. However, the functions of 78D1 and 
89C1 are not exactly the same as those of template UGTs, as the template UGTs 
transfer Glc, while the target UGTs transfer Rha. Thus, the binding between UGTs 
and sugar moiety may differ between template and target UGTs. Herein, SpnG, a RhaT, 
was used as another template. SpnG is a bacterial 9-OH RhaT that transfers Rha from 
dTDP-Rha to spinosyn. Although it shares low sequence identity with 78D1 (13%) 
and 89C1(10%), the use of SpnG as a template was justified as it belongs to family 1 
(as do 78D1 and 89C1) and may share a common ancestor with the target UGTs from 
the evolutionary perspective, i.e. the active site (sugar portion) of SpnG may have 
some commonalities with the those of the target UGTs. 
As mentioned in the preface, another RhaT exists, WsaF, whose crystal has been 
solved. This enzyme was not used as a template mainly because it belongs to GT4 
family, which is remote from the family to which the target UGTs belong (GT1). 
Consequently, low ancestral commonality was expected between WsaF and the target 
UGTs. 
5.2.1 Identification of ckAAs – sugar moiety 
The identification of 78D1 and 89C1 ckAAs towards sugar moiety focused on the 
ckAAs interacting with the –OH groups of Rha that are located at C2–C4 positions.  
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In addition to the absence of –OH group at C6 position of the sugar moiety, Glc and 
Rha have different forms in solution: Glc is present in a D-sugar form, while Rha is 
present in the L-sugar form. In Figure 5.5, UDP-b-L-Rha is shown in the 1C4 chair 
conformation linking an equatorial UDP in solution. However, a possible alternative 
ring conformation might be existed (axial leaving-group orientation 4C1)35 as a 
nucleophilic attack during catalysis275. 
Figure 5.5: Schematic representations of UDP-α-D-Glc in 4C1 conformation and UDP-β-L-Rha in both 
favoured 1C4 conformation and 4C1 conformation. Steric factors dictate that UDP-β -L Rha will exist in 
a conformation skewed between those drawn; one which allows an axial leaving-group orientation 
while fulfilling the stereo electronic considerations of an incipient oxocarbenium ion-like transition 
state35. 
5.2.1.1 ckAAs towards C2-C4 positions of the sugar moiety 
In the SpnG-dTDP complex263, dTDP binds the C-terminal domain of SpnG with its 
diphosphate pointing towards the active area of the sugar moiety, which is consistent 
with template GlcTs, such as VvGT1 (Figure 5.6). The docking analysis in the 
literature revealed that SpnG D316–Q317 facilitate Rha binding, as was observed in 
GlcTs: i.e. D316 binds Rha-O3 and O4, while Q317 binds Rha-O2 and O3. 
 
Figure 5.6: Overlay of overall crystal structure of VvGT1 (tan colour), chain A of SpnG (violet red 
colour), and the DQ motif of VvGT1 (D374-Q375) and SpnG (D316-Q317) in active site. 
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MSA was performed on template enzymes (seven GlcTs and SpnG) and target 
enzymes (78D1 and 89C1) (Figure 5.7). At sites equivalent to the D/E-Q motif in 
different templates, D374–N375 and D356–H357 dyads were observed in 78D1 and 
89C1 respectively. 
 
Figure 5.7: MSA of potential ckAAs towards C2-C4 positions of sugar moiety using templates of seven 
GlcTs (left) and SpnG (right). The colours of residues represent their different properties: small and 
hydrophobic amino acids AVFPMILW are coloured red, acidic amino acids DE are coloured blue, basic 
amino acids RK are coloured magenta, and hydroxyl/sulfhydryl/amine amino acids STYHCNGQ are 
coloured green. The last line of symbols denotes the degree of conservation: conserved (*), conserved 
mutations (:), semi-conserved mutations (.), and non-conserved mutations (). This Figure demonstrates 
that the potential ckAAs towards C3 and C4 positions of the sugar moiety are highly conserved as D/E. 
The potential ckAAs towards C2 and C3 positions of sugar moiety are conserved in GlcTs as Q, but 
varied in RhaTs as Q (in SpnG), N (in 78D1) and H (in 89C1). 
UGT 78D1: ckAAs towards C2-C4-positions of the sugar moiety 
SDM was used to construct mutants 78D1 D374A, N375A, and N375Q to explore the 
role of the D-N dyad (Figure 5.8).  
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Figure 5.8: Relative activities of mutations (WT activity set as 100%) of ckAAs towards C2-C4 
positions of sugar moiety (alanine scanning). The pink rectangle means original activities were retained 
at level 1 (<20%); the red rectangle means original activities were retained at level 0 (no activity). The 
olive green ‘WT’ indicates positive activity was detected in the WT (data from Chapter 3). 
Taken together, the MSA and SDM results indicated that 78D1 D374 is a ckAA that 
plays a significant role in Rha transfer (the original UDP-Rha and dTDP-Rha activities 
were significantly reduced to <1% by a D374 to A substitution), possibly interacting 
with Rha-O3 and Rha-O4. 
Further, N375 in 78D1 may act as a ckAA, as suggested by the observation that A 
substitution of N375 completely abolished the original UDP-Rha and dTDP-Rha 
activities. Based on the MSA results, the loss of UDP-Rha and dTDP-Rha activities 
can be explained by the possible role of N375 in 78D1 in Rha-O2 and Rha-O3 binding, 
with the alanine substitution eliminating the interaction between N375 and Rha. 
Notably, new UDP-Glc and UDP-GlcNAc activities were acquired by 78D1 (see MS 
in Appendix, Figure A.9) as a result of N375Q substitution, and the original Rha 
transfer activities were greatly simultaneously reduced (4.3% original UDP-Rha and 
1.2% original dTDP-Rha activity retained). This result implies the possible 
‘recognition role’ of the N residue, i.e. specifically recognising Rha. 
Thus far, no clear conclusion has been made on how UGT recognises and even 
discriminates between the different sugar donors. Although some studies present 
successful cases of donor specificity switching by point substitutions (e.g. H374Q of 
Aralia cordata UDP-Gal anthocyanin GalT successfully acquiring a UDP-Glc 
activity103), few studies successfully changed donor specificities of RhaTs and non-
RhaTs. 
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A comparison of 78D1 and 78D2 revealed that they belong to the same UGT group 
(Group F) and share a high AA identity (71%), suggesting that one of them may have 
arisen from the other via gene duplication during evolution. However, they function 
quite differently: 78D1 transfers Rha, while 78D2 transfers Glc and GlcNAc. MSA 
revealed different AA at 44th position within the PSPG motif in these enzymes: 78D1 
harbours N375 while 78D2 harbours Q381. 
Interestingly, according to previous studies, AA 44 within the PSPG motif may be 
associated with donor specificity recognition and discrimination. For example, many 
studies claim that Q is responsible for recognising Glc, while H is responsible for 
recognising Gal (discussed in Chapter 4). Thus, a question arises whether the fact that 
78D1 does not recognise and transfer Glc is because of the absence of Q as AA 44 
within the PSPG motif. If so, 78D1 N375Q would acquire UDP-Glc activity. This was 
subsequently proved by the observation that 78D1 N375Q exhibited UDP-Glc and 
UDP-GlcNAc activities, and the original UDP-Rha and dTDP-Rha activities were 
significantly attenuated. However, the discrimination between transferring Rha and 
Glc/GlcNAc cannot be fully accomplished by point substitution, as 78D2 Q381N did 
not acquire UDP-Rha/dTDP-Rha activity (c.f. Chapter 4). This paradox may be linked 
to the difficulty of substituting the entire set of sugar recognition AAs during evolution, 
with many key sugar recognition AAs located at other sites230. 
Apart from the discrimination of Rha and Glc by 78D1 and 78D2, previous studies 
also provided evidence that AA 44 within the PSPG motif might be associated with 
donor specificity. For example, 78D3 shares 75% AA identify with 78D2 but uses 
UDP-Arabinose (Ara). Ara is present in solution in the L-b form and compared with 
Glc lacks –OH at C6 position. In 78D3, AA 44 within the PSPG motif is H (site 386). 
A previous study demonstrated that 78D3 acquired new UDP-Glc activity when H was 
replaced with Q276, which was consistent with the result presented in the current 
chapter that UDP-Glc activity could be conferred on 78D1 by replacing of AA 44 
within the PSPG motif with Q.  
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UGT 89C1: ckAAs towards C2-C4-positions of sugar moiety 
Following the same methodology, D356 and H357 mutants of 89C1 were subjected to 
SDM, and their activities were examined (Figure 5.9). 
Figure 5.9: Relative activities of mutations (WT activity set as 100%) of ckAAs towards C2-C4 
positions of sugar moiety (alanine scanning). The pink rectangle means original activities were retained 
at level 1 (<20%); the red rectangle means original activities were retained at level 0 (no activity). The 
olive green ‘WT’ indicates positive activity was detected in the WT (data from Chapter 3). 
Based on the activity comparison between WT and mutants, and the MSA results, 
89C1 D356 may be the ckAA as an alanine substitution resulted in a pronounced 
reduction of the original activities (2.0% original UDP-Rha and 12% original dTDP-
Rha activities retained), with the possible role of binding Rha-O3 and Rha-O4. 
The analysis indicated that 89C1 H357 might also be a ckAA (no Rha transfer activity 
of H357A was detected), possibly binding Rha-O2 and Rha-O3 (based on MSA data). 
Moreover, 89C1 H357 revealed the Rha recognition and discrimination role of this 
residue: the enzyme gained the UDP-Glc activity upon H357Q substitution (see MS 
in Appendix, Figure A.10). However, the Rha transfer activity of 89C1 was not fully 
abolished by substituting H with Q, as H357Q retained 12% of the original UDP-Rha 
activity and 4.3% of the original dTDP-Rha activity. It is possible that some piecemeal 
assembly of smaller functional domains in 89C1 from the perspective of enzyme 
evolution that may aid in Rha recognition, and thus retention of a partial Rha transfer 
activity277. 
5.2.1.2 ckAAs towards C6 position of sugar moiety 
The binding pattern at the C6 position of the sugar moiety is a major difference 
between GlcTs and RhaTs. Since there is no –OH group at C6 position of Rha, no 
direct hydrogen bonds can be formed between RhaTs and C6 position of Rha.   
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Figure 5.10: MSA of potential ckAAs towardsC6 position of sugar moiety using templates of seven 
GlcTs (left) and SpnG (right). The colours of residues represent their different properties: small and 
hydrophobic amino acids AVFPMILW are coloured red, acidic amino acids DE are coloured blue, basic 
amino acids RK are coloured magenta, and hydroxyl/sulfhydryl/amine amino acids STYHCNGQ are 
coloured green. The last line of symbols denotes the degree of conservation: conserved (*), conserved 
mutations (:), semi-conserved mutations (.), and non-conserved mutations ().  
MSA analysis revealed that potential ckAAs towards C6 position of Rha are not 
conserved, with different results with different templates (Figure 5.10). When GlcTs 
were used as templates, 78D1 A141 and 89C1 P147 appeared at a site equivalent to 
VvGT1 T141 that is responsible for Glc-O6 binding. Since no hydrogen bonds can be 
formed between RhaTs and Rha, hydrophobic interactions may be mainly responsible 
for stacking the methyl group of C6263. This might explain why a handful of 
hydrophobic AAs appear in the vicinity of an equivalent site with potential ckAAs 
towards C6 position of Rha in 78D1 (136-WVAFWA-141) and 89C1 (143-ISFLPI-
148). Subsequent SDM supported the important role of 78D1 A141 and 89C1 P147, 
as 78D1 A141T and 89C1 P147A abolished all Rha transfer activity (GAR panel, not 
shown: Rha activity was completely abolished in both mutants and no new donor 
activity was acquired). The activity loss may be explained by the destruction of the 
hydrophobic environment. In addition, 78D1 A141 and 89C1 P147 may be located in 
a linker that may affect the conformation of nearby domains (discussed in Chapter 4), 
thus affecting the location of ckAAs that bind the acceptor and abolishing the original 
activity. 
A previous docking experiment of SpnG revealed the presence of the hydrophobic AA 
W142 near the methyl group at C6 position of Rha263. However, MSA analysis of 
SpnG and the target UGTs revealed no corresponding 78D1 and 89C1 AAs at sites 
equivalent to SpnG W142, which may be associated with a low conservation of ckAAs 
at C6 position and low sequence similarities of the N-terminal regions of the bacterial 
RhaT SpnG and plant RhaTs 78D1 and 89C1.  
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5.2.2 Identification of ckAAs: the phosphate moiety 
Since 78D1 and 89C1 use nucleoside sugar donors that contain phosphate, their 
ckAAs towards phosphate are expected to be conserved with other UGTs. As 
discussed in Chapter 4, possible ckAAs towards phosphate include T19, T280, and 
H350 (VvGT1 numbering). MSA analysis (Figure 5.11) revealed that 78D1 harbours 
A23, T280, and H350, while 89C1 harbours G20, S250, and H332, at the equivalent 
respective sites. 
 
Figure 5.11: MSA of potential ckAAs towards phosphate. The colours of residues represent their 
different properties: small and hydrophobic AAs AVFPMILW are coloured red; acidic AAs DE are 
coloured blue; basic AAs RK are coloured magenta; hydroxyl/sulfhydryl/amine AAs STYHCNGQ are 
coloured green. The last line symbols denote the degree of conservation: conserved (*), conserved 
mutations (:), semi-conserved mutations (.), and non-conserved mutations (). This Figure demonstrates 
the degree of conservation of three main ckAAs towards phosphate binding follow the sequence as 
H250 (VvGT1 numbering), T280 (VvGT1 numbering), and T19 (VvGT1 numbering).  
UGT 78D1: ckAAs towards phosphate moiety 
 
Figure 5.12: Relative activities of mutations (WT activity set as 100%) of ckAAs towards phosphate 
(alanine scanning). The pink rectangle means original activities were retained at level 1 (<20%); the 
red rectangle means original activities were retained at level 0 (no activity). The olive green ‘WT’ 
indicates positive activity was detected in the WT (data from Chapter 3). 
As shown in Figure 5.12, substitutions of potential ckAAs in 78D1 that might interact 
with phosphate significantly impaired the original enzyme activity. Given the high 
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degree of conservation at T280 and H350, it is not surprising that T280A and H350A 
substitutions greatly reduced the original activity. Based on MSA prediction, T280 
and H350 bound phosphate following the same pattern as that of VvGT1 (Figure 5.13). 
 
Figure 5.13: Phosphate binding site overlay of modelled 78D1 (blue) and crystal VvGT1 (tan) complex 
with U2F (PDB: 2C1Z). This Figure demonstrates 78D1 T280 and H350 are conserved to bind 
phosphate in the same manner as do VvGT1 T280 and H350. 
A23 is observed at a site equivalent to VvGT1 T19. A hydrogen bond cannot be formed 
between A and phosphate, in contrast to that between T and phosphate, as the side 
chain of A does not have a propensity to form hydrogen bonds. However, mutant 
A23T only retained 2.4% of the original UDP-Rha activity and <1% of the original 
dTDP-Rha activity, indicating the significant role of A23 in 78D1. One possible 
explanation is that 78D1 A23 may be positioned near the phosphate group, providing 
a proper hydrophobic environment for phosphate accommodation. Thus, the 
substitution altered the hydrophobic environment and affected the original enzyme 
activities. Further, the additional side chain of T may be too long for the active site, 
causing steric hindrance, and disrupting the interaction between 78D1 and the 
substrate. 
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UGT 89C1: ckAAs towards phosphate moiety 
 
Figure 5.14: Relative activities of mutations (WT activity set as 100%) of ckAAs towards phosphate 
(alanine scanning). The green rectangle means original activities were retained at level 4 (>80%); the 
yellow rectangle means original activities were retained at level 2 (20%-50%); the pink rectangle means 
original activities were retained at level 1 (<20%); the red rectangle means original activities were 
retained at level 0 (no activity). The olive green ‘WT’ indicates positive activity was detected in the 
WT (data from Chapter 3). 
At the equivalent ckAA site that is responsible for binding phosphate in template 
UGTs, 89C1 harbours G20, S250, and H332 (Figure 5.11). As indicated by MSA 
analysis, H is highly conserved and H332A substitution greatly reduced the original 
enzyme activities (5.5% of the original UDP-Rha activity and 3.3% of the original 
dTDP-Rha activity were retained). Hence, 89C1 H332 is regarded as a ckAA that may 
bind phosphate in the same manner as VvGT1 H350 (Figure 5.14).  
At the site equivalent to VvGT1 T280, 89C1 harbours S, which possesses similar 
characteristics to T. Although S and T have different structures (T has an additional 
CH3 group), the side-chain atoms N and OG of S can take the same positions as the 
side-chain atoms N and OG1 of T (Figure 5.15). This would indicate that S can interact 
with phosphate via a hydrogen bond. Subsequently, this hypothesis was confirmed by 
SDM data, since 89B1 S250A retained 29% of the original UDP-Rha activity and 22% 
of the original dTDP-Rha.  
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Figure 5.15: Phosphate binding site overlay of modelled 89C1 (coral) and crystal VvGT1 (tan) complex 
with U2F (PDB: 2C1Z). This Figure demonstrates 89C1S250 and H332 binds phosphate in the same 
manner as do VvGT1 T280 and H350. 
The least conserved AA in 89C1 is G20. As an AA without any side chain, G probably 
does not interact with the substrate directly. Thus, most likely, G20 is not a ckAA 
interacting with phosphate; this was consistent with SDM revealing no activity loss 
by G20A. In fact, the enzyme activity was slightly enhanced in G20A. This may be 
because the nucleoside is always stacked in a hydrophobic environment and alanine 
substitution increased the degree of hydrophobicity of the environment. 
5.2.3 Identification of ckAAs: the uridine moiety 
As already mentioned, two AAs are responsible for binding uridine moiety in template 
UGTs: AAs 1 (conserved W) and 27 (conserved E) within the PSPG motif. Based on 
the MSA analysis (Figure 5.16), the potential ckAAs that interact with uridine at 
equivalent sites are also conserved in 78D1 and 89C1: both of them are W and E as 
the AAs 1 and 27, respectively, within the PSPG motif. 
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Figure 5.16: MSA of potential ckAAs towards uridine. The colours of residues represent their different 
properties: small and hydrophobic AAs AVFPMILW are coloured red; acidic AAs DE are coloured 
blue; basic AAs RK are coloured magenta; hydroxyl/sulfhydryl/amine AAs STYHCNGQ are coloured 
green. The last line symbols denote the degree of conservation: conserved (*), conserved mutations (:), 
semi-conserved mutations (.), and non-conserved mutations (). This Figure demonstrates the two 
potential ckAAs towards uridine are located in the 1st and 27th position within the PSPG motif with a 
high degree of conservation. 
 
UGT 78D1: ckAAs towards the uridine moiety 
 
Figure 5.17: Relative activities of mutations (WT activity set as 100%) of ckAAs towards uridine 
(alanine scanning). The pink rectangle means original activities were retained at level 1 (<20%); the 
red rectangle means original activities were retained at level 0 (no activity). The olive green ‘WT’ 
indicates positive activity was detected in the WT (data from Chapter 3). 
Figure 5.17 shows the results of SDM analysis of potential ckAAs interacting with 
uridine in 78D1. Substitutions of both W332 and E358 greatly reduced the original 
enzyme activity (W332A retained <1% of the original UDP-Rha and dTDP-Rha 
activities; E358A retained 14% of the original UDP-Rha activity and 6.4% of the 
original dTDP-Rha activity). This indicated that W332 and E358 are important for 
enzyme activity, probably by binding uridine in the same manner as template UGTs, 
as suggested by MSA analysis. Further, this suggested that W332 might interact with 
the uracil ring by pi-pi interaction, with E358 interacting with ribose via hydrogen 
bonds (Figure 5.18). Moreover, substitution of W had a greater effect on enzyme 
activity than that of E, indicating that the impact of binding between W and the uracil 
ring may be greater than that of hydrogen bond formation between E and ribose.   
                                                           Chapter 5 
 206 
Figure 5.18: Uridine binding site overlay of modelled 78D1 (blue) and crystal VvGT1 (tan) complex 
with U2F (PDB: 2C1Z). The hydrogen bonds of VvGT1 and model UGTs towards U2F is represented 
by a solid and dash line respectively due to the interaction between VvGT1 and U2F being measured in 
crystal and the interaction between model UGTs and U2F being putative. This Figure demonstrates 
78D1 W332 and E358 binds uridine in the same manner as VvGT1 W332 and E358. 
UGT 89C1: ckAAs towards the uridine moiety 
 
Figure 5.19: Relative activities of mutations (WT activity set as 100%) of ckAAs towards uridine 
(alanine scanning). The pink rectangle means original activities were retained at level 1 (<20%); the 
red rectangle means original activities were retained at level 0 (no activity). The olive green ‘WT’ 
indicates positive activity was detected in the WT (data from Chapter 3). 
Alanine substitutions of 89C1 W314 and E340 (Figure 5.19) significantly reduced its 
original activity: 89C1 W314A retained 3.6% and 2.9% of the original UDP-Rha and 
dTDP-Rha activities, respectively; 89C1 E340A retained 15% and 17% of the original 
UDP-Rha and dTDP-Rha activities, respectively. Taken together with the MSA data, 
the reduction of activities by these substitutions may be associated with W314 and 
E340 binding to uracil and ribose, respectively, as the corresponding residues in 
VvGT1 (Figure 5.20). Further, A substitution of W resulted in a greater reduction of 
enzyme activity than that of E, which is consistent with the analysis of 78D1. This 
suggests that the pi-pi binding between W and the uracil ring plays a more significant 
role in the enzyme activity than that of E. 
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Figure 5.20: Uridine binding site overlay of modelled 89C1 (coral) and crystal VvGT1 (tan) complex 
with U2F (PDB: 2C1Z). The hydrogen bonds of VvGT1 and model UGTs towards U2F is represented 
by a solid and dash line respectively because the interaction between VvGT1 and U2F is measured in 
crystal and the interaction between model UGTs and U2F is putative. This Figure demonstrates 
89C1W314 and E340 binds uridine in the same manner as VvGT1 W332 and E358. 
Apart from UDP, 78D1 and 89C1 can also transfer Rha from dTDP. The structures of 
dTDP and UDP differ: dTDP has an additional CH3 group at the C5 position of uracil 
and lacks an –OH group at the 2¢ position of ribose (Figure 5.21). Based on the results 
described above, both W and E play significant roles in dTDP-Rha activity, indicating 
that the potential ckAAs that interact with both UDP and dTDP may be conserved in 
78D1 and 89C1. This suggests that the additional CH3 group at the C5 position of 
uracil may not affect the formation of pi-pi interaction between W and the thymine 
ring, and the absence of –OH group at the 2¢ position of ribose may not disrupt the 
hydrogen bonding effect between E and 3¢ of ribose (Figure 5.21).  
 
Figure 5.21: Putative UDP or dTDP binding site in 78D1 model. The structural difference of UDP has 
been highlighted in the yellow circle. This figure demonstrates how dTDP is tolerated in the active site 
of 78D1: the additional CH3 group at C5 of the uracil ring in dTDP does not affect its pi-pi interaction 
with W. The missing –OH group at 2’ of ribose disconnects its hydrogen bond towards E, but the 
hydrogen bond between 3’ of ribose and E remains. 
The model proposed above is supported by some examples. For instance, SpsA shows 
compatibility with UDP and dTDP sugars163. In the crystal structure of the SpsA+UDP 
complex, the uracil ring is stabilised by an aromatic AA (F233) via pi-pi interaction 
and ribose is bound to a negatively charged AA (D98) via hydrogen bond163, showing 
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the same binding pattern as template GlcTs. When dTDP was docked in the active site 
of SpsA, SpsA appeared to pose no steric barrier to dTDP occupying the place of 
UDP163: the additional methyl group of dTDP is easily accommodated within the 
nucleotide-binding pocket and flanked on one side by the aromatic ring of F233; the 
3¢ of ribose bound D98 in the same manner as that observed for UDP. 
5.2.4 Homology model validation 
As introduced in Chapter 4, a model is a good way to visualise the interaction between 
the enzyme and substrate, although it was not used to guide the design of the 
experiments. As discussed in Chapter 4, C-terminal models of 78D1 and 89C1 were 
constructed using the SWISS-MODEL249 program and the template UGTs that shared 
the highest percentage of identical AAs (Figure 5.22). 
  
Figure 5.22: Homology modelling zone validation of 78D1 and 89C1. Left: Limit for the homology 
modelling defined by Rost (1999). The location of ‘X’ means the point of the modelling zone different 
target UGTs locate. They are represented by different colours corresponding to the name of the UGT 
shown in the table (right). All target UGTs are located in the safe homology modelling zone. Right: 
The percentage of identical residues between target and template UGT and the number of aligned 
residues of target UGT. 
As shown above, the combinations of the percentage of identical AAs and the number 
of aligned AAs in both 78D1 and 89C1 fell in the ‘safe homology modelling zone’, 
by using VvGT1 and 72B1 as templates, respectively. This meant that homology 
modelling could indeed be applied for the template and target proteins250.   
Table 5.3: Scoring of model quality validation 
Model Template QMEAN Residues in outlier region (Ramachandran plots) 
78D1 VvGT1  -0.44 -  
89C1 72B1 -2.76 I296 
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The qualities of 78D1 and 89C1 models (C-terminal) were determined. They both 
exhibited QMEAN scores that were in the recommended region in the Swiss-Model 
program (-4.00 to +4.00). More than 99% of all AAs were located in the allowed 
regions of Ramachandran plots. Every AA investigated in this chapter was in the 
allowed area based on Ramachandran plots. This scoring demonstrates the reliability 
of the constructed 78D1 and 89C1 models. Thus, the overlaying of target UGTs on 
template UGTs was reasonable and enabled useful interpretation of the SDM data.  
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5.3 Conclusions 
As demonstrated in the current Chapter, 78D1 and 89C1 showed dual activities of 
UDP-Rha and dTDP-Rha (with KMP as the acceptor). The results of the MSA and 
SDM analyses were used to investigate the ckAAs of 78D1 and 89C1 (Figures 5.23 
and 5.24). 
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The proposed active site of 78D1 is summarised in Figure 5.23. The potential ckAAs 
were deduced from MSA analysis. The levels of significance (shown by different 
colours) of the potential ckAAs are indicated by the percentage of the retained original 
activities in alanine mutants. Based on MSA, D374 and N375 might bind Rha; W332 
and E358 probably bind uridine; and A23, W332, and H350 might interact with 
phosphate. Subsequently, SDM suggested that these potential ckAAs greatly affected 
enzyme activity (<20% of the original enzyme activities were retained by the alanine 
mutants) and could be regarded as ckAAs.  
Furthermore, UDP-Rha and dTDP-Rha activities of 78D1 were successfully changed 
to UDP-Glc and UDP-GlcNAc activities, respectively, by substituting of N375 with 
Q. 
 
Figure 5.23: Potential ckAAs in 78D1 towards UDP-Rha and dTDP-Rha. The level of significance of 
potential ckAAs (from MSA) is based on the experimental results of alanine scanning and is indicated 
by colour: Level 0, Very Strong (alanine mutants retained original activity 0%, in red); Level 1, Strong 
(alanine mutants retained original activity <20%, pink); Level 2, Medium (alanine mutants retained 
original activity 20~50%, in yellow); Level 3, Weak (alanine mutants retained original activity 51~80%, 
in light green); Level 4, Very Weak/No (alanine mutants retained original activity >80%, in green).  
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Similarly, the active site of 89C1 is proposed in Figure 5.24. The MSA analysis 
suggested the potential ckAAs. The percentage of the retained original activities in 
alanine mutants reflected the level of significance (shown by different colours). In 
summary, MSA analysis suggested that D356 and H357 are involved in Rha binding; 
W314 and E340 interact with uridine; and G20, S250, and H332 bind phosphate. 
Subsequent SDM analysis substantiated the notion that the AAs might be ckAAs 
(except for G20 and S250) as <20% of the original enzyme activities were retained by 
alanine mutants.  
Furthermore, UDP-Glc activity was successfully conferred by the H357 point 
substitution. 
 
Figure 5.24: Potential ckAAs in 89C1 towards UDP-Rha and dTDP-Rha. The level of significance of 
potential ckAAs (from MSA) is based on the experimental results of alanine scanning and is indicated 
by colour: Level 0, Very Strong (alanine mutants retained original activity 0%, in red); Level 1, Strong 
(alanine mutants retained original activity <20%, pink); Level 2, Medium (alanine mutants retained 
original activity 20~50%, in yellow); Level 3, Weak (alanine mutants retained original activity 51~80%, 
in light green); Level 4, Very Weak/No (alanine mutants retained original activity >80%, in green).
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Final Conclusions 
In this project, an MS-based method was developed to explore UGTs’ substrate 
specificity and kinetics. Additionally, MSA using template UGTs with crystal 
structures was employed to investigate the ckAAs in target UGTs.  
The MS-based method was developed in the study of WT recombinant UGTs from 
group B, D, F, H and L as the models (Chapter 3): ‘full scan’ mode of the MS was 
used to screen the potential glycosylated product after reaction; ‘product ion’ mode of 
the MS was used to confirm the formation of the glycosylated product; ‘multiple 
reaction monitoring’ (MRM) mode was used to quantify the formation of the 
glycosylated product as a function of reaction time. New activities were discovered 
(e.g. UDP-GlcNAc activity for 73B4 and 78D2 and dTDP-Rha activity for 78D1 and 
89D1). Kinetic parameters not only revealed the catalytic capability and efficiency of 
specific UGTs, but also indicated the kinetic mechanisms (determined by the KM ratio; 
e.g. GlcTs generally adopted a Bi-Bi random mechanism. 73B4 showed a donor 
dependent kinetic mechanism). The details of the full kinetic characterisation of tested 
UGTs were firstly described, providing clues to their metabolism in vivo and their use 
as biocatalysts in potential further applications such as glycoconjugates synthesis.  
Due to the lack of structural information, MSA with existing crystal availability is 
probably one of the fastest approaches to understand ckAAs in target UGTs without 
crystallography data. By comparing target UGTs and seven template UGTs with 
known crystal structures, the potential ckAAs towards the donor (the C2, C3, C4 and 
C6 positions of sugar, phosphate and nucleotide base), were indicated. Subsequent 
alanine screening or similar AA swapping in the site of potential ckAAs (by SDM) 
substantiated/disproved the role of potential ckAAs. These findings showed that most 
potential ckAAs were conserved (especially those ckAAs within the PSPG motif) and 
might follow a similar or the same interaction pattern with template UGTs, in which 
alanine mutants showed a significant reduction in their original activity. However, a 
few (e.g. 78D2 D380, 73B5 Q398 and 89B1 Q390) did not follow the same trend, as 
their alanine mutants retained most activity, probably suggesting the catalytic 
mutation occurred during evolution. With a combination of MSA and SDM, this 
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project not only presented a systematic active site analysis of UGTs, but also showed 
the significance of specific ckAAs in active sites for individual UGTs (e.g. Figure 
4.33), by means of experimentally-determined data, and shed light on the 
understanding of UGTs’ active sites and gave detailed ckAAs information of specific 
UGTs.  
Furthermore, we were also particularly interested in individual UGTs with specific 
functions. 78D1 and 89C1 transfer Rha rather than the Glc as do most UGTs. This 
project revealed that ckAAs in the RhaTs 78D1 and 89C1 followed a very similar 
interaction pattern to the GlcTs. Additionally, one of the ultimate targets is to 
manipulate GT activity freely based on an understanding of its ckAAs, as this will 
provide broader catalytic tools with desired activity. In this project, point mutagenesis 
on 78D1 N375Q acquired new UDP-GlcNAc and UDP-Glc activity, and on 89C1 
H357Q acquired new UDP-Glc activity. Although the ckAAs for conferring sugar 
selectivity are still under investigation, the new activity shed fresh light on the active 
site manipulation with the UGTs.  
In summary, the project not only provided specific knowledge of the individual GTs 
that have been tested, but also shed light on systematic understanding of UGTs, laying 
the foundation for a study of glycan structures and functions (especially in plants) as 
well as developing technologies with potential commercial value.
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Future work 
Although the aims setup in the beginning have been achieved, there are still many 
interesting questions and problems which arose during the study. We hereby propose 
the following areas to continue in this study.  
1) To explore the in vitro activity of UGTs that showed no activity in the current setup. 
This will probably involve the optimisation of the experimental conditions (such as 
buffer, pH, temperature), checking protein folding (using CD) and using broader 
libraries (e.g. UDP-Xylose, UDP-Arabinose). Some of the current kinetic results will 
need to be optimised with a substrate range of 1/5-5KM as discussed in Chapter 3. The 
in vivo function in plants will also be investigated (e.g. using gene knockouts). 
2) To obtain crystal structures of representative UGTs, especially the complex with 
substrates in the active site. For example, 78D2 is an interesting enzyme, as it showed 
a broad range of donor specificity and relatively was not highly conserved in terms of 
its catalytic effects at some sites. Other interesting UGTs included 73B4 (dual activity 
with UDP-Glc and UDP-GlcNAc), 78D1 and 89C1 (dual activity with UDP-Rha and 
dTDP-Rha) and 73C5 (dual activity with UDP-Glc and UDP-Gal) due to their broad 
range of activities.  
3) To continue exploring the ckAAs towards specific sites. A deeper understanding of 
the active site lays the foundation for a rational active site manipulation of UGTs with 
desired activities, which is crucial for the development of UGT genetic engineering. 
Some areas are recommended for further exploration: A) ckAAs towards the C6 
position of the sugar moiety. As shown in Chapter 4, ckAAs towards the C6 position 
of the sugar were not highly conserved and MSA might not provide an accurate result 
due to the relatively low conservation in the N-terminal domain. Thus, manual MSA 
and the adjacent 5-10 AAs in the vicinity of the tested site in this project should be 
investigated; B) ckAAs towards the C2-C4 positions of the sugar moiety. As shown 
in Chapter 4, ckAAs towards these positions of sugar are significant as they 
determined the enzyme activity by interacting with the sugar moiety predominantly. 
In addition, this might relate to donor recognition and discrimination as donors differ 
mostly in the C2-C4 positions (e.g. Glc and GlcNAc). The identification of ckAAs 
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that ‘recognise’ a donor might expand to a region (by technology such as ‘domain 
swapping’) rather than a single ckAA.  
Apart from these interesting areas, related experiments need to be optimised. For 
example, some technologies such as circular dichroism should be used to make sure 
that the point mutagenesis does not affect the stability and overall conformation of the 
protein. Detailed kinetic parameters (e.g. KM and Kd) of the mutants should be 
measured to confirm the specific role of ckAAs (binding AA or catalytic AA), which 
could be achieved by associating with other technologies (e.g. Isothermal Titration 
Calorimetry, molecular docking and dynamic simulation studies)
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Appendix 
A.1 Bi-Bi enzymatic reaction kinetic equations 
For Bi-Bi enzymatic reactions under steady-state assumptions, an ordered sequential 
reaction in both directions is:  
 
Figure A.1: Bi-Bi ordered sequential enzymatic mechanism. A, B: substrates; E: enzyme; P, Q: products. 
EAB: enzyme – substrate A – substrate B central complex; EPQ: enzyme – product P – product Q 
complex. 
The velocity of the reaction is given: 
, = -.-/-0-1 23 [5][7]8-9.-9/-90-91 23 [:][;]-9.-1 -/+-0 +-.-1 -9/+-0 5 +-/-0-1 7 +-.-/-90 5 :+-90-91 -9.+-9/ : ; +-/-90-91 7 : ; +-.-/-90 5 7 :+-.-/ -0+-1 5 7 +-/-0-91 7 ; +-9.-9/-90 : + -9/+-0 ; 																														 Equation 
A.1 
For the initial velocity study, the product formation is very limited, i.e., [P]=[Q]=0. 
The equation can be simplified: 
, = =>?@ 5 [7]AB5A7+A7 5 +A5 7 + 5 [7]																																																																																	Equation A.2  
Where 
CDE = F9GFG : inhibitor parameter of enzyme-substrate A; 
CE = FHFIFJFG(FHFI+FHFJ+FIFJ+FIF9J): Michaelis parameter of substrate A; 
CM = FI(F9NFH+F9NF9J+FHFJ)FN(FHFI+FHFJ+FIFJ+FIF9J) : Michaelis parameter of substrate B; 
OPQR = FHFIFJFHFI+FHFJ+FIFJ+FIF9J ∗ [S] : maximum velocity reaction. 
In reciprocal form ([B] is varied at fixed [A]), 
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., = A7=>?@ . + AB55 .7 + .=>?@ . + A55 																																																											 Equation A.3  
A random sequential mechanism, where the sequence of substrates binding with 
enzymes does not follow a compulsory order, has the following reaction schema: 
 
Figure A.2: Bi-Bi random sequential enzymatic mechanism. A, B: substrates; E: enzyme; P, Q: products. 
EAB: enzyme – substrate A – substrate B central complex; EPQ: enzyme – product P – product Q 
complex. 
In the random sequential mechanism, the first binding step of one substrate towards 
an enzyme does not create an active enzyme complex. The transitory complex (EA 
complex or EB complex) will transfer to be active only when the co-substrate binds 
(Figure A.2). Hence, the first binding step is characterised by a pure dissociation 
parameter for the specific substrate. Due to the alternate reaction pathways, the 
random mechanism is defined by complex rate equations. Under the steady state 
assumption, a random Bi-Bi system will be defined by a very complicated rate 
equation. If there are no unusual rate constants, the random Bi-Bi system will appear 
as a rapid equilibrium random system278. The equation of Bi-Bi random sequential 
system can be simplified and made identical to that for the steady state ordered Bi-Bi 
system.  
A.2 Confirmation of positive substrate specificity 
Figures A.3, A.5 and A.6 show how the positive substrate specificities were confirmed 
using 78D2 as an example. 
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Figure A.3: MS of 78D2 positive activity with UDP-Glc. Peak at 447 in ‘full scan’ mode represents the 
product KMP-Glc, which fragments back to peak 284 (the aglycone) in ‘product ion’ mode. This 
chromatography is representative of other experiments with positive activity with UDP-Glc. 
Figure A.3 demonstrates the positive activity of 78D2 towards UDP-Glc. In the 
negative-ion mode, the deprotonated molecular ions [M-H+]- are usually the most 
abundant species. Thus, a peak of 447 [KMP+Glc-H+]- revealed the presence of KMP-
Glc. In some cases, the predominant ions were always accompanied by some salt 
adducts and, possibly, traces of dimeric or doubly charged materials. However, in this 
figure, these ions are too small to be observed. 
Subsequent ‘product ion’ mode captured the ions of KMP-Glc (447) and fragmented 
them at a collision energy of 10 eV. Ions of 284/285 were observed, indicating the 
breaking of glycosidic bonds and the production of the aglycone (KMP). 
Consequently, the positive activity of 78D2 towards UDP-Glc was confirmed. 
In ‘product ion’ mode, the predominant fragment was the m/z of the aglycone, i.e. 
KMP, which should give a peak of 285. However, a peak of 284 was also produced. 
This phenomenon indicated the glycosidic bond of KMP-Glc, when catalysed by 
78D2, might be broken in distinct cleavage ways, i.e. homolytically and heterolytically. 
As introduced in Chapter 1, collision energy-induced homolytic or heterolytic 
cleavage might happen in negative electrospray ionisation tandem QQQ-MS for 
glycosylated flavonoids279. Thus, the fragments at 285 [(KMP-Glc – Glc-H+)-] and 284 
[(KMP-Glc – Glc-H+ – H*)-] were produced via heterolytic and homolytic cleavage of 
glycosidic bond respectively.  
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Apart from the predominant ions of KMP (284/285), ions of 227 and 255 were also 
observed. Previous studies showed that flavones generally exhibited neutral losses of 
CO (except genkwanin) that might possibly be attributed to the C ring279, which 
explained the peak at 255 representing the ion [KMP-H-CO-H*]- and the peak at 227 
representing the ion [KMP-H-2CO-H*]- (Figure A.4). 
 
Figure A.4: Proposed fragmentation from KMP 
Apart from UDP-Glc, 78D2 also showed positive activity towards UDP-Gal (Figure 
A.5 right), UDP-GlcNAc (Figure A.5 left) and GDP-Glc (Figure A.6), which were 
also confirmed in ‘full scan’ mode and ‘product ion’ mode of MS. 
 
Figure A.5: MS of 78D2 positive activity with UDP-GlcNAc (left) and UDP-Gal (right). Peak of 
488/447 in ‘full scan’ mode represents the product KMP-GlcNAc/KMP-Gal, which fragments back to 
peak 285 (aglycone) in ‘product ion’ mode. This chromatography is representative of other experiments 
with positive activity for UDP-GlcNAc and UDP-Gal. 
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Figure A.6: MS of 78D2 positive activity with GDP-Glc. Peak at 447 in ‘full scan’ mode represents 
product KMP-Glc, which fragments back to peak 284 (aglycone) in ‘product ion’ mode.   
Figures above demonstrate the confirmation of activity of 78D2 towards UDP-
GlcNAc, UDP-Gal and GDP-Glc, with the ions of the Glycosylated-KMP (KMP-
GlcNAc, KMP-Gal and KMP-Glc respectively) detected at 448, 447 and 447 
respectively in ‘full scan’ mode of MS. Subsequently, the ‘product ion’ mode of MS 
showed that the aglycone KMP was observed, indicating that the glycosidic bonds of 
the Glycosylated-KMP were broken. 
A.3 MS of RhaTs 
 
Figure A.7: MS of 78D1 positive activity with UDP-Rha (left) or dTDP-Rha (right) as donors. The 
product KMP-Rha is displayed as peak 431.00 in the negative-ion mode of MS. The ‘product ion’ 
shows that the product peak 431.00 can be fragmented into the aglycone fragment (284.90). 
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Figure A.8: MS of 89C1 positive activity with UDP-Rha (left) or dTDP-Rha (right) as donors. The 
product KMP-Rha is displayed as peak 431.00 in the negative-ion mode of MS. The ‘product ion’ 
mode shows the product peak 431.00 can be fragmented into the aglycone fragment (284.90). 
 
Figure A.9: MS of 78D1 N374Q positive activity with UDP-Glc (left) or UDP-GlcNAc (right) as donors. 
The products KMP-Glc and KMP-GlcNAc are displayed as peak 447.00 and 488.00 respectively in the 
negative-ion mode of MS. The ‘product ion’ mode shows the product peak can be fragmented into the 
aglycone fragment (284.10/284.90). 
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Figure A.10: MS of 89C1H357Q positive activity with UDP-Glc. The product KMP-Glc is displayed 
as peak 447.00. The ‘product ion’ mode of MS shows the peak of 447.00 can be fragmented as aglycone 
284.20. 
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